WO2016088996A1 - Composition, using natural extracts, for treating and preventing periodontal diseases - Google Patents

Composition, using natural extracts, for treating and preventing periodontal diseases Download PDF

Info

Publication number
WO2016088996A1
WO2016088996A1 PCT/KR2015/010428 KR2015010428W WO2016088996A1 WO 2016088996 A1 WO2016088996 A1 WO 2016088996A1 KR 2015010428 W KR2015010428 W KR 2015010428W WO 2016088996 A1 WO2016088996 A1 WO 2016088996A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
composition
vitamin
periodontal disease
treating
Prior art date
Application number
PCT/KR2015/010428
Other languages
French (fr)
Korean (ko)
Inventor
우진오
정동균
이대정
Original Assignee
주식회사 제이앤케이 글로벌리소스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 제이앤케이 글로벌리소스 filed Critical 주식회사 제이앤케이 글로벌리소스
Publication of WO2016088996A1 publication Critical patent/WO2016088996A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras

Definitions

  • the present invention relates to a composition for the treatment and prevention of periodontal disease using a natural extract, and more specifically, because the composition for the treatment and prevention of periodontal disease using a natural extract can be used in combination with dental treatment in the treatment of periodontal disease. It relates to a composition for the treatment and prevention of periodontal disease using a natural extract that can be helpful and can be taken long-term without resorting to antibiotics.
  • Republic of Korea Patent Publication No. 10-0431170 is a composition for the treatment of periodontal disease containing plant extracts, cinnamon, missing, Hojang-geun, gojija, bokbunja, eoseongcho, browning, dansam extract selected from the group of 1 or 2 It provides a composition for treating periodontal disease containing more than one species as an active ingredient, excellent plant growth inhibitory activity of periodontal disease-causing bacteria, plant extracts excellent in inhibiting activity of proteolytic enzymes secreted by periodontal disease-causing bacteria
  • the present invention discloses a composition for treating periodontal disease, which is excellent in treating periodontal disease.
  • Republic of Korea Patent Publication No. 10-1358507 relates to a composition for anti-inflammatory, antibacterial and deodorant in the oral cavity containing red ginseng and natural plant-derived extracts, oral with anti-inflammatory, antibacterial and deodorant effects derived from red ginseng and natural plants It discloses a composition for anti-inflammatory, antibacterial and deodorant and a method for preparing the same.
  • Korean Laid-open Patent Publication No. 10-2012-0117387 relates to oral compositions for preventing and alleviating gum disease, which is beneficial to gum and dental health such as kelp, shiitake mushroom, green tea extract, tocopherol, and propolis. It discloses a composition for oral cavity having the gum and dental health and oral cleansing effect using the ingredients as a raw material.
  • Natural extracts namely, the treatment and prevention of periodontal disease using plant extracts have been developed a lot, but the composition for the prevention and treatment related to chronic periodontal disease or peri-implantitis has not been developed yet, and treatment and prevention effect of periodontal disease At the same time, it helps to form bones and includes functional elements that enhance immunity, thus maximizing the effect of periodontal disease treatment, and treating and preventing periodontal disease effective treatment for chronic periodontal disease and peri-implantitis. It wasn't.
  • the purpose of one embodiment of the present invention is to use the natural extracts to prepare a composition for the treatment and prevention of periodontal disease because it can be used in conjunction with dental treatment periodontal periodontal It is to provide a composition for treating and preventing periodontal disease using a natural extract that can be useful for the treatment of the disease, and can be taken for a long time without resorting to antibiotics. More specifically, calcium, avocado extract, corn extract and vitamin C and bone soluble propolis extract, corn extract, cinnamon and vitamin C, which help bone formation, and thistle extract to help boost immunity.
  • composition for the treatment and prevention of periodontal disease is prepared to include all of vitamin B1, vitamin B2 and vitamin B6. It is an object of the present invention to provide a composition for the treatment and prevention of periodontal disease using natural extracts effective for the prevention and treatment of patients.
  • one embodiment of the present invention is calcium, avocado extract, water soluble propolis extract, corn extract, cinnamon extract, thistle extract, vitamin C, vitamin B1, vitamin B2 And it provides a composition for the treatment and prevention of periodontal disease using a natural extract, characterized in that it comprises a vitamin B6.
  • Composition for treating and preventing periodontal disease using the natural extract is calcium 35 to 60% by weight, avocado extract 0.5 to 7% by weight, water soluble propolis extract 5 to 25% by weight, corn extract 2 to 15% by weight, cinnamon extract 0.5 to 7 wt%, thistle extract 2-15 wt%, vitamin C 1-10 wt%, vitamin B1 0.01-0.3 wt%, vitamin B2 0.01-0.3 wt% and vitamin B6 0.01-0.3 wt% You can do
  • composition for the treatment and prevention of periodontal disease using the natural extract may be characterized in that the addition of any one or more from the group consisting of additives consisting of silicon dioxide, magnesium stearate, crystalline cellulose and a color coating agent in the form of a tablet form. have.
  • composition for treating and preventing periodontal disease using natural extracts is a composition for treating and preventing periodontal disease that can be ingested in parallel with dental treatment, and can be ingested at the same time as treatment with dental treatment. It can help prevent periodontal disease and treat periodontal disease.
  • periodontal disease which is composed of natural extracts, not antibiotics or chemical raw materials, it can minimize the side effects that can occur in the human body due to the abuse of antibiotics, and can be taken for a long period of time periodontal disease As well as preventing and can increase the treatment effect of periodontal disease.
  • Composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention including all three components that are excellent in bone formation function, immune function enhancement function, periodontal inflammation prevention and treatment functions required for dental care Because of this, the effect of preventing and treating periodontal disease is excellent.
  • compositions for treating and preventing periodontal disease only with ingredients such as water-soluble propolis extract, corn extract, cinnamon extract and vitamin C, which help to strengthen the alveolar bone and periodontal ligament around teeth, Since the ingredient for promoting bone formation and the ingredient for enhancing immunity were added together to prepare a composition for the treatment and prevention of periodontal disease, the effect of preventing and treating periodontal disease than the existing composition for treating and preventing periodontal disease Has the advantage of being superior.
  • 1 is a questionnaire of the questionnaire conducted for the adjuvant composition for treatment and prevention of periodontal disease according to an embodiment of the present invention.
  • 2 and 3 is a periodontal disease that occurs when two or more weeks of taking the drug W recipe (Recipe W) prepared with the adjuvant composition for treatment and prevention of periodontal disease according to an embodiment of the present invention among the results of the treatment evaluation test It is a graph showing the decrease rate of the 11 bacterial bacteria causing disease.
  • 6 and 7 are graphs showing the reduction rate of treponema denticola (Td) and parvimonas micra (Pm) of the results of the treatment evaluation test.
  • composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention (hereinafter, also referred to as 'composition for treating and preventing periodontal disease'), calcium, avocado extract, water-soluble propolis extract, corn extract, cinnamon It may be characterized by including the extract, thistle extract, vitamin C, vitamin B1, vitamin B2 and vitamin B6.
  • Three functions that are essential for the prevention and treatment of periodontal disease during dental care are bone formation, prevention and treatment of periodontal inflammation, and immunity enhancement.
  • Ingredients such as calcium, avocado extract, corn extract, and vitamin C have a strong bone-forming effect because they help to maintain and secure implant prostheses, helping to prevent and treat inflammation around the implant.
  • ingredients such as water soluble propolis extract, corn extract, cinnamon extract and vitamin C are effective in preventing or treating periodontitis because they strengthen the alveolar bone and periodontal ligament around teeth.
  • ingredients such as thistle extract, vitamin B1, vitamin B2 and vitamin B6, help to boost the body's overall immunity, and in particular, the components that help the liver function, which directly helps skin inflammation, especially vitamin B
  • the group is excellent in boosting immunity because it helps nutritional and metabolic disorders and helps prevent and treat periodontal disease.
  • the composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention is calcium, avocado extract, water-soluble propolis extract, corn extract, cinnamon extract, thistle extract, vitamin C, vitamin B1, vitamin B2 and Since it contains vitamin B6, it helps to form bones, prevents and treats periodontal inflammation, and because immunity is strengthened, it is necessary ingredients.
  • the composition for treating and preventing periodontal disease there is an advantage that the prevention and treatment effect of periodontal disease is superior to the existing periodontal disease treatment and prevention composition.
  • Composition for treating and preventing periodontal disease using a natural extract calcium 35 to 60% by weight, avocado extract 0.5 to 7% by weight, water soluble propolis extract 5 to 25% by weight, corn extract 2 to 15% by weight, cinnamon extract 0.5-7%, thistle extract 2-15%, vitamin C 1-10%, vitamin B1 0.01-0.3%, vitamin B2 0.01-0.3% and vitamin B6 0.01-0.3% It may be characterized by comprising a%.
  • Calcium is a component of the skeleton and teeth, 99% of the calcium content in the body is present here, and is also involved in maintaining the normal function of muscles and nerves. In addition, it regulates the contraction and relaxation of skeletal muscle and myocardial cells, and is a nutrient essential for the action of many enzymes associated with blood coagulation. Bone is composed of osteoblasts and osteoclasts (Osteoclast) cells, osteoblasts secrete collagen to form a support structure of bone, osteoblasts mature into osteocytes (Osteocytes) and cause calcification of bones. Therefore, the more calcium intake is maintained in the blood calcium concentration, calcium can be used for bone formation.
  • Ostoclast osteoblasts and osteoclasts
  • osteoclasts are stimulated by parathyroid hormones and are greatly activated when a diet is low in calcium, and the activated osteoclasts release calcium from the bone and enter the blood. Lowering calcium levels in the blood promotes the activation of osteoclasts. Since bone is formed and degraded by bone turnover (Bone remodeling) of osteoblasts and osteoclasts, calcium intake is important for bone formation and maintenance.
  • calcium is preferably contained in 35 to 60% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract.
  • This is a content set according to the functional labeling functional dietary standard, according to the functional labeling functional food is known that the calcium content is 220 to 660mg per day.
  • the composition when the composition contains less than 35% by weight of calcium relative to the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and the weight of components other than calcium Considered together, the calcium content contained in the composition for treating and preventing periodontal disease is lower than the lowest daily intake content according to the functional food functional labeling standards, there is a fear that the effect of calcium is not properly expressed.
  • Excessive calcium intake causes Nephrolithiasis, Milk-alkali syndrome, which is caused by the ingestion of milk and absorbent alkaline gels for a long time, with or without hypercalcemia and alkalosis. It may cause adverse effects such as moderate alkalosis, abnormal serum phosphatase levels, severe renal failure with hypertension and calcification, and problems with calcium-mineral interactions.
  • the calcium is preferably contained in 35 to 60% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts.
  • calcium may be used to prepare a composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention using calcium phosphate, but other types of calcium may be used.
  • avocado Persea americana Mill
  • avocado contains 18.7 g of fat, 720 mg of potassium, 0.21 mg of vitamin B2, 61.90 mg of vitamin C, 71.80 mg of vitamin B6, 1.34 mg of vitamin E, and 5.30 mg of dietary fiber.
  • Antioxidant activity, Acetyl CoA carboxylase inhibition, and antimicrobial activity have been reported as avocados.
  • the total polyphenol and flavonoid contents in methanol extracts of avocado pulp, seeds and husks were measured.
  • the total polyphenol contents were 13.89 ⁇ g / mg for avocado pulp extract, 137.2 ⁇ g / mg for seed extract and 223.45 for shell extract. It was measured to be ⁇ g / mg, it was found that the polyphenol content in the seeds and shells is 10 to 20 times more than the pulp of avocado, having a high antioxidant capacity.
  • avocado extract has an excellent polyphenol content and excellent antioxidant activity, and as the concentration of avocado increases the activity of glycoprotein (ALP) of the cell membrane increases osteoblasts.
  • the avocado extract is effective in reducing the activity of TRAP enzyme (a cytochemical marker enzyme that can measure the degree of bone destruction in rats) without cytotoxicity and inhibits the differentiation of osteoclasts.
  • TRAP enzyme a cytochemical marker enzyme that can measure the degree of bone destruction in rats
  • TRAP enzyme a cytochemical marker enzyme that can measure the degree of bone destruction in rats
  • ALP glycoprotein of the cell membrane While increasing (ALP) activity has been reported to be cytotoxic to osteoclasts, it has been demonstrated that avocado extracts have the effect of proliferating osteoblasts and inhibiting osteoclasts.
  • avocado extract has the effect of helping the synthesis of collagen (Collagen) and proteoglycan (Proteoglycan). Therefore, it plays a very important role in strengthening bones by secreting collagen, proliferating osteoblasts forming bone support structures
  • avocado extract has osteoblast proliferation effect and osteoclast suppression effect, which helps bone formation. When used as a composition for treating and preventing periodontal disease, it has excellent effect on recovery and function after bone transplantation, implant and periodontal surgery. There is.
  • the avocado extract is preferably contained in an amount of 0.5 to 7% by weight based on the total weight of the composition for treating and preventing periodontal disease using a natural extract.
  • the composition containing the avocado extract when the composition containing the avocado extract is less than 0.5% by weight relative to the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and components other than avocado extract Considering the weight together, the content of avocado extract contained in the composition for the treatment and prevention of periodontal disease is too small, so the osteoblast proliferation and osteoclast inhibitory effects of the avocado extract are not properly expressed, so there is no possibility of adding meaning. have.
  • the avocado extract contained in the therapeutic and prophylactic composition is so excessive that the amount of vitamin E contained in the avocado extract exceeds the daily intake limit, thus preventing the absorption of vitamin K in the body. It may reduce platelet aggregation, cause bleeding after surgery, and may cause adverse symptoms such as gastrointestinal disorders, muscle weakness, headaches and chronic fatigue.
  • the avocado extract is preferably contained in an amount of 0.5 to 7% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts.
  • the avocado extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably washing and drying the avocado and pulverized and then using an extract extracted with an organic solvent such as methanol or ethanol have.
  • an organic solvent such as methanol or ethanol have.
  • the avocado was washed, dried and pulverized, and then avocado extract (Avocado Fruit 10: 1 Extract (Persea Gratissima)) extracted and extracted by adding ethanol was used.
  • Propolis is collected from the sap of trees, the bark of lost trees, and the surgery of flowers by bees, and is used for self-defense of honey bees or repair of honeycombs, mainly resins, beeswax, essential oils, pollen, various organic and mineral substances. It is composed of, and has been reported to be effective in antibacterial, antifungal, antiviral, antitumor, human immune reinforcement, wound healing as well as antioxidant activity. Various organic and mineral substances in propolis contain a large amount of more than 20 different flavonoids, and these flavonoids have been reported to exhibit strong antibacterial effects. Flavonoids of propolis are all aglycone different from flavonoids of other plants, and this compound is involved in the antibacterial action of propolis.
  • propolis since propolis does not have an antibacterial action against enterobacteriaceae, it is a very safe natural antimicrobial substance because it does not adversely affect enteric strains useful for the human body, that is, bifidobacteria or lactic acid bacteria even when administered orally.
  • Propolis has been reported to have excellent antioxidant and antibacterial effects in the oral cavity.
  • Water-soluble flavonoid mixtures are effective in treating mucosal inflammation, and are effective in treating mucosal inflammation, such as clinically inhibiting gingival bleeding in patients with periodontal disease, and reduce caries morbidity due to the antibacterial and antioxidant effects of flavonoids.
  • Flavonoids are excellent in reducing caries activity by reducing acid production in human oral saliva. For this reason, propolis has been actively developed as a component of oral health-related foods or products such as mouthwashes, periodontal disease treatments or supplements, toothpastes and the like.
  • Periodontal disease patients are suffering from inflammation occurring around various implants, especially after implantation, resulting in many problems. Patients take antibiotics to treat inflammation. Long-term use of antibiotics can cause resistance. Therefore, propolis is in the spotlight as an anti-inflammatory agent using a natural extract that can be taken in the long term because it does not develop resistance.
  • Propolis extract which is used as a dietary supplement, is made from bees by mixing their secretions with resins obtained from plants, and removing wax, extracted with water or alcohol, or extracted with carbon dioxide. will be. Total flavonoids must be present in at least 1% and para-coumaric and cinnamic acid should be identified. In addition, diethylin glycol should not be detected.
  • the composition for treating and preventing periodontal disease of the present invention is water-soluble to prevent allergic reactions and inflammation or ulceration of mucous membranes. Propolis extract was used.
  • the water-soluble propolis extract is preferably contained in 5 to 25% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is the amount of water-soluble propolis extract is set in consideration of the intake in the human application test confirmed the functionality.
  • the total flavonoid 16 to 17 mg is most preferred as the daily intake. Since the propolis extract used as a dietary supplement should contain at least 1% of total flavonoids, the water-soluble propolis extract is preferably 160 to 200 mg in daily intake.
  • the composition containing the water-soluble propolis extract less than 5% by weight based on the total weight of the composition for treating and preventing periodontal disease
  • the total weight and water-soluble propolis extract for treating and preventing periodontal disease Considering the weight of other ingredients together, the water-soluble propolis extract contained in the composition for treating and preventing periodontal disease is less than the minimum daily intake set in consideration of the intake in the functional application test. Therefore, there is a fear that the antioxidant action and the antibacterial action effect of the water-soluble propolis extract are not properly expressed.
  • the total weight of the composition for treating and preventing periodontal disease and the weight of components other than the water-soluble propolis extract may be considered together.
  • the amount of water-soluble propolis extract contained in the composition for treating and preventing periodontal disease is too excessive than the highest daily intake of the functional food functional labeling standard, it is not common, but it is a rare side effect of propolis. It may cause an allergic reaction and inflammation or ulceration of the mucous membrane.
  • the water-soluble propolis extract is preferably contained in 5 to 25% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts.
  • the water-soluble propolis extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably by applying heat to the raw raw raw propolis to remove the bewax (beewax), then extracted into the spirit Extracted extracts may be used.
  • a water-soluble propolis extract (Water Soluble Bee Propolis Ext. 70%) prepared by applying heat to a raw propolis raw material to remove non-wax, and then adding alcohol, was used.
  • Corn extract (corn unchecked quantitative extract, Zea Mays L.) is currently used as a component of health functional foods and products aimed at preventing periodontal disease or preventing periodontal disease. This is due to the fact that Zea Mays L. (hereinafter referred to as 'ZML'), an unchecked quantitative extract from corn, was found to be effective in improving purulent and periodontitis in 1958. It has been shown in the experiment that when taken, it has the effect of preventing and regenerating alveolar bone absorption and destruction of periodontal ligament. In addition, as a result of the reduction of dental rhythm and alveolar bone resorption in patients with periodontitis, ZML was reported to stop inflammatory degradation of bone in about 80% after topical treatment. It has been found to be effective in alleviating periodontal disease.
  • Corn extract is composed mainly of phytosterol consisting of beta-Sitosterol, Stigmasterol and Ergosterol, Squlaene, a hydrocarbon, Carotene and Tocopherol (liposoluble vitamins). Tocopherol).
  • the composition for the treatment and prevention of periodontal disease according to an embodiment of the present invention uses that containing 10% or more of beta-sitosterol.
  • Beta-sitosterol is the most widely distributed plant sterol, a precursor of vitamin D, or provitamin D, which promotes absorption of calcium, promotes alveolar bone formation, regenerates periodontal ligament fibers, Excellent function of normalization and anti-inflammatory action. Beta-sitosterol promotes osteoblast production by activating the endoplasmic reticulum of osteoblasts, promotes the regeneration of the collapsed alveolar bone, and prevents the absorption of the alveolar bone, thereby strengthening the gums. In addition, it is excellent in regenerating damaged periodontal ligament fibers and preventing abnormal shaking of teeth.
  • the composition for treating and preventing periodontal disease according to an embodiment of the present invention is beta-sitosterol. It is important to use corn extracts containing more than 10%.
  • the corn extract is preferably contained by containing 2 to 15% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts.
  • This is a periodontal disease is determined based on the content of the corn extract listed in the general medicine, the daily intake is preferably 80 to 120mg.
  • the total weight of the composition for treating and preventing periodontal disease and components other than corn extract Considering the weight together, the amount of corn extract contained in the composition for treating and preventing periodontal disease is too small, activating osteoblast vesicles of corn extract, and promoting calcium absorption as a precursor of vitamin D, alveolar bone Effects such as promoting regeneration and periodontal ligament fiber regeneration are not properly expressed, there is a fear that it does not add meaning.
  • the corn extract exceeds 15% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease, considering the total weight of the composition for the treatment and prevention of periodontal disease and the weight of components other than corn extract, periodontal disease
  • the amount of corn extract contained in the therapeutic and prophylactic composition is so excessive that the production cost may increase, resulting in a decrease in productivity, which may affect the component content of other periodontal disease treatment and prophylactic compositions. not.
  • the corn extract is preferably contained by containing 2 to 15% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts.
  • the corn extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably washing the corn and cornbeard together, dried and pulverized, ethanol or water is added to the pulverized ground After the extraction can be used to extract the extract can be used, corn unchecked quantitative extract commonly used in the manufacture of periodontal disease medicines.
  • the corn extract (GMO Free Corn Silk with 10% Beta Sitosterol (Zea Mays)) was prepared by washing corn, drying and pulverizing, and adding ethanol to the pulverized powder. .
  • Cinnamon is a dry, evergreen tropical cinnamon tree belonging to the family Lauraceae. Herbal medicine has been used for the treatment of headache, fever, nervousness, and pain.
  • the main ingredients of cinnamon are essential oils called cinnamon oils, which are Cinnamic aldehyde, Campen cineol, Linalool, Eugenol, Sugar, Fat, Phosphorus, Iron, Because it contains ingredients such as vitamin A, vitamin B1, and vitamin B2, it is widely used as a fragrance component in beverages, chewing gums, toothpaste and cosmetics, and bad breath remover. have.
  • it stimulates the gastrointestinal mucosa, stimulates secretion, suppresses spasms of pain in the stomach, promotes the movement of the gastrointestinal tract, and releases gas and improves absorption.
  • cinnamon stimulates nerves, promotes blood circulation, warms the body, and has an antiseptic effect of inhibiting abnormal fermentation in the intestine.
  • Cinnamic aldehydes of cinnamon have a function of persistent peripheral vasodilation (hypertension) and platelet aggregation inhibition, and effects such as sweating and clay. It is widely used for colds, analgesic, and dysmenorrhea, and cinnamon extract is also excellent in antimicrobial activity to suppress food corruption.
  • Cinnamon extract can be used as a natural antibiotic and bad breath remover because of its unique flavor, antioxidant and anti-inflammatory properties.
  • it since it is excellent in inhibiting inflammation by acting as a natural antibiotic with water-soluble propolis which is a component of the composition for treating and preventing periodontal disease of the present invention, it is an important component in the composition for treating and preventing periodontal disease.
  • the cinnamon extract is preferably contained in 0.5 to 7% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract.
  • the cinnamon extract when the cinnamon extract is contained in an amount of less than 0.5% by weight based on the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and components other than cinnamon extract Considering the weight together, the content of cinnamon extract in the composition for the treatment and prevention of periodontal disease is too small, and the antioxidant and anti-inflammatory effects of cinnamon extract may not be properly expressed, which may prevent it from functioning as a natural antibiotic. .
  • cinnamon extract when included in excess of 7% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease, considering the total weight of the composition for the treatment and prevention of periodontal disease and the weight of components other than cinnamon extract, periodontal disease
  • the amount of cinnamon extract contained in the therapeutic and prophylactic composition is so excessive that it can be fatal to a person with a fever or a lot of heat in the body, there is a fear that productivity may decrease due to increased production cost, and treatment and prevention of other periodontal disease It is not preferable because it may affect the component content of the composition.
  • the cinnamon extract is preferably contained in an amount of 0.5 to 7% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts.
  • the cinnamon extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably extract the water by grinding the cinnamon, it can be used through the process of filtration, concentration and purification have.
  • after adding water to the cinnamon is repeated three times the extraction process to extract for 2 hours at a temperature of 75 to 85 °C, after the filtration process, concentrated under reduced pressure and purified at a temperature of 75 to 85 °C
  • the cinnamon extract (Cinnamon Bark 2: 1 Extract (Cinnamomum Zeylanicum)) prepared by drying was purchased and used.
  • Milk Thistle is an asteraceae, scientific name is Silybum marianum (L.) Gaertn, tinnitus is Carduus silybum, and fruit and seeds are used for food.
  • herbalists have used thistle (milk thistle) seeds to protect the liver, such as chronic epilepsy, and in Europe, major countries such as Silymarin of thistle (milk thistle) protect liver cells from free radicals. Because it is known to be used as a liver supplement or a dietary supplement.
  • Thistle (milk thistle) extract is produced by pulverizing thistle milk (milk thistle), extracted by alcohol, filtration, concentration and purification, 320 ⁇ 660mg of functional ingredient silymarin (Silymarin) It is a raw material containing about / g.
  • Silymarin consists of four isomers: Silybin (A, B), Silychristin, Silydianin, and Isosilybin (A, B).
  • Thistle contains a component called Silymarin (Silymarin) is known to be effective in improving the function of the liver. Since the antioxidant activity is 10 times higher than vitamin E, glutathione secretion is increased to facilitate liver detoxification, which is effective in regenerating liver tissue, which helps restore liver function. In addition, silymarin (Silymarin), which is extracted from the seeds of thistle, has the effect of inhibiting the proliferation of cancer cells, and the research results are also effective in preventing and treating inflammation or liver damage, which is a side effect of cancer patients undergoing chemotherapy. Turned out to be excellent.
  • the milk thistle silymarin (Silymarin) component is used as a liver supplement and a dietary supplement because it has an excellent antioxidant activity, such as protecting the liver cells from free radicals, and is beneficial for liver health.
  • the recovery of liver function is very important in the treatment of periodontal disease because of the direct relationship between skin and immunity. Therefore, the milk thistle silymarin (Silymarin) component is effective in restoring liver function, it is an essential ingredient for recovery and function after bone graft, implant and periodontal surgery, so the composition for the treatment and prevention of periodontal disease Essential ingredient in the.
  • the thistle extract is preferably contained in an amount of 5 to 15% by weight relative to the total weight of the composition for treating and preventing periodontal disease using natural extracts. This is the content set according to the functional labeling standards of functional foods.
  • thistle seeds and berries are used as food ingredients, and thistle extract is also used as a general medicine.
  • Thistle extract is used abroad as a dietary supplement and medicine. It is listed as a food in the Prehensine Database and as a Dietary Supplement in the USP-NP.
  • the WHO monograph recommends 200-400 mg daily intake of silymarin, but functional health foods are considered in consideration of safety as a dietary supplement.
  • the daily intake is preferably 80 to 240 mg based on silymarin.
  • the composition of the composition for treating and preventing periodontal disease when the composition of the composition for treating and preventing periodontal disease is less than 5% by weight based on the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and components other than thistle extract Considering the weight together, the amount of thistle extract contained in the composition for treating and preventing periodontal disease is too small, compared to the minimum daily intake set in consideration of the content set according to the functional food functional labeling standard. There is a fear that the function recovery effect is not properly expressed, so there is no meaning to add.
  • thistle extract contains more than 15% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease, when considering the total weight of the composition for the treatment and prevention of periodontal disease and the weight of components other than thistle extract, health function
  • the amount of thistle extract contained in the composition for the treatment and prevention of periodontal disease is too much higher than the maximum daily intake set in consideration of the content set according to the food functional labeling criteria, and thus, harmful symptoms such as diarrhea, headache and joint pain may occur. There is concern.
  • the thistle extract is preferably contained by containing 5 to 15% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts.
  • the thistle extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably, thistle is pulverized and extracted with alcohol, and then the extract prepared through the process of filtration, concentration and purification to use Can be. In the present invention, thistle was pulverized and extracted by the addition of alcohol, and then the extracted extract was filtered and concentrated and stagnant thistle extract (Milk Thistle 80% Silymarin (Silybum marianum)) purchased and used.
  • Vitamin C is a six-carbon lactone, and plants and most animals can synthesize vitamin C in the body, but humans, primates, guinea pigs, large bats, and some species of birds and fish can synthesize it. Therefore, it must be in the form of food. Vitamin C contains both reduced ascorbic acid and oxidized dehydroascorbic acid, which can be converted. In fact, there are two types of food we eat.
  • Vitamin C has the function of forming connective tissue, which is used as a coenzyme of various enzymatic reactions in vivo, and is involved in the synthesis of collagen, a major protein constituting connective tissue such as skin, skeleton, blood vessels and cartilage.
  • connective tissue a major protein constituting connective tissue such as skin, skeleton, blood vessels and cartilage.
  • the amino acids proline and lysine are hydrated to form hydroxyproline and hydroxylysine
  • vitamin C plays a role in reducing the iron content of the hydroxylase. To maintain collagen tissue.
  • the electron donating function of vitamin C induces antioxidant activity to remove free radicals such as reactive oxygen species (ROS) and reactive nitrogen species (RNS).
  • free radicals such as reactive oxygen species (ROS) and reactive nitrogen species (RNS).
  • ROS reactive oxygen species
  • RNS reactive nitrogen species
  • tissues susceptible to damage from free radicals such as eyeballs, neutrophils, and semen, are known to have a relatively high content of vitamin C.
  • LDL low density lipoprotein
  • the radicals of vitamin C have a relatively long half-life of 5 to 10 seconds compared to other antioxidants, and thus are recognized as stable antioxidants.
  • Vitamin C is also known to be excellent in iron absorption effects, such as promoting the absorption of vegetable iron that is not bound to hemoglobin by converting iron to a reduced form in the small intestine.
  • vitamin C is necessary for the formation and maintenance of connective tissue, and it is effective for iron absorption and protects cells from harmful oxygen. Therefore, vitamin C is recovered and improved after bone transplantation, implant and periodontal surgery.
  • vitamin C is preferably contained in an amount of 1 to 10% by weight based on the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is a content set according to the recommended daily intake of adult men and women.
  • the average requirement for vitamin C in men and women is 75 mg / day and the recommended intake is 100 mg / day.
  • the recommended intake is set based on the amount of urine excretion while keeping leukocytes' vitamin C levels to a maximum.
  • composition of the composition for treating and preventing periodontal disease is less than 1% by weight of the total weight of the composition, when considering the total weight of the composition for treating and preventing periodontal disease and the weight of components other than vitamin C, The content of vitamin C contained in the composition for the treatment and prevention of periodontal disease is less than the average required amount of, there is no meaning to add vitamin C, there is a fear that the effect of vitamin C is not properly expressed.
  • vitamin C when vitamin C is included in an amount of more than 10% by weight based on the total weight of the composition for treating and preventing periodontal disease, when considering the total weight of the composition for treating and preventing periodontal disease and the weight of the components other than vitamin C, the amount of vitamin C contained in the composition for the treatment and prevention of periodontal disease is too excessive than the recommended intake of, may cause problems due to the excessive supply of vitamin C.
  • vitamin C When supplemental foods in which excess vitamin C is added, it is known to mainly cause gastrointestinal symptoms such as nausea, vomiting, bloating, abdominal pain and diarrhea. In addition, fishery excretion and nephrolithiasis, increased uric acid excretion, excessive iron absorption, and vitamin B12 levels have been reported. In pregnant women, excessive vitamin C ingestion has been reported to cause vitamin C dependence in newborns. In animal and in vitro studies, vitamin C is pro-Oxidant and may have adverse effects. It is reported that it is possible.
  • the vitamin C is preferably contained in an amount of 1 to 10% by weight based on the total weight of the composition for treating and preventing periodontal disease using a natural extract.
  • Vitamin B1 is a hexagonal ring (Pyrimidine) containing nitrogen in the center and sulfur pentagonal ring (Thiazole) connected by a methylene bridge.
  • Pork, sunflower seeds, brewer's yeast, soybeans, potato wheat germ, whole grains and fortified grains, peas, asparagus, meat guts, peanuts and other seeds, mushrooms and watermelons are good sources of vitamin B1.
  • vitamin B1 there are many foods containing vitamin B1, but in general, the content is low, so it is desirable to eat a variety of foods.
  • Thiamin pyrophosphate (TPP), a coenzyme form of vitamin B1 has two phosphate groups, including pyruvate, alpha-ketoglutarate, and branched-chain keto acids. It serves to catalyze the decarboxylation of the same alpha-keto acids. It also catalyzes the transketolation reaction between hexose phosphates and pentose phosphates. Transketolase, which is required for ketotransition reactions, is an enzyme that requires TPP to produce pentose sugar from glucose, which is hexose, in the Pentose phosphate pathway. Vitamin B1 is therefore required for the metabolism of carbohydrates and branched amino acids (leucine, isoleucine, valine). That is, vitamin B1 is involved in energy metabolism, so the required amount of vitamin B1 is highly correlated with energy consumption.
  • vitamin B1 is required for carbohydrate and energy metabolism, when used as a composition for the treatment and prevention of periodontal disease, it can solve the weakness of carbohydrate metabolism that should be chewed and digested by periodontal disease patients. It performs an effective function in periodontal regeneration of patients with chronic periodontal disease.
  • vitamin B1 is preferably contained in an amount of 0.01 to 0.3% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is a content set according to the recommended daily intake of adult men and women.
  • the average vitamin B1 requirement of Korean adults is 1.0mg / day for males and 0.9mg / day for females.
  • the recommended intake is 120% of the average intake, 1.2mg / day for males and 1.1mg / day for females.
  • the indicator used in setting the recommended intake is the red blood cell's transketolase activity. The activity of this enzyme is measured by comparing the activity with and without the addition of the coenzyme of vitamin B1 after the destruction of blood cells.
  • vitamin B1 When vitamin B1 is contained in an amount of less than 0.01% by weight based on the total weight of the composition for treating and preventing periodontal disease, when considering the total weight of the composition for treating and preventing periodontal disease and the weight of components other than vitamin B1, The content of vitamin B1 contained in the composition for the treatment and prevention of periodontal disease is less than the average required amount of, it does not mean adding vitamin B1, there is a fear that the effect of vitamin B1 is not properly expressed.
  • vitamin B1 naturally, but there have been reports of toxicity when high concentrations of vitamin B1 are consumed for therapeutic purposes.
  • High levels of vitamin B1 usually cause central nervous system-related symptoms such as headaches, nausea, anxiety, insomnia, tachycardia, and lack of energy.
  • the vitamin B1 is preferably contained in an amount of 0.01 to 0.3% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using a natural extract.
  • Vitamin B2 (Riboflavin) is a three-hexagonal ring molecule, usually present in the form of Flavin adenine dinucleotide (FAD) and Flavin mononucleotide (FMN) in the biological world, with very few free vitamin B2. Vitamin B2 is relatively stable against acid, heat and oxidation, but weak against alkali and light. Animal foods such as liver, meat, chicken and fish and dairy products are good sources of vitamin B2, and soybeans, green vegetables, grains and eggs are also used as sources of vitamin B2.
  • FAD Flavin adenine dinucleotide
  • FMN Flavin mononucleotide
  • Vitamin B2 has excellent caloric metabolism. Coenzymes of vitamin B2 are involved in various enzymatic reactions, especially in caloric metabolism. Various types of vitamin B2 enzymes are used for the metabolism of carbohydrates, fats and amino acids, dehydrogenation, hydroxylation, oxidative decarboxylation, dioxygenation and oxygen peroxide. It is essential for the reduction reaction.
  • vitamin B2 Deficiency of vitamin B2 causes deficiency such as stomatitis, stomatitis, and periarthritis in the oral cavity, oral or rash of the nose and mouth, seborrheic dermatitis of the vulva, ocular hyperemia, photophobia, premature cataract, and anemia. . Therefore, vitamin B2 deficiency causes various symptoms for the oral cavity, and proper intake of vitamin B2 is effective for periodontal disease and chronic periodontal disease because vitamin B2 has an excellent function in energy generation and metabolism.
  • the composition for the treatment and prevention of periodontal disease of the present invention there is a concern that the metabolism may not be smooth due to the high content of plant extracts, that is, fat-soluble components, the treatment and prevention of periodontal disease because the metabolism can be smoothed by the addition of vitamin B2 It is an essential ingredient to enhance the effect of the composition.
  • vitamin B2 is preferably contained in an amount of 0.01 to 0.3% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is a content set according to the recommended daily intake of adult men and women.
  • the average amount of vitamin B2 can be set based on the activity of glutathione reductase in red blood cells and the amount of vitamin B2 excretion in urine.
  • the average amount of vitamin B2 in Korean adults is 1.3 mg / day for men and 1.0 mg / day for women.
  • the recommended intake is 120% of the average intake for men 1.5mg / day and women 1.2mg / day.
  • the composition of the composition for treating and preventing periodontal disease is less than 0.01% by weight of vitamin B2
  • the total weight of the composition for treating and preventing periodontal disease and the weight of components other than vitamin B2 are considered. Since vitamin B2 content in the composition for the treatment and prevention of periodontal disease is less than the average required amount of vitamin B2, it may not effectively affect calorie metabolism (the metabolic pathways of carbohydrates, fats and amino acids). There is no meaning or the effect of vitamin B2 may not be properly expressed.
  • the vitamin B2 is preferably contained in an amount of 0.01 to 0.3% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract.
  • Vitamin B6 is present in foods in pyridoxine (Pyridoxine, PN), pyridoxal (PL), pyridoxamine (Pyridoaxamine, PM) or in their respective phosphorylated forms (PLP, PNP, PMP).
  • PLP, PMP, and protein are present in a combined form.
  • PN, PNP, and sugar are present in a combined form.
  • Coenzyme forms of vitamin B6 are PLP and PMP, in particular PLP is a form of biological activity is very high.
  • the free form of vitamin B6 varies with acidity, but is relatively unstable and easily denatured.
  • Sources of vitamin B6 include animal foods such as fish, pork, chicken, eggs and animal intestines (liver and kidneys), as well as brown rice, soybeans, and oats. Dairy products are relatively low in vitamin B6.
  • Vitamin B6 is a necessary ingredient for the use of proteins and amino acids.
  • PLP is a coenzyme of enzymes involved in the metabolism of about 100 kinds of amino acids such as aminotransferase, decarboxylase and stereoisase.
  • PLP is required for the reaction to synthesize non-essential amino acids, and if there is no PLP, all amino acids become essential amino acids and must be supplied by meal.
  • PLP is a stereoisomer and acts on the interconversion of D-type and L-type amino acids. Since only L-type amino acids are used when protein is synthesized in the human body, the action of PLP is important.
  • vitamin B6 also acts as a coenzyme of the catabolism of the homocysteine and Phosphorylase (Phosphorylase) reaction, it is also an essential component in maintaining the homocysteine level of blood normal.
  • Phosphorylase Phosphorylase
  • vitamin B6 is a necessary ingredient for the prevention and treatment of oral diseases such as stomatitis, stomatitis, and sulfitis.
  • the liver function is restored by working with thistle (milk thistle) extract of the composition for the treatment and prevention of periodontal disease of the present invention
  • the vitamin complex of vitamin B1, vitamin B2 and vitamin B6 is milk thistle (thistle extract) )
  • the metabolism facilitates to enhance immunity and to treat and prevent periodontal disease is excellent.
  • vitamin B6 is preferably contained in an amount of 0.01 to 0.3% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is set according to the recommended daily intake of adult men and women.
  • the average amount of vitamin B6 in Korean adults is 1.3mg / day for men and 1.2mg / day for women, and the recommended intake is 120mg of average intake, 1.5mg / day for men and 1.4mg / day for women.
  • composition of the composition for the treatment and prevention of periodontal disease contains less than 0.01% by weight of vitamin B6, when considering the total weight of the composition for treating and preventing periodontal disease and the weight of components other than vitamin B6,
  • the content of vitamin B6 contained in the composition for the treatment and prevention of periodontal disease is less than the average required amount of, it does not mean adding vitamin B6, there is a fear that the effect of vitamin B6 is not properly expressed.
  • Vitamin B6 excess from food has not been reported, but it has been reported that sensory neuropathy and skin lesions may occur when a large amount of the drug is taken for the purpose of treating diseases such as premenstrual syndrome. Ingestion of high doses of vitamin B6 can cause nerve damage, tingling limbs, staggering steps, loss of sensation around the mouth, and loss of muscle coordination.
  • the vitamin B6 is preferably contained in an amount of 0.01 to 0.3% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using a natural extract.
  • the composition for treating and preventing periodontal disease using a natural extract calcium 35 to 60% by weight, avocado extract 0.5 to 7% by weight, water soluble propolis extract 5 to 25% by weight, corn extract 2 to 15% by weight, cinnamon extract 0.5 to 7% by weight, thistle extract 2 to 15% by weight, vitamin C 1 to 10% by weight, vitamin B1 0.01 to 0.3% by weight, vitamin B2 0.01 to 0.3% by weight and vitamin B6 0.01 to Most preferably, it comprises 0.3% by weight.
  • the composition for the treatment and prevention of periodontal disease using the natural extract by adding any one or more from the additive group consisting of silicon dioxide, magnesium stearate, crystalline cellulose and a color coating agent in the form of a tablet It may be characterized in that it is manufactured as.
  • compositions for the treatment and prevention of periodontal disease using the natural extract in the form of tablets for easy ingestion added silicon dioxide, magnesium stearate, crystalline cellulose and color coating agent
  • Components of the additive group consisting of does not cause interaction with each component of the composition for treating and preventing periodontal disease using the natural extract, it is preferable that the composition is composed of components that do not affect the effective aspect.
  • 0.1 to 1 parts by weight of silicon dioxide, 0.1 to 1.5 parts by weight of magnesium stearate, crystals, corresponding to an additive group based on 100 parts by weight of the composition for treating and preventing periodontal disease using the natural extract 12 to 26 parts by weight of cellulose and 1 to 5 parts by weight of the color coating agent may be added to form a tablet formulation.
  • the content of the components of the additive group consisting of silicon dioxide, magnesium stearate, crystalline cellulose and a color coating agent is suitable for preparing a periodontal disease treatment and prevention composition using a natural extract in a tablet form, and treatment of periodontal disease using a natural extract. And it can be set to an optimized content so as not to affect the effect of the composition for prevention.
  • the ratio of 0.1 to 1 parts by weight of silicon dioxide, 0.1 to 1.5 parts by weight of magnesium stearate, 12 to 26 parts by weight of crystalline cellulose and 1 to 5 parts by weight of the color coating agent based on 100 parts by weight of the composition for treating and preventing periodontal disease using a natural extract. It is preferred to prepare further in the form of tablet form by further addition.
  • composition for the treatment and prevention of periodontal disease using a natural extract according to an embodiment of the present invention.
  • the periodontal disease adjuvant composition using the natural extract prepared as in Example was prepared in a tablet form of the drug recipe W. (Recipe W) to be administered to the study subjects, and expressed in the recipe W. (Recipe W) in the questionnaire and the questionnaire results. It is.
  • 1 is a questionnaire of a survey conducted to grasp the effects and use status of purchase patients with the composition for the treatment and prevention of periodontal disease according to an embodiment of the present invention.
  • the questionnaire items in this study were classified by patient symptom, non-answered phone call, effectiveness of recipe W after 1 month of receiving dose, status of effect compared to other products, classification by period, periodontal condition improvement, periodontal
  • the questionnaire consists of 9 questions such as improvement by symptom, repurchase status for one month, and intention of continuous taking. About 10 selected dentists at Seoul National University, Hallym University, and Pusan National University evaluated the selected items and evaluated the suitability of the selected items.
  • the number of males and females of recipe W is 251 females and 105 males.
  • the ages are 2 in 20s, 4 in 30s, 35 in 50s, 127 in 50s, 116 in 60s, and 70s. It is distributed in 65, 80 and 7 members.
  • Symptoms included 248 patients with peri-implantitis, 80 chronic periodontal diseases, 28 general periodontal diseases, 18 in the implant plan, and 6 patients with osteoporosis medication.
  • the most common symptom was improvement of tooth agitation and gum weakness (71 cases), improvement of pain and swelling of 61 cases, improvement of bleeding when brushing teeth, improvement of ache 42, and improvement of bad breath.
  • 251 of the 356 subjects responded to the telephone questionnaire.
  • 251 respondents showed peri-implantitis 70% (182), chronic periodontal disease 23% (59), periodontal disease 4% (10), and 3% (7) of the implant plan.
  • 0% (1 person) is a substitute for osteoporosis drugs, which is biased for patients with peri-implant peritonitis, but the number of patients is considered as a basis for introducing periodontal disease supplements.
  • the results of the survey can be considered as the final result, considering that the proportion of symptom by 356 subjects and that of symptom by 251 respondents are almost similar.
  • the results of Recipe W the patients who took it continuously seemed to be effective enough. Among the 173 patients who took more than a month, 22% (99) of the actual repurchase patients were repurchased. 56.9% (143 patients) of the patients desired showed the importance of taking the patient.
  • the quantitative value (concentration) of the causative agent of periodontal disease-causing bacteria before and after ingestion of the composition for treating and preventing periodontal disease was analyzed.
  • the periodontal disease adjuvant composition using the natural extract prepared as in Example was prepared as a drug recipe W. (Recipe W) in the tablet form to be taken by the subjects.
  • the treatment efficacy evaluation was commissioned by Hallym University and was given a clinical approval number, such as “IRB Approval Number 14-1-58, Hallym University Institutional Review Board.”
  • a total of 30 subjects consisted of adults aged 25 to 75 years. The average age of the subjects was 44.73 years. Patients diagnosed with mild chronic simple periodontitis were selected. Patients who had not received treatment for periodontal disease within the last 6 months and who voluntarily agreed and signed the subject's consent It was made.
  • the sample was collected and sealed in a preservative solution and container of the cytoperio analysis system (cytogen co. Ltd). Co. Ltd,) was sent to a laboratory for genetic testing, extracted DNA from the sample and attached a DNA probe (fluorescent marker) and analyzed the type and quantitative value (concentration) of the causative agent causing periodontal disease by real-time PCR.
  • cytoperio analysis system cytogen co. Ltd. Co. Ltd,
  • the causative agents of investigation were aggregatibacter actinomycetemcomitans (Aa), porphyromonas gingivalis (Pg), tannerella forsythia (Tf), treponema denticola (Td), prevotella intermedia (Pi), fusobacterrium nucleatum (Fn), parvimonas micra (Pm), campylob camp A total of 11 bacteria were identified, including eikenella corrodens (Ec), streptococcus mutans (Sm), and streptococcus sorbinus (Ss).
  • the reduction of bacteria was confirmed by quantitative analysis of each bacterium before and after taking the drug and after 3 weeks of taking the drug. A total of 30 subjects were included in a single group. Thirty subjects measured the reduction of periodontal disease-causing bacteria after two weeks of administration, and thirteen subjects measured the reduction of periodontal disease-causing bacteria after three weeks of administration. . Since the test results did not follow the normal distribution in all strains as an objective evaluation method before and after treatment, the statistical significance was evaluated by the Wilcoxon signed rank test, a nonparametric size comparison method, and evaluated under the conditions shown in Table 1 below. Was determined at P ⁇ 0.05.
  • Table 2 shows the 11 bacterial levels causing periodontal disease, aggregatibacter actinomycetemcomitans (Aa) was not detected in all subjects.
  • the levels of the remaining 10 bacteria except for Aa were all decreased, and the levels of 11 bacteria, which cause periodontal disease, were higher when taking drugs for 3 weeks or more than when taking drugs for 2 weeks or more. The decrease was found to be greater.
  • the decrease rate of the 11 bacterial bacteria causing the periodontal disease caused by taking the drug for two weeks or more is shown in the graphs of FIGS. 2 and 3, and the cause of the periodontal disease caused by taking the drug for three weeks or more 11
  • the rate of reduction of bacterial levels of the species is shown in the graphs of FIGS. 4 and 5.
  • Table 2 Considering the results of quantitative value (concentration) of periodontal disease-causing bacteria shown in Table 2 above, the number of bacteria was increased and decreased or the number of bacteria was not changed, and the statistical significance of the normality and P value of the treatment efficacy evaluation test.
  • Table 3 summarizes the statistical significance according to the normality and P value of the treatment efficacy evaluation test before and after 2 weeks of taking the drug
  • Table 4 shows the treatment corresponding to before and after 3 weeks of taking the drug. It is the result that summarized the statistical significance by the normality and P-value of the efficacy evaluation test.
  • the quantitative value (concentration) of the causative agent of periodontal disease-causing bacteria before and after ingestion of the composition for treating and preventing periodontal disease According to the analysis results, no aggregatibacter actinomycetemcomitans (Aa) was detected in all the subjects, and among the 10 causes of periodontal disease, more than half of the patients showed a decrease in the number of bacteria. Td), prevotella intermedia (Pi), fusobacterrium nucleatum (Fn), parvimonas micra (Pm), and campylobacter rectus (Cr).
  • Pg is anaerobic bacilli, closely related to acute or chronic periodontitis, and high frequency in periodontal sac of adult periodontitis patients. It was investigated. Td is a helix bacteria and is detected in most parts of periodontal pockets and is known to be associated with acute progressive periodontitis and necrosis or ulcerative periodontitis. Pi is a black pigment producing bacterium that causes hormone-related periodontitis and promotes complex infections. Fn is an anaerobic Gram-negative bacterium and is known to be detected with high frequency with helix bacteria in almost all areas where acute necrotic ulcerative gingivitis occurs.
  • Pm is an anaerobic Gram-positive cocci and has been reported to be associated with recurrent or refractory periodontal disease and implant failure.
  • Cr is an anaerobic Gram-negative bacillus and is known to cause periodontal pocket formation and secondary bacterial infections.
  • the amount of microbial reduction after taking Td and Pm also showed statistical significance.
  • the present invention can be used in combination with dental treatment because it was prepared using a natural extract for the treatment and prevention of periodontal disease can be useful in the treatment of periodontal disease, and can be taken in the long term without depending on antibiotics Since it is a composition for treating and preventing periodontal disease using a natural extract, it can be usefully used for long-term periodontal disease treatment and prophylaxis.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a composition, using natural extracts, for treating and preventing periodontal diseases and, specifically, to a composition, using a natural extract, for treating and preventing periodontal diseases, characterized by containing calcium, an avocado extract, a water-soluble propolis extract, a corn extract, a cinnamon extract, a thistle extract, vitamin C, vitamin B1, vitamin B2, and vitamin B6. The composition for treating and preventing periodontal diseases is prepared using the natural extracts, and thus can be used in conjunction with dental treatment, so that the composition can be helpful in the treatment of periodontal diseases, and patients can take the composition for a long period of time even without depending on antibiotics. In addition, the composition contains all of the ingredients, which are excellent in three functions necessary for dental treatment, that is, a bone formation function, an immune enhancement function, and a periodontitis prevention and treatment function, and thus the composition has excellent effects of preventing and treating periodontal diseases.

Description

천연 추출물을 이용한 치주질환 치료 및 예방용 조성물Composition for the treatment and prevention of periodontal disease using natural extracts
본 발명은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물에 관한 것으로, 보다 구체적으로는 천연 추출물을 이용하여 치주질환 치료 및 예방용 조성물을 제조하였기 때문에 치과 치료와 병행하여 사용할 수 있으므로 치주질환 치료에 도움이 될 수 있고, 항생제에 의존하지 않고 장기적으로 복용할 수 있는 장점이 있는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물에 관한 것이다.The present invention relates to a composition for the treatment and prevention of periodontal disease using a natural extract, and more specifically, because the composition for the treatment and prevention of periodontal disease using a natural extract can be used in combination with dental treatment in the treatment of periodontal disease. It relates to a composition for the treatment and prevention of periodontal disease using a natural extract that can be helpful and can be taken long-term without resorting to antibiotics.
현대사회에는 잘못된 식습관을 가진 사람들 및 고령화로 인해 면역력이 줄어들거나 영양 및 대사 장애로 인해 치주질환이 발생한 환자의 수가 증가하고 있다. 이러한 치주질환 환자가 섭취할 수 있도록 치주질환을 예방하거나 치료할 수 있는 효과를 가지는 건강기능식품 및 치료제는 현재 많이 개발되고 있다.In modern society, the number of people with poor eating habits and the aging of the immune system is reduced due to aging or periodontal disease due to nutritional and metabolic disorders is increasing. Nutraceuticals and therapeutic agents having the effect of preventing or treating periodontal disease so that the periodontal disease can be ingested are currently being developed.
그러나 합성물질로 제조된 합성의약품 치주질환 치료제는 항생제의 사용으로 인해 항생제 오남용과 같은 부작용을 초래할 수 있어 치주질환 치료제를 장기간 복용하는 것이 어려우며, 시중에 통용되고 있는 치주질환 치료제의 대부분이 치주질환 치료 효과가 입증되지 않은 상태로 시판되고 있어 많은 문제가 발생하고 있다. 이러한 문제를 해결하기 위해, 천연 추출물 즉, 식물 추출물을 이용한 치주질환 치료제 및 예방제에 대한 개발이 필요하다.However, synthetic drug periodontal disease treatments made of synthetic materials can cause side effects such as misuse of antibiotics due to the use of antibiotics, making it difficult to take periodontal disease treatments for a long time, and most of the commonly used treatments for periodontal disease are treatment of periodontal disease. Many problems arise as it is marketed in an unproven state. In order to solve this problem, it is necessary to develop a treatment and prevention of periodontal disease using natural extracts, that is, plant extracts.
대한민국 등록특허공보 제10-0431170호는 식물추출물을 함유하는 치주질환치료용 조성물에 대한 것으로서, 계피, 결명자, 호장근, 구기자, 복분자, 어성초, 갈화, 단삼 추출물의 군에서 선택되는 1종 또는 2종 이상을 유효성분으로 함유하는 치주질환 치료용 조성물을 제공하고 있으며, 치주질환 유발균의 생육억제 활성이 우수하며, 치주질환 유발균이 분비하는 단백질 분해효소의 억제활성이 매우 우수한 식물 추출물을 주원료로 하여 치주질환 치료에 탁월한 효과가 있는 치주질환치료용 조성물에 대해 개시하고 있다.Republic of Korea Patent Publication No. 10-0431170 is a composition for the treatment of periodontal disease containing plant extracts, cinnamon, missing, Hojang-geun, gojija, bokbunja, eoseongcho, browning, dansam extract selected from the group of 1 or 2 It provides a composition for treating periodontal disease containing more than one species as an active ingredient, excellent plant growth inhibitory activity of periodontal disease-causing bacteria, plant extracts excellent in inhibiting activity of proteolytic enzymes secreted by periodontal disease-causing bacteria The present invention discloses a composition for treating periodontal disease, which is excellent in treating periodontal disease.
또한, 대한민국 등록특허공보 제10-1358507호는 홍삼 및 천연식물 유래 추출물을 포함하는 구강 내 항염, 항균 및 소취를 위한 조성물에 관한 것으로서, 홍삼 및 천연식물 유래의 항염, 항균 및 소취 효과가 있는 구강 내 항염, 항균 및 소취를 위한 조성물 및 이의 제조방법에 대해 개시하고 있다.In addition, the Republic of Korea Patent Publication No. 10-1358507 relates to a composition for anti-inflammatory, antibacterial and deodorant in the oral cavity containing red ginseng and natural plant-derived extracts, oral with anti-inflammatory, antibacterial and deodorant effects derived from red ginseng and natural plants It discloses a composition for anti-inflammatory, antibacterial and deodorant and a method for preparing the same.
아울러, 대한민국 공개특허공보 제10-2012-0117387호는 잇몸질환예방 및 완화를 위한 구강 조성물에 대한 것으로서, 다시마, 표고버섯, 녹차추출물, 토코페롤, 프로폴리스 등 잇몸과 치아 건강에 유익하고 항균작용을 지니는 성분을 원료로 사용하여 잇몸과 치아건강 및 구강 청결 효과를 지니는 구강용 조성물에 대해 개시하고 있다.In addition, Korean Laid-open Patent Publication No. 10-2012-0117387 relates to oral compositions for preventing and alleviating gum disease, which is beneficial to gum and dental health such as kelp, shiitake mushroom, green tea extract, tocopherol, and propolis. It discloses a composition for oral cavity having the gum and dental health and oral cleansing effect using the ingredients as a raw material.
천연 추출물 즉, 식물 추출물을 이용한 치주질환 치료제 및 예방제는 현재 많이 개발되고 있으나, 아직까지는 만성치주질환이나 임플란트 주위염에 관련된 예방 및 치료 목적으로 사용되는 조성물이 개발되지 않았으며, 치주질환 치료 및 예방 효과와 동시에 뼈를 형성시키는 데 도움이 되고 면역력이 증강되는 기능 요소까지 포함하고 있어서 치주질환 치료의 효과를 극대화 시키고, 만성치주질환과 임플란트 주위염에 효과적인 치주질환 치료 및 예방용 치료 및 예방용 조성물은 개발되지 않았다.Natural extracts, namely, the treatment and prevention of periodontal disease using plant extracts have been developed a lot, but the composition for the prevention and treatment related to chronic periodontal disease or peri-implantitis has not been developed yet, and treatment and prevention effect of periodontal disease At the same time, it helps to form bones and includes functional elements that enhance immunity, thus maximizing the effect of periodontal disease treatment, and treating and preventing periodontal disease effective treatment for chronic periodontal disease and peri-implantitis. It wasn't.
[선행기술문헌][Preceding technical literature]
[특허문헌][Patent Documents]
대한민국 등록특허공보 제10-0431170호Republic of Korea Patent Publication No. 10-0431170
대한민국 등록특허공보 제10-1358507호Republic of Korea Patent Publication No. 10-1358507
대한민국 공개특허공보 제10-2012-0117387호Republic of Korea Patent Application Publication No. 10-2012-0117387
본 발명은 전술한 것과 같은 문제점을 해결하기 위해 도출된 것으로서, 본 발명의 일 실시형태의 목적은 천연 추출물을 이용하여 치주질환 치료 및 예방용 조성물을 제조하였기 때문에 치과 치료와 병행하여 사용할 수 있으므로 치주질환 치료에 도움이 될 수 있고, 항생제에 의존하지 않고 장기적으로 복용할 수 있는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 제공하는 것이다. 보다 구체적으로, 뼈 형성에 도움을 주는 칼슘, 아보카도 추출물, 옥수수 추출물 및 비타민 C와 치주질환에 도움이 되는 수용성 프로폴리스 추출물, 옥수수 추출물, 계피 추출물 및 비타민 C, 그리고 면역력 증강에 도움이 되는 엉겅퀴 추출물, 비타민 B1, 비타민 B2 및 비타민 B6가 모두 포함되도록 치주질환 치료 및 예방용 조성물을 제조함으로써, 치과 진료에 필요한 3가지 기능에 대해 효과가 있는 성분이 모두 포함되도록 구성되었기 때문에 만성 치주질환 및 임플란트 주위염 환자의 예방 및 치료에 효과가 있는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 제공하는데 그 목적이 있다.The present invention has been derived to solve the problems as described above, the purpose of one embodiment of the present invention is to use the natural extracts to prepare a composition for the treatment and prevention of periodontal disease because it can be used in conjunction with dental treatment periodontal periodontal It is to provide a composition for treating and preventing periodontal disease using a natural extract that can be useful for the treatment of the disease, and can be taken for a long time without resorting to antibiotics. More specifically, calcium, avocado extract, corn extract and vitamin C and bone soluble propolis extract, corn extract, cinnamon and vitamin C, which help bone formation, and thistle extract to help boost immunity. Chronic periodontal disease and peri-implantitis because the composition for the treatment and prevention of periodontal disease is prepared to include all of vitamin B1, vitamin B2 and vitamin B6. It is an object of the present invention to provide a composition for the treatment and prevention of periodontal disease using natural extracts effective for the prevention and treatment of patients.
상기와 같은 목적을 달성하기 위한 본 발명의 일 실시형태로서, 본 발명의 일 실시형태는 칼슘, 아보카도 추출물, 수용성 프로폴리스 추출물, 옥수수 추출물, 계피 추출물, 엉겅퀴 추출물, 비타민 C, 비타민 B1, 비타민 B2 및 비타민 B6를 포함하여 조성되는 것을 특징으로 하는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 제공한다.As one embodiment of the present invention for achieving the above object, one embodiment of the present invention is calcium, avocado extract, water soluble propolis extract, corn extract, cinnamon extract, thistle extract, vitamin C, vitamin B1, vitamin B2 And it provides a composition for the treatment and prevention of periodontal disease using a natural extract, characterized in that it comprises a vitamin B6.
상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물은 칼슘 35 내지 60중량%, 아보카도 추출물 0.5 내지 7중량%, 수용성 프로폴리스 추출물 5 내지 25중량%, 옥수수 추출물 2 내지 15중량%, 계피 추출물 0.5 내지 7중량%, 엉겅퀴 추출물 2 내지 15중량%, 비타민 C 1 내지 10중량%, 비타민 B1 0.01 내지 0.3중량%, 비타민 B2 0.01 내지 0.3중량% 및 비타민 B6 0.01 내지 0.3중량%를 포함하여 조성되는 것을 특징으로 할 수 있다.Composition for treating and preventing periodontal disease using the natural extract is calcium 35 to 60% by weight, avocado extract 0.5 to 7% by weight, water soluble propolis extract 5 to 25% by weight, corn extract 2 to 15% by weight, cinnamon extract 0.5 to 7 wt%, thistle extract 2-15 wt%, vitamin C 1-10 wt%, vitamin B1 0.01-0.3 wt%, vitamin B2 0.01-0.3 wt% and vitamin B6 0.01-0.3 wt% You can do
또한, 상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물에 이산화규소, 스테아린산마그네슘, 결정셀룰로스 및 색상코팅제로 이루어진 첨가제군에서 어느 하나 이상을 더 첨가하여 정제 형태의 제형으로 제조되는 것을 특징으로 할 수 있다.In addition, to the composition for the treatment and prevention of periodontal disease using the natural extract may be characterized in that the addition of any one or more from the group consisting of additives consisting of silicon dioxide, magnesium stearate, crystalline cellulose and a color coating agent in the form of a tablet form. have.
아울러, 상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 100중량부에 대해 첨가제군에 해당하는 이산화규소 0.1 내지 1중량부, 스테아린산마그네슘 0.1 내지 1.5중량부, 결정셀룰로스 12 내지 26중량부 및 색상코팅제 1 내지 5중량부의 비율로 더 첨가하여 정제 형태의 제형으로 제조되는 것을 특징으로 할 수 있다.In addition, 0.1 to 1 parts by weight of silicon dioxide, 0.1 to 1.5 parts by weight of magnesium stearate, 12 to 26 parts by weight of crystalline cellulose and a color coating agent based on 100 parts by weight of the composition for treating and preventing periodontal disease using the natural extract. It may be characterized in that it is added to the ratio of 1 to 5 parts by weight to prepare a formulation in tablet form.
본 발명의 일 실시형태에 따른 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물은, 치과 치료와 병행하면서 섭취할 수 있는 치주질환 치료 및 예방용 조성물로서, 치과 진료를 병행하면서 치료와 동시에 섭취할 수 있기 때문에 치주질환을 예방하고, 치주질환을 치료하는데 도움이 될 수 있다.The composition for treating and preventing periodontal disease using natural extracts according to one embodiment of the present invention is a composition for treating and preventing periodontal disease that can be ingested in parallel with dental treatment, and can be ingested at the same time as treatment with dental treatment. It can help prevent periodontal disease and treat periodontal disease.
또한, 항생제나 화학원료가 아닌 천연 추출물을 원료로 하여 구성되어 있는 치주질환 치료 및 예방용 조성물이기 때문에, 항생제 오남용으로 인해 인체에 발생할 수 있는 부작용을 최소화할 수 있고, 장기적인 복용이 가능하여 치주질환을 예방함은 물론이고 치주질환의 치료 효과를 높일 수 있다.In addition, because it is a composition for the treatment and prevention of periodontal disease, which is composed of natural extracts, not antibiotics or chemical raw materials, it can minimize the side effects that can occur in the human body due to the abuse of antibiotics, and can be taken for a long period of time periodontal disease As well as preventing and can increase the treatment effect of periodontal disease.
본 발명의 일 실시형태에 따른 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물은, 치과 진료에 필요한 3가지 기능인 뼈 형성 기능, 면역력 증강 기능, 치주염증 예방 및 치료 기능이 뛰어난 성분들을 모두 포함하고 있기 때문에 치주질환을 예방하고 치료하는 효과가 뛰어나다.Composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention, including all three components that are excellent in bone formation function, immune function enhancement function, periodontal inflammation prevention and treatment functions required for dental care Because of this, the effect of preventing and treating periodontal disease is excellent.
치아 주위 치조골 및 치주인대를 튼튼하게 하여 치주염증의 예방 및 치료에 도움이 되는 수용성 프로폴리스 추출물, 옥수수 추출물, 계피 추출물 및 비타민 C와 같은 성분으로만 치주질환 치료 및 예방용 조성물을 제조하지 않고, 뼈 형성을 촉진하는 원료 성분과 면역력을 증강시킬 수 있는 원료 성분을 함께 첨가하여 치주질환 치료 및 예방용 조성물을 제조하였기 때문에, 기존의 치주질환 치료 및 예방용 조성물보다 치주질환의 예방 및 치료의 효과가 뛰어나게 되는 장점이 있다.Without preparing a composition for treating and preventing periodontal disease only with ingredients such as water-soluble propolis extract, corn extract, cinnamon extract and vitamin C, which help to strengthen the alveolar bone and periodontal ligament around teeth, Since the ingredient for promoting bone formation and the ingredient for enhancing immunity were added together to prepare a composition for the treatment and prevention of periodontal disease, the effect of preventing and treating periodontal disease than the existing composition for treating and preventing periodontal disease Has the advantage of being superior.
즉, 치아 주위 치조골 및 치주인대를 튼튼하게 하여 치주염증의 예방 및 치료에 도움이 되는 수용성 프로폴리스 추출물, 옥수수 추출물, 계피 추출물 및 비타민 C와 같은 성분과, 임플란트 보철물을 튼튼하게 유지하는 작용을 하여 임플란트 주위의 염증을 예방 및 치료하는데 도움이 되는 칼슘, 아보카도 추출물, 옥수수 추출물 및 비타민 C와 같은 성분을 첨가하고, 신체의 전반적인 면역력 증강에 도움이 되며, 특히 간 기능에 도움을 주는 성분으로 구성되어 피부 염증에 직접적으로 도움이 되는 엉겅퀴 추출물, 비타민 B1, 비타민 B2 및 비타민 B6와 같은 성분을 첨가하여, 상기 10가지 성분이 모두 포함되도록 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 제조함으로써, 뼈 형성에 도움이 되고, 치주질환을 예방 및 치료하는데 도움이 되고, 면역력이 증강되기 때문에 기존의 치주질환 치료 및 예방용 조성물보다 치주질환의 예방 및 치료 효과가 뛰어나게 되는 장점이 있다.In other words, it strengthens the alveolar bone and periodontal ligament around the teeth to help prevent and treat periodontal inflammation, and to maintain components such as water-soluble propolis extract, corn extract, cinnamon extract and vitamin C and implant prosthesis It contains ingredients such as calcium, avocado extract, corn extract and vitamin C, which help prevent and treat inflammation around the implant, and helps to boost the body's overall immunity. By adding ingredients such as thistle extract, vitamin B1, vitamin B2 and vitamin B6, which are directly conducive to skin inflammation, by preparing a composition for treating and preventing periodontal disease using natural extracts to include all 10 components, bone Helps in formation, prevents and treats periodontal disease, and Since the force is enhanced there is a remarkably advantage that the prevention and treatment of existing periodontal disease treatment and prevention of periodontal disease the composition than for.
도 1은 본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 보조제 조성물에 대해서 실시한 설문조사의 설문지이다.1 is a questionnaire of the questionnaire conducted for the adjuvant composition for treatment and prevention of periodontal disease according to an embodiment of the present invention.
도 2와 도 3은 치료 유효성 평가 시험의 결과 중 본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 보조제 조성물로 제조한 레시피 더블유(Recipe W)를 2주 이상 약물을 복용하였을 때 발생하는 치주질환 유발 원인균인 11종의 세균 수치의 감소율을 나타낸 그래프이다.2 and 3 is a periodontal disease that occurs when two or more weeks of taking the drug W recipe (Recipe W) prepared with the adjuvant composition for treatment and prevention of periodontal disease according to an embodiment of the present invention among the results of the treatment evaluation test It is a graph showing the decrease rate of the 11 bacterial bacteria causing disease.
도 4와 도 5는 치료 유효성 평가 시험의 결과 중 본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 보조제 조성물로 제조한 레시피 더블유(Recipe W)를 3주 이상 약물을 복용하였을 때 발생하는 치주질환 유발 원인균인 11종의 세균 수치의 감소율을 나타낸 그래프이다.4 and 5 of the results of the treatment evaluation test periodontal periodontal disease that occurs when taking a drug for three weeks or more recipe W (recipe W) prepared with the adjuvant composition for treatment and prevention of periodontal disease according to an embodiment of the present invention It is a graph showing the decrease rate of the 11 bacterial bacteria causing disease.
도 6과 도 7은 치료 유효성 평가 시험의 결과 중 treponema denticola(Td) 및 parvimonas micra(Pm)의 감소율을 나타난 그래프이다. 6 and 7 are graphs showing the reduction rate of treponema denticola (Td) and parvimonas micra (Pm) of the results of the treatment evaluation test.
이하, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시형태를 들어 상세히 설명한다. 본 발명의 실시형태는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 더욱 완전하게 설명하기 위해서 제공되는 것이다. 따라서, 본 발명의 실시형태는 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 이하 설명하는 실시형태로 한정되는 것은 아니다.Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily practice the present invention. Embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art. Accordingly, embodiments of the invention may be modified in many different forms and should not be construed as limited to the embodiments set forth herein.
본 발명의 명세서 전체에서, 어떤 부분이 어떤 구성요소를 “포함”한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함하는 것을 의미한다.Throughout the specification of the present invention, when a part is said to "include" a certain component, it means to include other components rather than to exclude the other components unless otherwise stated.
본 발명의 일 실시형태에 따른 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물(이하, ‘치주질환 치료 및 예방용 조성물’이라고도 함)은, 칼슘, 아보카도 추출물, 수용성 프로폴리스 추출물, 옥수수 추출물, 계피 추출물, 엉겅퀴 추출물, 비타민 C, 비타민 B1, 비타민 B2 및 비타민 B6를 포함하여 조성되는 것을 특징으로 할 수 있다.Composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention (hereinafter, also referred to as 'composition for treating and preventing periodontal disease'), calcium, avocado extract, water-soluble propolis extract, corn extract, cinnamon It may be characterized by including the extract, thistle extract, vitamin C, vitamin B1, vitamin B2 and vitamin B6.
치과 진료 시 치주질환 예방 및 치료를 위해 꼭 필요한 3가지 기능은, 뼈 형성 기능, 치주염증의 예방 및 치료 기능, 면역력 증강 기능이다.Three functions that are essential for the prevention and treatment of periodontal disease during dental care are bone formation, prevention and treatment of periodontal inflammation, and immunity enhancement.
칼슘, 아보카도 추출물, 옥수수 추출물 및 비타민 C와 같은 성분은 임플란트 보철물을 튼튼하게 유지하는 작용을 하여 임플란트 주위의 염증을 예방 및 치료하는데 도움이 되기 때문에 뼈 형성 효과가 뛰어나다.Ingredients such as calcium, avocado extract, corn extract, and vitamin C have a strong bone-forming effect because they help to maintain and secure implant prostheses, helping to prevent and treat inflammation around the implant.
또한, 수용성 프로폴리스 추출물, 옥수수 추출물, 계피 추출물 및 비타민 C와 같은 성분은 치아 주위 치조골 및 치주인대를 튼튼하게 하기 때문에 치주염증을 예방하거나 치료하는데 효과적이다.In addition, ingredients such as water soluble propolis extract, corn extract, cinnamon extract and vitamin C are effective in preventing or treating periodontitis because they strengthen the alveolar bone and periodontal ligament around teeth.
아울러, 엉겅퀴 추출물, 비타민 B1, 비타민 B2 및 비타민 B6와 같은 성분은 신체의 전반적인 면역력 증강에 도움이 되며, 특히 간 기능에 도움을 주는 성분으로 구성되어 피부 염증에 직접적으로 도움이 되고, 특히 비타민 B 군은 영양 장애 및 대사 장애에 도움이 되어 치주질환의 예방 및 치료에 도움이 되기 때문에 면역력 증강 효과가 뛰어나다.In addition, ingredients such as thistle extract, vitamin B1, vitamin B2 and vitamin B6, help to boost the body's overall immunity, and in particular, the components that help the liver function, which directly helps skin inflammation, especially vitamin B The group is excellent in boosting immunity because it helps nutritional and metabolic disorders and helps prevent and treat periodontal disease.
따라서, 본 발명의 일 실시형태에 따른 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물은 칼슘, 아보카도 추출물, 수용성 프로폴리스 추출물, 옥수수 추출물, 계피 추출물, 엉겅퀴 추출물, 비타민 C, 비타민 B1, 비타민 B2 및 비타민 B6를 포함하여 조성되기 때문에, 뼈 형성에 도움이 되고, 치주염증의 예방 및 치료에 도움이 되고, 면역력이 증강되기 때문에 꼭 필요한 성분들이기 때문에, 상기 10가지 성분이 모두 포함되도록 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 제조함으로써, 기존의 치주질환 치료 및 예방용 조성물보다 치주질환의 예방 및 치료 효과가 뛰어나게 되는 장점이 있다.Therefore, the composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention is calcium, avocado extract, water-soluble propolis extract, corn extract, cinnamon extract, thistle extract, vitamin C, vitamin B1, vitamin B2 and Since it contains vitamin B6, it helps to form bones, prevents and treats periodontal inflammation, and because immunity is strengthened, it is necessary ingredients. By preparing the composition for treating and preventing periodontal disease, there is an advantage that the prevention and treatment effect of periodontal disease is superior to the existing periodontal disease treatment and prevention composition.
본 발명의 일 실시형태에 따른 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물은, 칼슘 35 내지 60중량%, 아보카도 추출물 0.5 내지 7중량%, 수용성 프로폴리스 추출물 5 내지 25중량%, 옥수수 추출물 2 내지 15중량%, 계피 추출물 0.5 내지 7중량%, 엉겅퀴 추출물 2 내지 15중량%, 비타민 C 1 내지 10중량%, 비타민 B1 0.01 내지 0.3중량%, 비타민 B2 0.01 내지 0.3중량% 및 비타민 B6 0.01 내지 0.3중량%를 포함하여 조성되는 것을 특징으로 할 수 있다.Composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention, calcium 35 to 60% by weight, avocado extract 0.5 to 7% by weight, water soluble propolis extract 5 to 25% by weight, corn extract 2 to 15% by weight, cinnamon extract 0.5-7%, thistle extract 2-15%, vitamin C 1-10%, vitamin B1 0.01-0.3%, vitamin B2 0.01-0.3% and vitamin B6 0.01-0.3% It may be characterized by comprising a%.
1. 칼슘Calcium
칼슘은 골격과 치아의 구성성분으로 체내 칼슘 함량의 99%가 여기에 존재하며, 근육 및 신경의 정상적인 기능 유지에도 관여한다. 또한, 골격 근육과 심근육 세포의 수축 및 이완작용을 조절하며, 혈액 응고와 관련된 많은 효소의 작용에 꼭 필요한 영양소이다. 뼈에는 조골세포(Osteoblast)와 파골세포(Osteoclast)의 세포로 이루어져 있는데 조골세포에서는 콜라겐을 분비하여 뼈의 지지 구조물을 형성하고, 조골세포가 골세포(Osteocyte)로 성숙한 후 뼈의 석회화를 일으킨다. 따라서 칼슘의 섭취가 많을수록 혈중 칼슘 농도가 유지되어 칼슘이 뼈의 형성에 사용될 수 있다. 이와는 달리, 파골세포는 부갑상선 호르몬에 의해 자극되고 칼슘이 부족한 식사를 했을 때 크게 활성화되고, 활성화된 파골세포에 의해 뼈에서 칼슘을 방출하여 혈액으로 들어가게 한다. 혈중 칼슘 농도가 낮아지면 파골세포의 활성화가 촉진된다. 이러한 조골세포와 파골세포의 골회전(Bone turnover, Bone remodeling)에 의해 뼈가 형성되고 분해되고 있기 때문에 칼슘의 섭취는 뼈의 생성 및 유지에 중요하다.Calcium is a component of the skeleton and teeth, 99% of the calcium content in the body is present here, and is also involved in maintaining the normal function of muscles and nerves. In addition, it regulates the contraction and relaxation of skeletal muscle and myocardial cells, and is a nutrient essential for the action of many enzymes associated with blood coagulation. Bone is composed of osteoblasts and osteoclasts (Osteoclast) cells, osteoblasts secrete collagen to form a support structure of bone, osteoblasts mature into osteocytes (Osteocytes) and cause calcification of bones. Therefore, the more calcium intake is maintained in the blood calcium concentration, calcium can be used for bone formation. In contrast, osteoclasts are stimulated by parathyroid hormones and are greatly activated when a diet is low in calcium, and the activated osteoclasts release calcium from the bone and enter the blood. Lowering calcium levels in the blood promotes the activation of osteoclasts. Since bone is formed and degraded by bone turnover (Bone remodeling) of osteoblasts and osteoclasts, calcium intake is important for bone formation and maintenance.
칼슘은 골형성을 촉진하고, 대사 촉진 및 대사 조절 호르몬에 중요한 역할을 하는데, 그 중에서도 뼈 형성에 도움을 줌으로써, 치주질환 치료 및 예방용 조성물로 사용하였을 때, 조골세포를 활성화하고 파골세포를 억제하여 임플란트와 뼈 이식의 성공확률을 높여줄 수 있고, 임플란트 주위의 뼈 형성 촉진과 초기 고정을 빠르게 도와 임플란트 성공률을 증대시켜 주는 효과가 있다. 즉, 칼슘은 뼈와 치아를 형성하는데 필요하고, 신경과 근육의 기능을 유지시켜 주는데 중요한 역할을 하며, 정상적인 혈액 응고에 필요하기 때문에, 골이식, 임플란트 및 치주 수술 이후에 회복과 기능 향상을 위해 꼭 필요한 성분이다.Calcium plays an important role in promoting bone formation and promoting metabolism and metabolic control hormones. Among them, calcium helps activate osteoblasts and inhibit osteoclasts when used as a composition for treating and preventing periodontal disease. Therefore, it is possible to increase the probability of success of implant and bone graft, and to promote bone formation and early fixation around the implant, thereby increasing the implant success rate. In other words, calcium is necessary for bone and teeth formation, plays an important role in maintaining nerve and muscle function, and is necessary for normal blood coagulation, so that it can be recovered and improved after bone transplantation, implant and periodontal surgery. It is an essential ingredient.
본 발명의 일 실시형태에 따르면, 칼슘은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 35 내지 60중량%로 포함되어 조성되는 것이 바람직하다. 이는 건강기능식품 기능성 표시기준에 따라 설정한 함량으로, 건강기능식품 기능성 표시기준에 따르면 칼슘의 함량은 1일 220 내지 660㎎인 것으로 공지되어 있다.According to one embodiment of the present invention, calcium is preferably contained in 35 to 60% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is a content set according to the functional labeling functional dietary standard, according to the functional labeling functional food is known that the calcium content is 220 to 660mg per day.
본 발명의 일 실시형태에 따르면, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 칼슘이 35중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 칼슘 이외의 성분의 중량을 함께 고려해 보았을 때, 건강기능식품 기능성 표시기준에 따른 1일 섭취 최저 함량보다 치주질환 치료 및 예방용 조성물에 포함된 칼슘의 함량이 미달하게 되어, 칼슘의 효과가 제대로 발현되지 않을 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 칼슘이 60중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 칼슘 이외의 성분의 중량을 함께 고려해 보았을 때, 건강기능식품 기능성 표시기준에 따른 1일 섭취 최고 함량보다 치주질환 치료 및 예방용 조성물에 포함된 칼슘의 함량이 너무 과도하게 되어, 칼슘의 과잉공급에 따른 유해영향을 초래할 우려가 있다.According to one embodiment of the present invention, when the composition contains less than 35% by weight of calcium relative to the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and the weight of components other than calcium Considered together, the calcium content contained in the composition for treating and preventing periodontal disease is lower than the lowest daily intake content according to the functional food functional labeling standards, there is a fear that the effect of calcium is not properly expressed. In addition, when calcium is included in excess of 60% by weight of the total weight of the composition for treating and preventing periodontal disease, considering the total weight of the composition for treating and preventing periodontal disease and the weight of components other than calcium, The content of calcium contained in the composition for treating and preventing periodontal disease is too excessive than the maximum content of daily intake according to the labeling standard, which may cause harmful effects due to the oversupply of calcium.
칼슘의 과잉섭취하게 되면, 신적증(Nephrolithiasis), 우유-알칼리증후군(Milk-alkali syndrome : 장기간 동안 우유와 흡수성 알칼리 젤을 섭취함으로써 초래되며 고칼슘혈증과 알칼리증을 동반하거나 동반하지 않는 신부전증 증상을 나타냄), 중등도의 알칼리증, 비정상적인 혈청 탈인산효소(Phosphatase) 수치, 고질소혈증과 석회화증을 수반하는 중증 신부전증, 칼슘-무기질 상호작용의 문제 등과 같은 유해영향을 초래할 수 있다.Excessive calcium intake causes Nephrolithiasis, Milk-alkali syndrome, which is caused by the ingestion of milk and absorbent alkaline gels for a long time, with or without hypercalcemia and alkalosis. It may cause adverse effects such as moderate alkalosis, abnormal serum phosphatase levels, severe renal failure with hypertension and calcification, and problems with calcium-mineral interactions.
따라서, 칼슘은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 35 내지 60중량%로 포함되어 조성되는 것이 바람직하다. 일반적으로 칼슘은 제삼인산칼슘을 사용하여 본 발명의 일 실시형태에 따른 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 제조할 수 있지만, 다른 종류의 칼슘을 사용하여도 무방하다.Therefore, the calcium is preferably contained in 35 to 60% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts. In general, calcium may be used to prepare a composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention using calcium phosphate, but other types of calcium may be used.
2. 아보카도 추출물2. Avocado Extract
아보카도는(Persea americana Mill)는 멕시코와 중앙아메리카 일대에서 유래하였다고 알려진 과일로서, 전 세계적으로 널리 소비되고 있다. 아보카도는 20여 종의 필수 영양소와 다양한 생리 활성 물질(Phytochemical)을 함유하고 있다. 즉 식용되는 지질함량이 25% 정도로서 단일불포화지방산이 많이 함유되어 있고, 카로티노이드(Carotenoids), 비타민 B, 비타민 C, 비타민 E, 테르페노이드(Terpenoids), 시토스테롤(Sitosterol), 페르세논 A(Persenone A), 페르세논 B(Persenone B), 페놀(Phenol), 단백질, 섬유, 망간, 인, 철, 칼륨 및 엽산 등이 함유되어 있다. 아보카도 100g에는 지방 18.7g, 칼륨 720㎎, 비타민 B2 0.21㎎, 비타민 C 61.90㎎, 비타민 B6 71.80㎎, 비타민 E 1.34㎎, 식이섬유 5.30㎎이 함유되어 있다.Avocado (Persea americana Mill) is a fruit known to originate in Mexico and Central America and is widely consumed around the world. Avocados contain over 20 essential nutrients and a variety of phytochemicals. In other words, edible lipid content is about 25% and contains a large amount of monounsaturated fatty acids, carotenoids (Carotenoids), vitamin B, vitamin C, vitamin E, Terpenoids (Sitosterol), Persenone A (Persenone A) ), Persenone B, Phenolic, Protein, Fiber, Manganese, Phosphorus, Iron, Potassium and Folic Acid. 100 g of avocado contains 18.7 g of fat, 720 mg of potassium, 0.21 mg of vitamin B2, 61.90 mg of vitamin C, 71.80 mg of vitamin B6, 1.34 mg of vitamin E, and 5.30 mg of dietary fiber.
아보카도의 활성효과로는 항산화 작용, Acetyl CoA carboxylase 저해, 항균활성 등이 보고되고 있다. 특히, 아보카도 과육과 씨 및 껍질의 메탄올 추출물에 존재하는 총 폴리페놀 및 플라보노이드 함량을 측정한 결과 총 폴리페놀 함량은 아보카도 과육출물이 13.89㎍/㎎, 씨 추출물이 137.2㎍/㎎, 껍질 추출물이 223.45㎍/㎎인 것으로 측정되어, 아보카도의 과육보다 씨 및 껍질에서 폴리페놀 함량이 10 내지 20배 정도 많이 존재하여 높은 항산화능을 가지는 것으로 나타났다.Antioxidant activity, Acetyl CoA carboxylase inhibition, and antimicrobial activity have been reported as avocados. In particular, the total polyphenol and flavonoid contents in methanol extracts of avocado pulp, seeds and husks were measured. The total polyphenol contents were 13.89 µg / mg for avocado pulp extract, 137.2 µg / mg for seed extract and 223.45 for shell extract. It was measured to be μg / mg, it was found that the polyphenol content in the seeds and shells is 10 to 20 times more than the pulp of avocado, having a high antioxidant capacity.
아보카도 추출물은 폴리페놀 함량이 우수하여 항산화 활성이 우수하고, 아보카도 농도의 증가에 따라 세포막의 당단백질(ALP)의 활성이 증가하게 되어 조골세포가 증가하는 효과가 있다. 또한, 아보카도 추출물은 TRAP 효소(쥐에서 뼈 파괴 정도를 측정할 수 있는 세포 화학적 표지 효소)의 활성을 세포 독성 없이 감소시키는 효과가 뛰어나 파골세포의 분화를 억제하며, 조골세포에 대해서는 세포막의 당단백질(ALP) 활성을 증가시키는 반면에, 파골세포에 대해서는 세포 독성이 존재하는 것으로 보고되고 있어, 아보카도 추출물이 조골세포를 증식시키며, 파골세포를 억제하는 효과가 있다는 것이 입증되고 있다. 또한, 아보카도 추출물은 콜라겐(Collagen) 및 프로테오클리칸(Proteoglycan)의 합성을 돕는 효과도 있다. 따라서, 콜라겐을 분비하여 뼈의 지지 구조물을 형성하는 조골세포를 증식시키고, 뼈에서 칼슘을 혈액으로 방출시키도록 유도하는 파골세포를 억제함으로써, 뼈를 튼튼하게 하는데 아주 중요한 역할을 한다.Avocado extract has an excellent polyphenol content and excellent antioxidant activity, and as the concentration of avocado increases the activity of glycoprotein (ALP) of the cell membrane increases osteoblasts. In addition, the avocado extract is effective in reducing the activity of TRAP enzyme (a cytochemical marker enzyme that can measure the degree of bone destruction in rats) without cytotoxicity and inhibits the differentiation of osteoclasts. For osteoblasts, the glycoprotein of the cell membrane While increasing (ALP) activity has been reported to be cytotoxic to osteoclasts, it has been demonstrated that avocado extracts have the effect of proliferating osteoblasts and inhibiting osteoclasts. In addition, avocado extract has the effect of helping the synthesis of collagen (Collagen) and proteoglycan (Proteoglycan). Therefore, it plays a very important role in strengthening bones by secreting collagen, proliferating osteoblasts forming bone support structures, and inhibiting osteoclasts leading to the release of calcium from the bone into the blood.
아보카도 추출물은 조골세포 증식작용과 파골세포 억제작용을 함으로써, 뼈 형성에 도움을 주기 때문에 치주질환 치료 및 예방용 조성물로 사용하였을 때, 골이식, 임플란트 및 치주 수술 이후에 회복과 기능 향상에 뛰어난 효과가 있다.Avocado extract has osteoblast proliferation effect and osteoclast suppression effect, which helps bone formation. When used as a composition for treating and preventing periodontal disease, it has excellent effect on recovery and function after bone transplantation, implant and periodontal surgery. There is.
본 발명의 일 실시형태에 따르면, 아보카도 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.5 내지 7중량%로 포함되어 조성되는 것이 바람직하다.According to one embodiment of the present invention, the avocado extract is preferably contained in an amount of 0.5 to 7% by weight based on the total weight of the composition for treating and preventing periodontal disease using a natural extract.
본 발명의 일 실시형태에 따르면, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 아보카도 추출물이 0.5중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 아보카도 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 치주질환 치료 및 예방용 조성물에 포함된 아보카도 추출물의 함량이 너무 작아서, 아보카도 추출물의 조골세포 증식작용과 파골세포 억제작용 효과가 제대로 발현되지 않아 첨가하는 의미가 없을 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 아보카도 추출물이 7중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 아보카도 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 치주질환 치료 및 예방용 조성물에 포함된 아보카도 추출물의 함량이 너무 과도하게 되어, 아보카도 추출물 속에 포함되어 있는 비타민 E의 함량이 1일 섭취기준을 초과하여 과잉섭취 하게 됨에 따라, 체내에서 비타민 K의 흡수를 방해하고, 혈소판 응집을 감소시키며, 수술 후 출혈을 초래할 수 있고, 위장 장애, 근육 약화, 두통 및 만성피로와 같은 유해증상이 나타날 우려가 있다.According to one embodiment of the present invention, when the composition containing the avocado extract is less than 0.5% by weight relative to the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and components other than avocado extract Considering the weight together, the content of avocado extract contained in the composition for the treatment and prevention of periodontal disease is too small, so the osteoblast proliferation and osteoclast inhibitory effects of the avocado extract are not properly expressed, so there is no possibility of adding meaning. have. In addition, when the avocado extract is included in excess of 7% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease, considering the total weight of the composition for treatment and prevention of periodontal disease and the weight of components other than avocado extract, periodontal disease The avocado extract contained in the therapeutic and prophylactic composition is so excessive that the amount of vitamin E contained in the avocado extract exceeds the daily intake limit, thus preventing the absorption of vitamin K in the body. It may reduce platelet aggregation, cause bleeding after surgery, and may cause adverse symptoms such as gastrointestinal disorders, muscle weakness, headaches and chronic fatigue.
따라서, 아보카도 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.5 내지 7중량%로 포함되어 조성되는 것이 바람직하다. 상기 아보카도 추출물은 본 발명이 속하는 기술 분야에 공지된 통상의 방법으로 제조된 것을 사용할 수 있으며, 바람직하게는 아보카도를 세척 및 건조해서 분쇄한 뒤 메탄올 또는 에탄올과 같은 유기용매로 추출된 추출물을 사용할 수 있다. 본 발명에서는 아보카도를 세척 및 건조해서 분쇄한 뒤, 에탄올을 첨가하여 추출하는 방식으로 추출된 아보카도 추출물(Avocado Fruit 10:1 Extract (Persea Gratissima))을 구입하여 사용하였다.Therefore, the avocado extract is preferably contained in an amount of 0.5 to 7% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts. The avocado extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably washing and drying the avocado and pulverized and then using an extract extracted with an organic solvent such as methanol or ethanol have. In the present invention, the avocado was washed, dried and pulverized, and then avocado extract (Avocado Fruit 10: 1 Extract (Persea Gratissima)) extracted and extracted by adding ethanol was used.
3. 수용성 프로폴리스 추출물3. Water Soluble Propolis Extract
프로폴리스는 꿀벌에 의하여 나무의 수액이나 유실수의 수피, 꽃의 수술로부터 채집되며, 꿀벌의 자기방어 또는 꿀벌집의 보수에 사용되는 물질로서, 주로 수지, 밀납, 정유, 화분, 각종 유기물 및 미네랄 물질로 구성되어 있고, 항산화 작용뿐만 아니라, 항균, 항진균, 항바이러스, 항종양, 인체면역보강, 상처 치유작용 등에 효과가 있는 것으로 보고되고 있다. 프로폴리스 내의 각종 유기물과 미네랄 물질에는 20종이 넘는 다양한 플라보노이드가 다량으로 함유되어 있고, 이러한 플라보노이드는 강력한 항균효능을 나타내는 것으로 보고되어 있다. 프로폴리스의 플라보노이드는 모두 아글리콘인 것이 다른 식물의 플라보노이드와는 차별화되는 점이며, 이 화합물이 프로폴리스의 항균작용에 관여하고 있다. 또한, 프로폴리스는 장내세균에 대해서는 항균작용을 하는 것이 아니기 때문에 경구 투여하여도 인체에 유용한 장내 균주, 즉 비피더스균이나 유산균에는 악영향이 끼치지 않아서 매우 안전한 천연 항균성 물질이다.Propolis is collected from the sap of trees, the bark of lost trees, and the surgery of flowers by bees, and is used for self-defense of honey bees or repair of honeycombs, mainly resins, beeswax, essential oils, pollen, various organic and mineral substances. It is composed of, and has been reported to be effective in antibacterial, antifungal, antiviral, antitumor, human immune reinforcement, wound healing as well as antioxidant activity. Various organic and mineral substances in propolis contain a large amount of more than 20 different flavonoids, and these flavonoids have been reported to exhibit strong antibacterial effects. Flavonoids of propolis are all aglycone different from flavonoids of other plants, and this compound is involved in the antibacterial action of propolis. In addition, since propolis does not have an antibacterial action against enterobacteriaceae, it is a very safe natural antimicrobial substance because it does not adversely affect enteric strains useful for the human body, that is, bifidobacteria or lactic acid bacteria even when administered orally.
프로폴리스는 항산화 작용 및 구강에서의 항균작용이 뛰어난 것으로 보고되고 있다. 수용성 플라보노이드 혼합물이 점막의 염증 치료에 효과적이며, 치주질환 환자에서 치은 출혈을 임상적으로 억제하는 등의 점막의 염증을 치료하는 기능이 뛰어나며, 플라보노이드의 항균 및 항산화 작용으로 인해 충치 이환율이 감소하는 효과가 있고, 플라보노이드가 사람의 구강 타액에서 산 생성을 감소시켜 우식활성을 감소시키는 효과가 뛰어나다. 그로 인해, 프로폴리스는 구강청결제, 치주질환 치료제 또는 보조제, 치약 등과 같은 구강과 관련된 건강 기능성 식품 또는 제품의 성분으로 활발히 개발되고 있다.Propolis has been reported to have excellent antioxidant and antibacterial effects in the oral cavity. Water-soluble flavonoid mixtures are effective in treating mucosal inflammation, and are effective in treating mucosal inflammation, such as clinically inhibiting gingival bleeding in patients with periodontal disease, and reduce caries morbidity due to the antibacterial and antioxidant effects of flavonoids. Flavonoids are excellent in reducing caries activity by reducing acid production in human oral saliva. For this reason, propolis has been actively developed as a component of oral health-related foods or products such as mouthwashes, periodontal disease treatments or supplements, toothpastes and the like.
치주질환 환자들은 각종 치주질환에서 발생하는 염증 중에서도 특히 임플란트 시술 후 임플란트 주위에 발생하는 염증으로 인해 고통받고, 이에 따라 많은 문제가 발생하고 있다. 환자들은 염증 치료를 위해서 항생제를 복용하게 되는데, 장기적인 항생제 복용은 내성이 생길 수 있는 문제점이 있다. 따라서, 프로폴리스는 내성이 생기지 않아서 장기적으로 복용할 수 있는 천연추출물을 이용한 염증 치료제로서 각광받고 있다.Periodontal disease patients are suffering from inflammation occurring around various implants, especially after implantation, resulting in many problems. Patients take antibiotics to treat inflammation. Long-term use of antibiotics can cause resistance. Therefore, propolis is in the spotlight as an anti-inflammatory agent using a natural extract that can be taken in the long term because it does not develop resistance.
건강기능식품으로 사용되는 프로폴리스 추출물은 꿀벌이 식물에서 채취한 수지에 자신의 분비물을 혼합하여 만든 프로폴리스에서 왁스를 제거하고, 물이나 주정으로 추출하거나 이산화탄소를 이용하여 추출한 후 식용에 적합하도록 만든 것이다. 총 플라보노이드는 1% 이상 함유하고 있어야 하며, 파라(ρ)-쿠마르산 및 계피산이 확인되어야 한다. 또한, 디에틸린글리콜은 검출되지 않아야 한다.Propolis extract, which is used as a dietary supplement, is made from bees by mixing their secretions with resins obtained from plants, and removing wax, extracted with water or alcohol, or extracted with carbon dioxide. will be. Total flavonoids must be present in at least 1% and para-coumaric and cinnamic acid should be identified. In addition, diethylin glycol should not be detected.
일반적으로 건강기능식품의 재료로 사용하기 위해서는, 프로폴리스의 원료를 유기용매로 추출하여 이용하는데, 드물지만 유기용매로 인해 알레르기 등의 부작용이 발생할 수 있다. 또한, 프로폴리스가 점막에 염증 또는 궤양을 일으켜 천식 등의 과민반응을 일으킬 수 있다고 보고되고 있기 때문에, 본 발명의 치주질환 치료 및 예방용 조성물은 알레르기 반응 및 점막의 염증 또는 궤양을 방지하기 위해 수용성 프로폴리스 추출물을 사용하였다. In general, in order to use as a material for health functional food, raw materials of propolis are extracted and used as an organic solvent, but in rare cases, side effects such as allergies may occur due to the organic solvent. In addition, since propolis has been reported to cause inflammation or ulceration on mucous membranes and cause hypersensitivity reactions such as asthma, the composition for treating and preventing periodontal disease of the present invention is water-soluble to prevent allergic reactions and inflammation or ulceration of mucous membranes. Propolis extract was used.
본 발명의 일 실시형태에 따르면, 수용성 프로폴리스 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 5 내지 25중량%로 포함되어 조성되는 것이 바람직하다. 이는 수용성 프로폴리스 추출물은 기능성이 확인된 인체적용시험에서의 섭취량을 고려하여 설정한 함량이다.According to one embodiment of the present invention, the water-soluble propolis extract is preferably contained in 5 to 25% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is the amount of water-soluble propolis extract is set in consideration of the intake in the human application test confirmed the functionality.
총 플라보노이드로서 16 내지 17㎎이 일일 섭취량으로 가장 바람직하다. 건강기능식품으로 사용되는 프로폴리스 추출물은 총 플라보노이드가 1% 이상 함유되어 있어야 하기 때문에, 수용성 프로폴리스 추출물은 160 내지 200㎎이 일일 섭취량으로 바람직하게 된다.As the total flavonoid, 16 to 17 mg is most preferred as the daily intake. Since the propolis extract used as a dietary supplement should contain at least 1% of total flavonoids, the water-soluble propolis extract is preferably 160 to 200 mg in daily intake.
본 발명의 일 실시형태에 따르면, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 수용성 프로폴리스 추출물이 5중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 수용성 프로폴리스 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 기능성이 확인된 인체적용시험에서의 섭취량을 고려하여 정한 1일 섭취 최저 함량보다 치주질환 치료 및 예방용 조성물에 포함된 수용성 프로폴리스 추출물의 함량이 미달하게 되어, 수용성 프로폴리스 추출물의 항산화 작용 및 구강에서의 항균작용 효과가 제대로 발현되지 않을 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 수용성 프로폴리스 추출물이 25중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 수용성 프로폴리스 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 건강기능식품 기능성 표시기준에 따른 1일 섭취 최고 함량보다 치주질환 치료 및 예방용 조성물에 포함된 수용성 프로폴리스 추출물의 함량이 너무 과도하게 되어, 일반적이지는 않지만, 드물게 나타나는 프로폴리스의 부작용인 알레르기 반응 및 점막의 염증 또는 궤양 등을 유발할 우려가 있다.According to one embodiment of the invention, when the composition containing the water-soluble propolis extract less than 5% by weight based on the total weight of the composition for treating and preventing periodontal disease, the total weight and water-soluble propolis extract for treating and preventing periodontal disease Considering the weight of other ingredients together, the water-soluble propolis extract contained in the composition for treating and preventing periodontal disease is less than the minimum daily intake set in consideration of the intake in the functional application test. Therefore, there is a fear that the antioxidant action and the antibacterial action effect of the water-soluble propolis extract are not properly expressed. In addition, when the water-soluble propolis extract contains more than 25% by weight of the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and the weight of components other than the water-soluble propolis extract may be considered together. When the amount of water-soluble propolis extract contained in the composition for treating and preventing periodontal disease is too excessive than the highest daily intake of the functional food functional labeling standard, it is not common, but it is a rare side effect of propolis. It may cause an allergic reaction and inflammation or ulceration of the mucous membrane.
따라서, 수용성 프로폴리스 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 5 내지 25중량%로 포함되어 조성되는 것이 바람직하다. 상기 수용성 프로폴리스 추출물은 본 발명이 속하는 기술 분야에 공지된 통상의 방법으로 제조된 것을 사용할 수 있으며, 바람직하게는 미가공된 프로폴리스 원재료에 열을 가하여 비왁스(beewax)를 제거한 후, 주정으로 추출된 추출물을 사용할 수 있다. 본 발명에서는 미가공된 프로폴리스 원재료에 열을 가하여 비왁스를 제거하고, 주정을 첨가한 뒤 추출하는 방식으로 제조된 수용성 프로폴리스 추출물(Water Soluble Bee Propolis Ext. 70%)을 구입하여 사용하였다.Therefore, the water-soluble propolis extract is preferably contained in 5 to 25% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts. The water-soluble propolis extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably by applying heat to the raw raw raw propolis to remove the bewax (beewax), then extracted into the spirit Extracted extracts may be used. In the present invention, a water-soluble propolis extract (Water Soluble Bee Propolis Ext. 70%) prepared by applying heat to a raw propolis raw material to remove non-wax, and then adding alcohol, was used.
4. 옥수수 추출물4. Corn Extract
옥수수 추출물(옥수수 불검화 정량 추출물, Zea Mays L.)은 현재 치주질환 치료제 또는 치주질환을 예방하는 것을 목적으로 하는 건강 기능성 식품 및 제품의 성분으로 많이 사용되고 있다. 이는 옥수수로부터 추출한 불검화 정량 추출물인 Zea Mays L.(이하 ‘ZML’이라고도 함)이 화농의 개선과 치주염에 효과가 있는 점이 1958년에 우연히 발견되면서, 국소적 치료와 병행해서 ZML을 규칙적으로 계속 복용할 경우 치조골 흡수 및 치주인대 파괴에 대한 예방 및 재생효과가 있는 것이 실험으로 밝혀졌으며, ZML 투여시 치아동요도가 약간 감소했으며 치주낭 깊이도 감소하는 효과가 임상실험 결과로 입증되고 있기 때문이다. 또한, 치주염 환자에서 치아동요도와 치조골 흡수를 감소시켜 주는 것을 관찰한 결과, 국소치료를 시행한 후 ZML을 투여하여 약 80% 정도에서 골의 염증성 분해 과정이 중지됨을 보고하면서 ZML이 골의 영양과정에서 유용하여 작용함으로써 치주질환을 완화하는 효과도 있음이 확인되었다.Corn extract (corn unchecked quantitative extract, Zea Mays L.) is currently used as a component of health functional foods and products aimed at preventing periodontal disease or preventing periodontal disease. This is due to the fact that Zea Mays L. (hereinafter referred to as 'ZML'), an unchecked quantitative extract from corn, was found to be effective in improving purulent and periodontitis in 1958. It has been shown in the experiment that when taken, it has the effect of preventing and regenerating alveolar bone absorption and destruction of periodontal ligament. In addition, as a result of the reduction of dental rhythm and alveolar bone resorption in patients with periodontitis, ZML was reported to stop inflammatory degradation of bone in about 80% after topical treatment. It has been found to be effective in alleviating periodontal disease.
옥수수 추출물은 주로 베타-시토스테롤(Beta-Sitosterol), 스티그마스테롤(Stigmasterol) 및 에르고스테롤(Ergosterol) 등으로 구성된 식물 스테롤(Phytosterol)과 탄화수소인 스쿠알렌(Squlaene), 지용성 비타민인 카로틴(Carotene) 및 토코페롤(Tocopherol) 등과 같은 불검화물로 구성되어 있다. 특히 본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 조성물은 베타-시토스테롤이 10% 이상 함유된 것을 사용한다.Corn extract is composed mainly of phytosterol consisting of beta-Sitosterol, Stigmasterol and Ergosterol, Squlaene, a hydrocarbon, Carotene and Tocopherol (liposoluble vitamins). Tocopherol). In particular, the composition for the treatment and prevention of periodontal disease according to an embodiment of the present invention uses that containing 10% or more of beta-sitosterol.
베타-시토스테롤은 가장 널리 분포되어 있는 식물 스테롤이고, 비타민 D의 전구물, 즉 프로비타민 D의 일종으로 칼슘이 흡수를 촉진하며, 치조골 형성을 촉진하고, 치주인대 섬유 재생작용을 하며, 상피세포와 정상화와 항염 작용의 기능이 뛰어나다. 베타-시토스테롤은 조골세포의 소포체를 활성화해 줌으로써 골세포의 생성을 촉진하여 허물어진 치조골 재생을 촉진하며, 치조골의 흡수를 막아주어 잇몸을 튼튼하게 해주는 효과가 뛰어나다. 또한, 파괴된 치주인대 섬유를 재생시키고, 치아의 비정상적인 흔들림을 막아주는 기능도 뛰어나다. 아울러, 손상된 상피세포를 회복시키는 기능이 뛰어나며, 잇몸을 튼튼하게 하여 세균 감염으로부터 저항할 수 있는 항염 작용이 뛰어나기 때문에, 본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 조성물은 베타-시토스테롤이 10% 이상 함유된 옥수수 추출물을 사용하는 것이 중요하다.Beta-sitosterol is the most widely distributed plant sterol, a precursor of vitamin D, or provitamin D, which promotes absorption of calcium, promotes alveolar bone formation, regenerates periodontal ligament fibers, Excellent function of normalization and anti-inflammatory action. Beta-sitosterol promotes osteoblast production by activating the endoplasmic reticulum of osteoblasts, promotes the regeneration of the collapsed alveolar bone, and prevents the absorption of the alveolar bone, thereby strengthening the gums. In addition, it is excellent in regenerating damaged periodontal ligament fibers and preventing abnormal shaking of teeth. In addition, because it has an excellent function of restoring damaged epithelial cells, and has excellent anti-inflammatory action that can strengthen gums and resist bacterial infection, the composition for treating and preventing periodontal disease according to an embodiment of the present invention is beta-sitosterol. It is important to use corn extracts containing more than 10%.
본 발명의 일 실시형태에 따르면, 옥수수 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 2 내지 15중량%로 포함되어 조성되는 것이 바람직하다. 이는 치주질환으로 일반의약품에 등재되어 있는 옥수수 추출물의 함량을 기준으로 정한 함량이며, 1일 섭취량은 80 내지 120㎎이 바람직하다.According to one embodiment of the present invention, the corn extract is preferably contained by containing 2 to 15% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts. This is a periodontal disease is determined based on the content of the corn extract listed in the general medicine, the daily intake is preferably 80 to 120mg.
본 발명의 일 실시형태에 따르면, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 옥수수 추출물이 2중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 옥수수 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 치주질환 치료 및 예방용 조성물에 포함된 옥수수 추출물의 함량이 너무 작아서, 옥수수 추출물의 조골세포의 소포체를 활성화 시키고, 비타민 D의 전구체로서 칼슘 흡수를 촉진하는 기능과, 치조골 재생 촉진 및 치주인대 섬유 재생 등과 같은 효과가 제대로 발현되지 않아 첨가하는 의미가 없을 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 옥수수 추출물이 15중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 옥수수 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 치주질환 치료 및 예방용 조성물에 포함된 옥수수 추출물의 함량이 너무 과도하게 되어, 생산 단가가 증가하여 생산성이 떨어질 우려가 있고, 다른 치주질환 치료 및 예방용 조성물의 성분 함량에 영향을 끼칠 수 있기 때문에 바람직하지 않다.According to an embodiment of the present invention, when the corn extract is contained in an amount of less than 2% by weight based on the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and components other than corn extract Considering the weight together, the amount of corn extract contained in the composition for treating and preventing periodontal disease is too small, activating osteoblast vesicles of corn extract, and promoting calcium absorption as a precursor of vitamin D, alveolar bone Effects such as promoting regeneration and periodontal ligament fiber regeneration are not properly expressed, there is a fear that it does not add meaning. In addition, when the corn extract exceeds 15% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease, considering the total weight of the composition for the treatment and prevention of periodontal disease and the weight of components other than corn extract, periodontal disease The amount of corn extract contained in the therapeutic and prophylactic composition is so excessive that the production cost may increase, resulting in a decrease in productivity, which may affect the component content of other periodontal disease treatment and prophylactic compositions. not.
따라서, 옥수수 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 2 내지 15중량%로 포함되어 조성되는 것이 바람직하다. 상기 옥수수 추출물은 본 발명이 속하는 기술 분야에 공지된 통상의 방법으로 제조된 것을 사용할 수 있으며, 바람직하게는 옥수수와 옥수수수염을 함께 세척하고 건조한 뒤 분쇄하고, 분쇄된 분쇄물에 에탄올 또는 물을 첨가한 뒤 추출하여 제조된 추출물을 사용할 수 있으며, 일반적으로 치주질환 의약품 제조에 많이 사용되는 옥수수불검화정량 추출물을 사용할 수 있다. 본 발명에서는 옥수수를 세척하고 건조한 뒤 분쇄하고, 분쇄된 분쇄물에 에탄올을 첨가한 뒤 추출하는 방식으로 제조된 옥수수추출물(GMO Free Corn Silk with 10% Beta Sitosterol (Zea Mays))을 구입하여 사용하였다.Therefore, the corn extract is preferably contained by containing 2 to 15% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts. The corn extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably washing the corn and cornbeard together, dried and pulverized, ethanol or water is added to the pulverized ground After the extraction can be used to extract the extract can be used, corn unchecked quantitative extract commonly used in the manufacture of periodontal disease medicines. In the present invention, the corn extract (GMO Free Corn Silk with 10% Beta Sitosterol (Zea Mays)) was prepared by washing corn, drying and pulverizing, and adding ethanol to the pulverized powder. .
5. 계피 추출물5. Cinnamon Extract
계피는 녹나무과(Lauraceae)에 속하는 상록열대 계피나무의 외피를 건조한 것으로 한방에서는 두통, 발열, 신경성심계항진(神經性心悸亢進), 진통 등의 치료제로 사용되어 왔다. 계피의 주요 성분은 계피유라고 하는 정유(Essential oil)로 신남산 알데하이드(Cinnamic aldehyde), 캄펜 시네올(Camphene cineol), 리나룰(Linalool), 유게놀(ERugenol), 당질, 지방질, 인, 철분, 비타민 A, 비타민 B1, 비타민 B2 등의 성분을 함유하고 있기 때문에, 음료, 츄잉검, 치약 및 화장품의 향성분, 구취제거제 등으로 많이 이용되고 있으며, 항산화작용 및 항궤양 유발 작용도 뛰어난 것으로 보고되고 있다. 또한, 위장 점막을 자극하여 분비를 왕성하게 하고, 위장의 경련성 통증을 억제하고 위장관의 운동을 촉진하여 가스를 배출하고 흡수를 좋게 하는 효과도 있다. 또한, 계피는 신경을 흥분시켜서 혈액순환을 촉진하고 몸을 따뜻하게 하며 장내의 이상 발효를 억제하는 방부 효과도 있다. 계피의 신남산 알데하이드는 지속적인 말초혈관 확장작용(혈압강하) 및 혈소판 응집억제작용의 기능도 있으며 발한 작용, 진토 작용 등과 같은 효과도 있다. 감기, 진통, 진경을 위해서 많이 사용되고 있으며, 계피 추출물에서는 음식물의 부패를 억제하는 항균활성 기능도 뛰어나다.Cinnamon is a dry, evergreen tropical cinnamon tree belonging to the family Lauraceae. Herbal medicine has been used for the treatment of headache, fever, nervousness, and pain. The main ingredients of cinnamon are essential oils called cinnamon oils, which are Cinnamic aldehyde, Campen cineol, Linalool, Eugenol, Sugar, Fat, Phosphorus, Iron, Because it contains ingredients such as vitamin A, vitamin B1, and vitamin B2, it is widely used as a fragrance component in beverages, chewing gums, toothpaste and cosmetics, and bad breath remover. have. In addition, it stimulates the gastrointestinal mucosa, stimulates secretion, suppresses spasms of pain in the stomach, promotes the movement of the gastrointestinal tract, and releases gas and improves absorption. In addition, cinnamon stimulates nerves, promotes blood circulation, warms the body, and has an antiseptic effect of inhibiting abnormal fermentation in the intestine. Cinnamic aldehydes of cinnamon have a function of persistent peripheral vasodilation (hypertension) and platelet aggregation inhibition, and effects such as sweating and clay. It is widely used for colds, analgesic, and dysmenorrhea, and cinnamon extract is also excellent in antimicrobial activity to suppress food corruption.
계피 추출물은 특유의 향과 항산화 및 항염 작용이 뛰어나기 때문에 천연 항생제 및 구취제거제로도 사용할 수 있다. 특히, 본 발명의 치주질환 치료 및 예방용 조성물의 성분인 수용성 프로폴리스와 함께 천연항생제로 작용하여 염증을 억제하는 효과가 뛰어나기 때문에, 치주질환 치료 및 예방용 조성물에서 중요한 성분이다.Cinnamon extract can be used as a natural antibiotic and bad breath remover because of its unique flavor, antioxidant and anti-inflammatory properties. In particular, since it is excellent in inhibiting inflammation by acting as a natural antibiotic with water-soluble propolis which is a component of the composition for treating and preventing periodontal disease of the present invention, it is an important component in the composition for treating and preventing periodontal disease.
본 발명의 일 실시형태에 따르면, 계피 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.5 내지 7중량%로 포함되어 조성되는 것이 바람직하다.According to one embodiment of the invention, the cinnamon extract is preferably contained in 0.5 to 7% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract.
본 발명의 일 실시형태에 따르면, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 계피 추출물이 0.5중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 계피 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 치주질환 치료 및 예방용 조성물에 포함된 계피 추출물의 함량이 너무 작아서, 계피 추출물의 항산화 및 항염 작용 효과가 제대로 발현되지 않아 천연 항생제로서의 역할을 제대로 수행하지 못할 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 계피 추출물이 7중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 계피 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 치주질환 치료 및 예방용 조성물에 포함된 계피 추출물의 함량이 너무 과도하게 되어, 열이 있거나 몸에 열이 많은 사람에게 치명적일 수 있으며, 생산 단가가 증가하여 생산성이 떨어질 우려가 있고, 다른 치주질환 치료 및 예방용 조성물의 성분 함량에 영향을 끼칠 수 있기 때문에 바람직하지 않다. According to one embodiment of the present invention, when the cinnamon extract is contained in an amount of less than 0.5% by weight based on the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and components other than cinnamon extract Considering the weight together, the content of cinnamon extract in the composition for the treatment and prevention of periodontal disease is too small, and the antioxidant and anti-inflammatory effects of cinnamon extract may not be properly expressed, which may prevent it from functioning as a natural antibiotic. . In addition, when the cinnamon extract is included in excess of 7% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease, considering the total weight of the composition for the treatment and prevention of periodontal disease and the weight of components other than cinnamon extract, periodontal disease The amount of cinnamon extract contained in the therapeutic and prophylactic composition is so excessive that it can be fatal to a person with a fever or a lot of heat in the body, there is a fear that productivity may decrease due to increased production cost, and treatment and prevention of other periodontal disease It is not preferable because it may affect the component content of the composition.
따라서, 계피 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.5 내지 7중량%로 포함되어 조성되는 것이 바람직하다. 상기 계피 추출물은 본 발명이 속하는 기술 분야에 공지된 통상의 방법으로 제조된 것을 사용할 수 있으며, 바람직하게는 계피를 분쇄하여 물로 추출한 뒤, 여과, 농축 및 정제의 과정을 거쳐 제조된 추출물을 사용할 수 있다. 본 발명에서는 계피에 물을 첨가한 뒤 75 내지 85℃의 온도에서 2시간 동안 추출하는 추출과정을 3번 반복한 뒤, 여과하는 과정을 거치고, 75 내지 85℃의 온도에서 감압 농축시키고 정제한 뒤 건조하는 방식으로 제조된 계피 추출물(Cinnamon Bark 2:1 Extract (Cinnamomum Zeylanicum))을 구입하여 사용하였다.Therefore, the cinnamon extract is preferably contained in an amount of 0.5 to 7% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts. The cinnamon extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably extract the water by grinding the cinnamon, it can be used through the process of filtration, concentration and purification have. In the present invention, after adding water to the cinnamon is repeated three times the extraction process to extract for 2 hours at a temperature of 75 to 85 ℃, after the filtration process, concentrated under reduced pressure and purified at a temperature of 75 to 85 ℃ The cinnamon extract (Cinnamon Bark 2: 1 Extract (Cinnamomum Zeylanicum)) prepared by drying was purchased and used.
6. 엉겅퀴 추출물6. Thistle Extract
엉겅퀴(밀크씨슬, Milk Thistle)는 국화과 식물로 학명은 Silybum marianum (L.) Gaertn이고, 이명은 Carduus silybum이며, 열매와 씨가 식용으로 사용된다. 전통적으로 본초학자들은 엉겅퀴(밀크씨슬) 씨를 만성간질병 등 간을 보호하기 위하여 사용하였고 유럽 등 주요 국가에서는 엉겅퀴(밀크씨슬)의 실리마린(Silymarin) 성분이 활성 산소로부터 간세포를 보호하는 등 항산화작용을 한다고 알려져 있기 때문에 간장치료제 또는 식이보충제로 많이 사용하고 있다.Milk Thistle is an asteraceae, scientific name is Silybum marianum (L.) Gaertn, tinnitus is Carduus silybum, and fruit and seeds are used for food. Traditionally, herbalists have used thistle (milk thistle) seeds to protect the liver, such as chronic epilepsy, and in Europe, major countries such as Silymarin of thistle (milk thistle) protect liver cells from free radicals. Because it is known to be used as a liver supplement or a dietary supplement.
엉겅퀴(밀크씨슬) 추출물은 엉겅퀴(밀크씨슬, Milk Thistle)를 분쇄하여 주정으로 추출하고 여과, 농축 및 정제의 과정을 거쳐 제조한 것으로써, 기능성분인 실리마린(Silymarin)이 320~660㎎/g 정도 함유되어 있는 원료이다. 실리마린은 Silybin(A, B)과 Silychristin, Silydianin, Isosilybin(A, B)의 4가지 이성체로 구성되어 있다.Thistle (milk thistle) extract is produced by pulverizing thistle milk (milk thistle), extracted by alcohol, filtration, concentration and purification, 320 ~ 660mg of functional ingredient silymarin (Silymarin) It is a raw material containing about / g. Silymarin consists of four isomers: Silybin (A, B), Silychristin, Silydianin, and Isosilybin (A, B).
엉겅퀴(밀크씨슬)에서는 실리마린(Silymarin)이라는 성분이 들어 있어 간의 기능을 좋게 하는 효능이 뛰어나다고 알려져 있다. 항산화 작용이 비타민 E의 10배에 달하기 때문에 글루타치온의 분비를 증가시켜 간 해독을 원활하게 하여 간의 조직을 재생하는 효능이 뛰어나 간 기능을 회복하는데 도움이 된다. 또한, 엉겅퀴의 씨앗에서 추출한 실리마린(Silymarin)은 암세포의 증식을 억제하는 효능이 있으며, 연구결과를 통해 암환자들이 항암치료를 받는 과정에서 발생하는 부작용인 염증이나 간 손상의 예방 및 치료에도 효과가 뛰어난 것으로 밝혀졌다.Thistle (milk thistle) contains a component called Silymarin (Silymarin) is known to be effective in improving the function of the liver. Since the antioxidant activity is 10 times higher than vitamin E, glutathione secretion is increased to facilitate liver detoxification, which is effective in regenerating liver tissue, which helps restore liver function. In addition, silymarin (Silymarin), which is extracted from the seeds of thistle, has the effect of inhibiting the proliferation of cancer cells, and the research results are also effective in preventing and treating inflammation or liver damage, which is a side effect of cancer patients undergoing chemotherapy. Turned out to be excellent.
즉, 엉겅퀴(밀크씨슬)의 실리마린(Silymarin) 성분은 활성 산소로부터 간세포를 보호하는 등의 항산화 작용이 뛰어나기 때문에 간장치료제 및 식이보충제로 사용되고 있으며, 간 건강에 도움이 된다. 치과 진료 특성상 피부와 면역력에 직접적인 연관이 있기 때문에 간 기능 회복은 치주질환에 치료에 매우 중요하다. 따라서, 엉겅퀴(밀크씨슬)의 실리마린(Silymarin) 성분은 간 기능 회복에 효과적이므로, 골이식, 임플란트 및 치주 수술 이후에 회복과 기능 향상을 위해 꼭 필요한 영양 성분이기 때문에 치주질환 치료 및 예방용 조성물에 꼭 필요한 원료 성분이다.That is, the milk thistle silymarin (Silymarin) component is used as a liver supplement and a dietary supplement because it has an excellent antioxidant activity, such as protecting the liver cells from free radicals, and is beneficial for liver health. The recovery of liver function is very important in the treatment of periodontal disease because of the direct relationship between skin and immunity. Therefore, the milk thistle silymarin (Silymarin) component is effective in restoring liver function, it is an essential ingredient for recovery and function after bone graft, implant and periodontal surgery, so the composition for the treatment and prevention of periodontal disease Essential ingredient in the.
본 발명의 일 실시형태에 따르면, 엉겅퀴 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 5 내지 15중량%로 포함되어 조성되는 것이 바람직하다. 이는 건강기능식품 기능성 표시기준에 따라 설정한 함량이다.According to one embodiment of the present invention, the thistle extract is preferably contained in an amount of 5 to 15% by weight relative to the total weight of the composition for treating and preventing periodontal disease using natural extracts. This is the content set according to the functional labeling standards of functional foods.
국내에서는 엉겅퀴 씨와 열매는 식품원료로 사용되고 있으며 엉겅퀴 추출물은 일반 의약품으로도 사용되고 있다. 국외에서도 엉겅퀴 추출물이 식이 보충제와 의약품으로 사용되고 있다. Prehensine Database에서는 식품으로, 미국약전(USP-NP)에는 Dietary Supplements로 등재되어 있다. 실리마린 210-260㎎/일의 양으로 진행된 임상실험에서는 부작용이 보고되지 않았고, WHO monograph에서는 실리마린의 일일 섭취량을 200-400㎎으로 권장하고 있으나, 건강기능식품으로서의 안전성을 고려하여 건강기능식품 기능성 표시기준에 따라 함량을 설정하면 일일 섭취량을 실리마린을 기준으로 80-240㎎인 것이 바람직하다.In Korea, thistle seeds and berries are used as food ingredients, and thistle extract is also used as a general medicine. Thistle extract is used abroad as a dietary supplement and medicine. It is listed as a food in the Prehensine Database and as a Dietary Supplement in the USP-NP. In clinical trials conducted with silymarin 210-260 mg / day, no adverse effects were reported. The WHO monograph recommends 200-400 mg daily intake of silymarin, but functional health foods are considered in consideration of safety as a dietary supplement. When the content is set according to the standard, the daily intake is preferably 80 to 240 mg based on silymarin.
본 발명의 일 실시형태에 따르면, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 엉겅퀴 추출물이 5중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 엉겅퀴 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 건강기능식품 기능성 표시기준에 따라 설정한 함량을 고려하여 정한 1일 섭취 최저 함량보다 치주질환 치료 및 예방용 조성물에 포함된 엉겅퀴 추출물의 함량이 너무 작아서, 엉겅퀴 추출물의 간 기능 회복 효과가 제대로 발현되지 않아 첨가하는 의미가 없을 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 엉겅퀴 추출물이 15중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 엉겅퀴 추출물 이외의 성분의 중량을 함께 고려해 보았을 때, 건강기능식품 기능성 표시기준에 따라 설정한 함량을 고려하여 정한 1일 섭취 최고 함량보다 치주질환 치료 및 예방용 조성물에 포함된 엉겅퀴 추출물의 함량이 너무 과도하게 되어, 설사, 두통 및 관절통과 같은 유해증상이 나타날 우려가 있다.According to one embodiment of the present invention, when the composition of the composition for treating and preventing periodontal disease is less than 5% by weight based on the total weight of the composition for treating and preventing periodontal disease, the total weight of the composition for treating and preventing periodontal disease and components other than thistle extract Considering the weight together, the amount of thistle extract contained in the composition for treating and preventing periodontal disease is too small, compared to the minimum daily intake set in consideration of the content set according to the functional food functional labeling standard. There is a fear that the function recovery effect is not properly expressed, so there is no meaning to add. In addition, if thistle extract contains more than 15% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease, when considering the total weight of the composition for the treatment and prevention of periodontal disease and the weight of components other than thistle extract, health function The amount of thistle extract contained in the composition for the treatment and prevention of periodontal disease is too much higher than the maximum daily intake set in consideration of the content set according to the food functional labeling criteria, and thus, harmful symptoms such as diarrhea, headache and joint pain may occur. There is concern.
따라서, 엉겅퀴 추출물은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 5 내지 15중량%로 포함되어 조성되는 것이 바람직하다. 상기 엉겅퀴 추출물은 본 발명이 속하는 기술 분야에 공지된 통상의 방법으로 제조된 것을 사용할 수 있으며, 바람직하게는 엉겅퀴를 분쇄하여 주정으로 추출한 뒤, 여과, 농축 및 정제의 과정을 거쳐 제조된 추출물을 사용할 수 있다. 본 발명에서는 엉겅퀴를 분쇄한 뒤 주정을 첨가하여 추출하고, 추출된 추출물을 여과시킨 뒤 농축하고 정체하는 방식으로 제조된 엉겅퀴 추출물(Milk Thistle 80% Silymarin (Silybum marianum))을 구입하여 사용하였다.Therefore, the thistle extract is preferably contained by containing 5 to 15% by weight relative to the total weight of the composition for the treatment and prevention of periodontal disease using natural extracts. The thistle extract may be prepared by a conventional method known in the art to which the present invention belongs, preferably, thistle is pulverized and extracted with alcohol, and then the extract prepared through the process of filtration, concentration and purification to use Can be. In the present invention, thistle was pulverized and extracted by the addition of alcohol, and then the extracted extract was filtered and concentrated and stagnant thistle extract (Milk Thistle 80% Silymarin (Silybum marianum)) purchased and used.
7. 비타민 C7. Vitamin C
비타민 C는 6개의 탄소로 이루어진 락톤(Lactone)이며, 식물과 대부분의 동물은 체내에서 비타민 C를 합성할 수 있지만, 사람, 영장류, 기니아피그, 큰 박쥐, 몇 종의 조류와 어류는 합성할 수 없으므로, 반드시 식품의 형태로 섭취해야 한다. 비타민 C라 함은 환원형의 아스코르빈산 (Ascorbic acid)과 산화형인 디하이드로아스코르빈산(Dehydroascorbic acid)을 모두 포함하며, 이 두 물질은 상호 전환이 가능하다. 실제로 우리가 섭취하는 식품에는 2가지 형태가 모두 존재한다.Vitamin C is a six-carbon lactone, and plants and most animals can synthesize vitamin C in the body, but humans, primates, guinea pigs, large bats, and some species of birds and fish can synthesize it. Therefore, it must be in the form of food. Vitamin C contains both reduced ascorbic acid and oxidized dehydroascorbic acid, which can be converted. In fact, there are two types of food we eat.
비타민 C는 결합조직을 형성할 수 있는 기능이 있는데, 생체 내에서 여러 가지 효소반응의 조효소로 쓰이며, 피부, 골격, 혈관, 연골 등의 결합조직을 구성하는 주요 단백질인 콜라겐의 합성에 관여한다. 아미노산인 프롤린(Proline)과 리신(Lysine)이 수산화되어 하이드록시프롤린(Hydroxyproline)과 하이드록시리신(Hydroxylysine)을 형성할 때 비타민 C가 수산화효소(Hydroxylase)의 철분을 환원형으로 유지시키는 역할을 하게 되어 콜라겐 조직을 유지하게 된다.Vitamin C has the function of forming connective tissue, which is used as a coenzyme of various enzymatic reactions in vivo, and is involved in the synthesis of collagen, a major protein constituting connective tissue such as skin, skeleton, blood vessels and cartilage. When the amino acids proline and lysine are hydrated to form hydroxyproline and hydroxylysine, vitamin C plays a role in reducing the iron content of the hydroxylase. To maintain collagen tissue.
비타민 C의 전자제공 기능은 활성산소종(Reactive Oxygen Species, ROS)과 활성질소종(Reactive Nitrogen Species, RNS) 등의 자유기를 제거하는 항산화 활성을 유도하는 역할을 한다. 특히 안구나 중성구, 정액 등과 같이 자유기로부터 손상을 받기 쉬운 조직은 비타민 C의 함량이 비교적 높은 것으로 알려졌으며, 이 외에도 저밀도지단백질(LDL) 등의 지질과산화의 개시를 방지하므로 비타민 E의 절약작용에도 관여한다. 또한, 비타민 C의 라디칼은 다른 항산화제에 비해 반감기(Half-life)가 5 내지 10초로 비교적 긴 편이어서 안정적인 항산화제로 인정받고 있다.The electron donating function of vitamin C induces antioxidant activity to remove free radicals such as reactive oxygen species (ROS) and reactive nitrogen species (RNS). In particular, tissues susceptible to damage from free radicals, such as eyeballs, neutrophils, and semen, are known to have a relatively high content of vitamin C. In addition, it prevents the onset of lipid peroxidation such as low density lipoprotein (LDL). Get involved. In addition, the radicals of vitamin C have a relatively long half-life of 5 to 10 seconds compared to other antioxidants, and thus are recognized as stable antioxidants.
비타민 C는 소장관에서 철분을 환원형으로 전환함으로써 헤모글로빈에 결합되어 있지 않은 식물성 철분의 흡수를 촉진하는 등의 철분 흡수 효과도 뛰어난 것으로 알려져 있다. 즉, 비타민 C는 결합조직의 형성과 기능 유지에 필요한 성분이며, 철의 흡수에 도움이 되고, 유해산소로부터 세포를 보호하는 역할을 하기 때문에, 골이식, 임플란트 및 치주 수술 이후에 회복과 기능 향상을 위해 꼭 필요한 성분이다.Vitamin C is also known to be excellent in iron absorption effects, such as promoting the absorption of vegetable iron that is not bound to hemoglobin by converting iron to a reduced form in the small intestine. In other words, vitamin C is necessary for the formation and maintenance of connective tissue, and it is effective for iron absorption and protects cells from harmful oxygen. Therefore, vitamin C is recovered and improved after bone transplantation, implant and periodontal surgery. Essential ingredient for
본 발명의 일 실시형태에 따르면, 비타민 C는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 1 내지 10중량%로 포함되어 조성되는 것이 바람직하다. 이는, 성인 남녀의 일일 권장 섭취량에 따라 설정한 함량이다.According to one embodiment of the present invention, vitamin C is preferably contained in an amount of 1 to 10% by weight based on the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is a content set according to the recommended daily intake of adult men and women.
성인 남녀의 비타민 C 평균 필요량은 75㎎/일이며, 권장 섭취량은 100㎎/일이다. 권장 섭취량은 백혈구의 비타민 C 농도를 최대한으로 유지하면서, 소변을 통한 배설양은 최소로 유지하는 양에 근거하여 설정된다.The average requirement for vitamin C in men and women is 75 mg / day and the recommended intake is 100 mg / day. The recommended intake is set based on the amount of urine excretion while keeping leukocytes' vitamin C levels to a maximum.
치주질환 치료 및 예방용 조성물 전체 중량에 대해서 비타민 C가 1중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 비타민 C 이외의 성분의 중량을 함께 고려해 보았을 때, 성인 남녀의 평균 필요량보다 치주질환 치료 및 예방용 조성물에 포함된 비타민C의 함량이 미달하게 되어, 비타민 C를 첨가하는 의미가 없고, 비타민 C의 효과가 제대로 발현되지 않을 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 비타민 C가 10중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 비타민 C 이외의 성분의 중량을 함께 고려해 보았을 때, 성인 남녀의 권장 섭취량보다 치주질환 치료 및 예방용 조성물에 포함된 비타민C의 함량이 너무 과도하게 되어, 비타민 C의 과잉공급에 따른 문제점이 발생할 수 있다.When the composition of the composition for treating and preventing periodontal disease is less than 1% by weight of the total weight of the composition, when considering the total weight of the composition for treating and preventing periodontal disease and the weight of components other than vitamin C, The content of vitamin C contained in the composition for the treatment and prevention of periodontal disease is less than the average required amount of, there is no meaning to add vitamin C, there is a fear that the effect of vitamin C is not properly expressed. In addition, when vitamin C is included in an amount of more than 10% by weight based on the total weight of the composition for treating and preventing periodontal disease, when considering the total weight of the composition for treating and preventing periodontal disease and the weight of the components other than vitamin C, The amount of vitamin C contained in the composition for the treatment and prevention of periodontal disease is too excessive than the recommended intake of, may cause problems due to the excessive supply of vitamin C.
과량의 비타민 C가 첨가되어 있는 보충용 식품을 섭취하게 될 경우, 오심, 구토, 복부 팽만감, 복통, 설사 등 주로 위장관 증상을 나타내는 것으로 알려져 있다. 이 밖에도 수산 배설 및 신결석, 요산 배설량 증가, 과도한 철 흡수, 비타민 B12 수준 저하 등이 보고되고 있다. 임산부의 경우 임신 중 과량의 비타민 C를 섭취하면 신생아에게 비타민 C 의존증을 유발시킨다는 사례 보고가 있으며, 동물시험과 In vitro 시험에서는 비타민 C가 과도하게 산화를 촉진(Pro-Oxidant)해 유해영향을 나타낼 수 있는 것으로 보고되고 있다.When supplemental foods in which excess vitamin C is added, it is known to mainly cause gastrointestinal symptoms such as nausea, vomiting, bloating, abdominal pain and diarrhea. In addition, fishery excretion and nephrolithiasis, increased uric acid excretion, excessive iron absorption, and vitamin B12 levels have been reported. In pregnant women, excessive vitamin C ingestion has been reported to cause vitamin C dependence in newborns. In animal and in vitro studies, vitamin C is pro-Oxidant and may have adverse effects. It is reported that it is possible.
따라서, 비타민 C는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 1 내지 10중량%로 포함되어 조성되는 것이 바람직하다.Therefore, the vitamin C is preferably contained in an amount of 1 to 10% by weight based on the total weight of the composition for treating and preventing periodontal disease using a natural extract.
8. 비타민 B18. Vitamin B1
비타민 B1(Thiamin, 티아민)은 가운데 위치한 탄소에 질소가 함유된 육각형의 환(Pyrimidine)과 황이 함유된 오각형의 환(Thiazole)이 메틸렌 다리(Methylene bridge)에 의해 연결되어 있다.Vitamin B1 (Thiamin) is a hexagonal ring (Pyrimidine) containing nitrogen in the center and sulfur pentagonal ring (Thiazole) connected by a methylene bridge.
돼지고기류, 해바라기씨, 맥주 효모, 두류, 감자류 밀 배아, 전곡과 강화된 곡류, 완두콩, 아스파라거스, 육류의 내장, 땅콩 및 기타 종실류, 버섯, 수박 등이 비타민 B1의 좋은 급원 식품이다. 이처럼 비타민 B1이 함유된 식품은 많으나, 일반적으로 함량은 낮기 때문에 다양한 식품을 섭취하는 것이 바람직하다.Pork, sunflower seeds, brewer's yeast, soybeans, potato wheat germ, whole grains and fortified grains, peas, asparagus, meat guts, peanuts and other seeds, mushrooms and watermelons are good sources of vitamin B1. As such, there are many foods containing vitamin B1, but in general, the content is low, so it is desirable to eat a variety of foods.
비타민 B1의 조효소 형태인 Thiamin pyrophosphate(TPP)는 인산기가 2개 첨가된 형태로 피루빈산염(Pyruvate), 알파케토글루타르산(α-Ketoglutarate), 분지상 케토산(Branched-Chain Keto acids) 등과 같은 알파케토산(α-Keto acids)의 탈탄산반응(Decarboxylation)을 촉매 시키는 역할을 한다. 또한, 육탄당인산(Hexose phosphates)과 오탄당인산(Pentose phosphates)의 케토전이(Transketolation) 반응을 촉매 시키는 역할도 한다. 케토전이 반응에 필요한 트랜스케톨레이즈(Transketolase)는 TPP를 필요로 하는 효소로 오탄당 인산회로(Pentose phosphate pathway)에서 육탄당인 포도당으로부터 오탄당을 만들어 낸다. 따라서 비타민 B1은 탄수화물과 분지상 아미노산(류신, 이소류신, 발린)의 대사에 필요하다. 즉 비타민 B1은 에너지 대사에 관여하므로, 비타민 B1의 필요량은 에너지 소모량과 상관이 크다.Thiamin pyrophosphate (TPP), a coenzyme form of vitamin B1, has two phosphate groups, including pyruvate, alpha-ketoglutarate, and branched-chain keto acids. It serves to catalyze the decarboxylation of the same alpha-keto acids. It also catalyzes the transketolation reaction between hexose phosphates and pentose phosphates. Transketolase, which is required for ketotransition reactions, is an enzyme that requires TPP to produce pentose sugar from glucose, which is hexose, in the Pentose phosphate pathway. Vitamin B1 is therefore required for the metabolism of carbohydrates and branched amino acids (leucine, isoleucine, valine). That is, vitamin B1 is involved in energy metabolism, so the required amount of vitamin B1 is highly correlated with energy consumption.
비타민 B1은 탄수화물과 에너지 대사에 필요하기 때문에, 치주질환 치료 및 예방용 조성물로 사용하였을 때, 치주질환 환자들이 씹어서 소화시켜야 하는 탄수화물의 대사에 약하다는 단점을 해결할 수 있으며, 에너지 대사에도 직접 관여하여 만성 치주질환 환자의 치주 재생에 효과적인 기능을 수행한다. Since vitamin B1 is required for carbohydrate and energy metabolism, when used as a composition for the treatment and prevention of periodontal disease, it can solve the weakness of carbohydrate metabolism that should be chewed and digested by periodontal disease patients. It performs an effective function in periodontal regeneration of patients with chronic periodontal disease.
본 발명의 일 실시형태에 따르면, 비타민 B1은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.01 내지 0.3중량%로 포함되어 조성되는 것이 바람직하다. 이는, 성인 남녀의 일일 권장 섭취량에 따라 설정한 함량이다.According to one embodiment of the present invention, vitamin B1 is preferably contained in an amount of 0.01 to 0.3% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is a content set according to the recommended daily intake of adult men and women.
우리나라 성인의 비타민 B1 평균 필요량은 남자 1.0㎎/일, 여자 0.9㎎/일이며, 권장 섭취량은 평균 섭취량의 120%로 남자 1.2㎎/일, 여자 1.1㎎/일이다. 권장 섭취량 설정 시 사용된 지표는 적혈구의 트랜스케톨레이즈(transketolase) 활성이다. 이 효소의 활성은 혈액 세포를 파괴한 후 비타민 B1의 조효소를 첨가했을 때와 하지 않았을 때의 활성을 비교하는 방법으로 측정된다.The average vitamin B1 requirement of Korean adults is 1.0mg / day for males and 0.9mg / day for females. The recommended intake is 120% of the average intake, 1.2mg / day for males and 1.1mg / day for females. The indicator used in setting the recommended intake is the red blood cell's transketolase activity. The activity of this enzyme is measured by comparing the activity with and without the addition of the coenzyme of vitamin B1 after the destruction of blood cells.
치주질환 치료 및 예방용 조성물 전체 중량에 대해서 비타민 B1이 0.01중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 비타민 B1 이외의 성분의 중량을 함께 고려해 보았을 때, 성인 남녀의 평균 필요량보다 치주질환 치료 및 예방용 조성물에 포함된 비타민 B1의 함량이 미달하게 되어, 비타민 B1을 첨가하는 의미가 없고, 비타민 B1의 효과가 제대로 발현되지 않을 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 비타민 B1이 0.3중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 비타민 B1 이외의 성분의 중량을 함께 고려해 보았을 때, 성인 남녀의 권장 섭취량보다 치주질환 치료 및 예방용 조성물에 포함된 비타민 B1의 함량이 너무 과도하게 되어, 과잉공급에 따른 문제점이 발생할 수 있다.When vitamin B1 is contained in an amount of less than 0.01% by weight based on the total weight of the composition for treating and preventing periodontal disease, when considering the total weight of the composition for treating and preventing periodontal disease and the weight of components other than vitamin B1, The content of vitamin B1 contained in the composition for the treatment and prevention of periodontal disease is less than the average required amount of, it does not mean adding vitamin B1, there is a fear that the effect of vitamin B1 is not properly expressed. In addition, when the total weight of the composition for the treatment and prevention of periodontal disease exceeds 0.3% by weight, when considering the total weight of the composition for the treatment and prevention of periodontal disease and components other than vitamin B1, adult men and women The amount of vitamin B1 contained in the composition for treating and preventing periodontal disease is too excessive than the recommended intake of may cause problems due to oversupply.
자연적으로 식품에 함유된 비타민 B1의 인체 독성은 매우 낮은 편이지만, 치료의 목적으로 고농도의 비타민 B1을 섭취하였을 때 독성이 나타난 사례가 보고되고 있다. 고농도 비타민 B1은 두통, 오심, 불안, 불면증, 빈맥, 기운 없음 등 대체로 중추신경계 관련 증상을 초래하는데, 비타민 B1의 섭취를 중지하거나 용량을 줄이면 없어진다.Naturally, human body toxicity of vitamin B1 in food is very low, but there have been reports of toxicity when high concentrations of vitamin B1 are consumed for therapeutic purposes. High levels of vitamin B1 usually cause central nervous system-related symptoms such as headaches, nausea, anxiety, insomnia, tachycardia, and lack of energy.
따라서, 비타민 B1은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.01 내지 0.3중량%로 포함되어 조성되는 것이 바람직하다.Therefore, the vitamin B1 is preferably contained in an amount of 0.01 to 0.3% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using a natural extract.
9. 비타민 B29. Vitamin B2
비타민 B2(Riboflavin, 리보플라빈)는 3개의 육각형 고리로 된 분자로서, 생물계에서는 보통 Flavin adenine dinucleotide(FAD)와 Flavin mononucleotide(FMN) 형태로 존재하고 유리상태의 비타민 B2는 아주 적다. 비타민 B2는 산, 열, 산화에 비교적 안정하지만, 알칼리나 빛에는 약하다. 간, 육류, 닭고기, 생선과 같은 동물성 식품과 유제품이 비타민 B2의 좋은 식품 급원이며, 이 밖에도 두류, 녹색 채소, 곡류, 난류도 비타민 B2의 급원으로 이용되고 있다.Vitamin B2 (Riboflavin) is a three-hexagonal ring molecule, usually present in the form of Flavin adenine dinucleotide (FAD) and Flavin mononucleotide (FMN) in the biological world, with very few free vitamin B2. Vitamin B2 is relatively stable against acid, heat and oxidation, but weak against alkali and light. Animal foods such as liver, meat, chicken and fish and dairy products are good sources of vitamin B2, and soybeans, green vegetables, grains and eggs are also used as sources of vitamin B2.
비타민 B2는 열량 대사 기능이 뛰어나다. 비타민 B2의 조효소는 여러 가지 효소반응에 관여하는데, 특히 열량 대사에서 중요한 역할을 수행한다. 다양한 종류의 비타민 B2 효소들이 탄수화물, 지방, 아미노산의 대사경로에서 탈수소화반응(Dehydrogenation), 수산화반응(Hydroxylation), 산화탈탄산반응(Oxidative decarboxylation), 이산소화반응(Dioxygenation), 산소의 과산화수소로의 환원 반응 등에 필수적이다.Vitamin B2 has excellent caloric metabolism. Coenzymes of vitamin B2 are involved in various enzymatic reactions, especially in caloric metabolism. Various types of vitamin B2 enzymes are used for the metabolism of carbohydrates, fats and amino acids, dehydrogenation, hydroxylation, oxidative decarboxylation, dioxygenation and oxygen peroxide. It is essential for the reduction reaction.
비타민 B2가 결핍되게 되면 주로 구강에 나타나는 구각염, 구순염, 설염 등과 구강염, 코, 입 주위의 안면이나 음낭, 외음부의 지루성 피부염, 안구충혈이나 광선 공포증, 조로성 백내장, 빈혈 등의 결핍증세가 나타나게 된다. 따라서, 비타민 B2는 결핍되게 되면 구강에 대해 다양한 증세를 나타나게 하며, 비타민 B2를 적절히 섭취하게 되면 에너지 생성 및 대사에 뛰어난 기능이 있기 때문에 치주질환 및 만성 치주질환에 효과적이다. 특히, 본 발명의 치주질환 치료 및 예방용 조성물은 식물추출물 즉, 지용성 성분들의 함량이 높아 대사가 원활하지 못할 우려가 있는데, 비타민 B2를 첨가함으로써 대사를 원활하게 할 수 있기 때문에 치주질환 치료 및 예방용 조성물의 효과를 높이기 위해 꼭 필요한 성분이다.Deficiency of vitamin B2 causes deficiency such as stomatitis, stomatitis, and periarthritis in the oral cavity, oral or rash of the nose and mouth, seborrheic dermatitis of the vulva, ocular hyperemia, photophobia, premature cataract, and anemia. . Therefore, vitamin B2 deficiency causes various symptoms for the oral cavity, and proper intake of vitamin B2 is effective for periodontal disease and chronic periodontal disease because vitamin B2 has an excellent function in energy generation and metabolism. In particular, the composition for the treatment and prevention of periodontal disease of the present invention there is a concern that the metabolism may not be smooth due to the high content of plant extracts, that is, fat-soluble components, the treatment and prevention of periodontal disease because the metabolism can be smoothed by the addition of vitamin B2 It is an essential ingredient to enhance the effect of the composition.
본 발명의 일 실시형태에 따르면, 비타민 B2는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.01 내지 0.3중량%로 포함되어 조성되는 것이 바람직하다. 이는, 성인 남녀의 일일 권장 섭취량에 따라 설정한 함량이다.According to one embodiment of the present invention, vitamin B2 is preferably contained in an amount of 0.01 to 0.3% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is a content set according to the recommended daily intake of adult men and women.
비타민 B2의 평균 필요량은 적혈구의 글루타치온 환원효소(Glutathione reductase)의 활성과 소변의 비타민 B2 배설량을 근거로 설정될 수 있는데, 우리나라 성인의 비타민 B2 평균 필요량은 남자 1.3㎎/일, 여자 1.0㎎/일이며, 권장 섭취량은 평균 섭취량의 120% 수준으로 남자 1.5㎎/일, 여자 1.2㎎/일이다.The average amount of vitamin B2 can be set based on the activity of glutathione reductase in red blood cells and the amount of vitamin B2 excretion in urine.The average amount of vitamin B2 in Korean adults is 1.3 mg / day for men and 1.0 mg / day for women. The recommended intake is 120% of the average intake for men 1.5mg / day and women 1.2mg / day.
치주질환 치료 및 예방용 조성물 전체 중량에 대해서 비타민 B2가 0.01중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 비타민 B2 이외의 성분의 중량을 함께 고려해 보았을 때, 성인 남녀의 평균 필요량보다 치주질환 치료 및 예방용 조성물에 포함된 비타민 B2의 함량이 미달하게 되어, 열량 대사(탄수화물, 지방, 아미노산의 대사경로)에 효과적으로 영향을 미치지 못할 수 있기 때문에, 비타민 B2를 첨가하는 의미가 없거나, 비타민 B2의 효과가 제대로 발현되지 않을 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 비타민 B2가 0.3중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 비타민 B2 이외의 성분의 중량을 함께 고려해 보았을 때, 성인 남녀의 권장 섭취량보다 치주질환 치료 및 예방용 조성물에 포함된 비타민 B2의 함량이 너무 과도하게 되어, 사람의 위장관에서 비타민 B2를 흡수하는 능력에 한계가 있으므로, 과잉 공급된 비타민 B2는 소변으로 단시간에 배설되기 때문에 비타민 B2의 배설량이 갑자기 증가되면서 노란색 소변이 배설 될 우려가 있다.When the composition of the composition for treating and preventing periodontal disease is less than 0.01% by weight of vitamin B2, the total weight of the composition for treating and preventing periodontal disease and the weight of components other than vitamin B2 are considered. Since vitamin B2 content in the composition for the treatment and prevention of periodontal disease is less than the average required amount of vitamin B2, it may not effectively affect calorie metabolism (the metabolic pathways of carbohydrates, fats and amino acids). There is no meaning or the effect of vitamin B2 may not be properly expressed. In addition, when the total weight of the composition for the treatment and prophylaxis of periodontal disease exceeds 0.3% by weight, when considering the total weight of the composition for the treatment and prevention of periodontal disease and components other than vitamin B2, adult men and women Vitamin B2 contained in the composition for the treatment and prevention of periodontal disease is too high than the recommended intake of, so the human body's ability to absorb vitamin B2 in the gastrointestinal tract is limited. Because of the sudden increase in the excretion of vitamin B2 yellow urine may be excreted.
따라서, 비타민 B2는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.01 내지 0.3중량%로 포함되어 조성되는 것이 바람직하다.Therefore, the vitamin B2 is preferably contained in an amount of 0.01 to 0.3% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract.
10. 비타민 B610. Vitamin B6
비타민 B6는 식품 중에 피리독신(Pyridoxine, PN), 피리독살(Pyridoxal, PL), 피리독사민(Pyridoaxamine, PM) 또는 각각의 인산화형태(PLP, PNP, PMP)로 존재한다. 동물성 식품에서는 주로 PLP, PMP와 단백질이 결합한 형태로 존재하며, 식물성 식품에서는 주로 PN, PNP와 당이 결합한 형태로 존재한다. 비타민 B6의 보조효소 형태는 PLP와 PMP이며, 특히 PLP는 생물학적 활성이 매우 큰 형태이다. 비타민 B6의 유리형태는 산도에 따라서 그 정도가 다르지만, 비교적 불안정해서 변성되기 쉬운 물질이다. Vitamin B6 is present in foods in pyridoxine (Pyridoxine, PN), pyridoxal (PL), pyridoxamine (Pyridoaxamine, PM) or in their respective phosphorylated forms (PLP, PNP, PMP). In animal foods, PLP, PMP, and protein are present in a combined form. In plant foods, PN, PNP, and sugar are present in a combined form. Coenzyme forms of vitamin B6 are PLP and PMP, in particular PLP is a form of biological activity is very high. The free form of vitamin B6 varies with acidity, but is relatively unstable and easily denatured.
비타민 B6의 급원으로는 생선, 돼지고기, 닭고기, 난류, 동물의 내장(간, 콩팥) 등의 동물성 식품을 비롯하여 현미, 대두, 귀리 등이 있으며, 유제품은 상대적으로 비타민 B6의 함량이 적다.Sources of vitamin B6 include animal foods such as fish, pork, chicken, eggs and animal intestines (liver and kidneys), as well as brown rice, soybeans, and oats. Dairy products are relatively low in vitamin B6.
비타민 B6는 단백질 및 아미노산의 이용에 필요한 성분이다. PLP는 아미노전이효소(Aminotransferase), 탈탄산효소(Decarboxylase) 및 입체이성질효소(Recemase) 등 100여 종의 아미노산 대사에 관여하는 효소의 조효소이다. 예를 들면 PLP는 비필수아미노산을 합성하는 반응에 필요하며, 만일 PLP가 없다면 모든 아미노산은 필수아미노산이 되어 식사를 통해 반드시 공급되어야 한다. 또한, PLP는 입체이성질효소로 D형 아미노산과 L형 아미노산의 상호전환에 작용한다. 인체에서 단백질이 합성될 때에는 L형 아미노산만이 사용되므로 PLP의 작용은 중요하다. 또한, 비타민 B6는 호모시스테인의 이화작용 및 인산화효소(Phosphorylase) 반응의 조효소로서도 작용하기 때문에, 혈액의 호모시스테인 수준을 정상으로 유지하는데도 꼭 필요한 성분이다.Vitamin B6 is a necessary ingredient for the use of proteins and amino acids. PLP is a coenzyme of enzymes involved in the metabolism of about 100 kinds of amino acids such as aminotransferase, decarboxylase and stereoisase. For example, PLP is required for the reaction to synthesize non-essential amino acids, and if there is no PLP, all amino acids become essential amino acids and must be supplied by meal. In addition, PLP is a stereoisomer and acts on the interconversion of D-type and L-type amino acids. Since only L-type amino acids are used when protein is synthesized in the human body, the action of PLP is important. In addition, vitamin B6 also acts as a coenzyme of the catabolism of the homocysteine and Phosphorylase (Phosphorylase) reaction, it is also an essential component in maintaining the homocysteine level of blood normal.
비타민 B6의 임상적 결핍증상은 간질성 혼수, 피부염, 구내염, 구순염, 설염, 우울증, 심정도 이상 등을 들 수 있으며, 동물에서는 빈혈, 지방간, 체내 저장 에너지 이용의 이상도 보고되고 있다. 따라서, 비타민 B6는 구내염, 구순염, 설염과 같은 구강질환을 예방 및 치료를 위해 필요한 성분이다. 특히, 본 발명의 치주질환 치료 및 예방용 조성물의 성분인 엉겅퀴(밀크씨슬) 추출물과 함께 작용하여 간 기능이 회복되고, 비타민 B1, 비타민 B2 및 비타민 B6의 비타민 복합체가 밀크씨슬(엉겅퀴 추출물)과 병행되어 신진대사를 원활히 하여 면역력을 증강 시키고 치주질환 치료 및 예방에 작용하는 효과가 뛰어나게 된다.Clinical deficiency symptoms of vitamin B6 include interstitial lethargy, dermatitis, stomatitis, cleft lip, pharyngitis, depression, severity abnormalities, and in animals, anemia, fatty liver, abnormal use of stored energy in the body has also been reported. Therefore, vitamin B6 is a necessary ingredient for the prevention and treatment of oral diseases such as stomatitis, stomatitis, and sulfitis. In particular, the liver function is restored by working with thistle (milk thistle) extract of the composition for the treatment and prevention of periodontal disease of the present invention, the vitamin complex of vitamin B1, vitamin B2 and vitamin B6 is milk thistle (thistle extract) ) In parallel with the metabolism facilitates to enhance immunity and to treat and prevent periodontal disease is excellent.
본 발명의 일 실시형태에 따르면, 비타민 B6는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.01 내지 0.3중량%로 포함되어 조성되는 것이 바람직하다. 이는 성인 남녀의 일일 권장 섭취량에 따라 설정한 함량이다.According to one embodiment of the present invention, vitamin B6 is preferably contained in an amount of 0.01 to 0.3% by weight relative to the total weight of the composition for treating and preventing periodontal disease using a natural extract. This is set according to the recommended daily intake of adult men and women.
우리나라 성인의 비타민 B6 평균 필요량은 남자 1.3㎎/일, 여자 1.2㎎/일이며, 권장 섭취량은 평균 섭취량의 120% 수준으로 남자 1.5㎎/일, 여자 1.4㎎/일이다.The average amount of vitamin B6 in Korean adults is 1.3mg / day for men and 1.2mg / day for women, and the recommended intake is 120mg of average intake, 1.5mg / day for men and 1.4mg / day for women.
치주질환 치료 및 예방용 조성물 전체 중량에 대해서 비타민 B6가 0.01중량% 미만으로 포함되어 조성될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 비타민 B6 이외의 성분의 중량을 함께 고려해 보았을 때, 성인 남녀의 평균 필요량보다 치주질환 치료 및 예방용 조성물에 포함된 비타민 B6의 함량이 미달하게 되어, 비타민 B6를 첨가하는 의미가 없고, 비타민 B6의 효과가 제대로 발현되지 않을 우려가 있다. 또한, 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 비타민 B6가 0.3중량%를 초과하여 포함될 경우, 치주질환 치료 및 예방용 조성물 전체 중량과 비타민 B6 이외의 성분의 중량을 함께 고려해 보았을 때, 성인 남녀의 권장 섭취량보다 치주질환 치료 및 예방용 조성물에 포함된 비타민 B6의 함량이 너무 과도하게 되어, 과잉공급에 따른 문제점이 발생할 수 있다.When the composition of the composition for the treatment and prevention of periodontal disease contains less than 0.01% by weight of vitamin B6, when considering the total weight of the composition for treating and preventing periodontal disease and the weight of components other than vitamin B6, The content of vitamin B6 contained in the composition for the treatment and prevention of periodontal disease is less than the average required amount of, it does not mean adding vitamin B6, there is a fear that the effect of vitamin B6 is not properly expressed. In addition, when the total weight of the composition for treating and preventing periodontal disease exceeds 0.3% by weight, when considering the total weight of the composition for treating and preventing periodontal disease and the weight of components other than vitamin B6, adult men and women The amount of vitamin B6 contained in the composition for the treatment and prevention of periodontal disease is too excessive than the recommended intake of may cause problems due to oversupply.
식품으로부터 섭취한 비타민 B6 과잉증은 보고된 바 없으나, 생리전증후군 등 질병 치료 목적으로 약제를 다량 장기간 복용한 경우, 감각성 신경증이나 피부병변이 발생할 수 있다고 보고되고 있다. 고용량의 비타민 B6를 섭취하면 신경손상을 유발하여 손발이 쑤시고, 걸음이 비틀거리며, 입 주위의 감각이 상실되고, 근육협동 기능의 손실되는 등의 신경증세가 나타날 우려가 있다.Vitamin B6 excess from food has not been reported, but it has been reported that sensory neuropathy and skin lesions may occur when a large amount of the drug is taken for the purpose of treating diseases such as premenstrual syndrome. Ingestion of high doses of vitamin B6 can cause nerve damage, tingling limbs, staggering steps, loss of sensation around the mouth, and loss of muscle coordination.
따라서, 비타민 B6는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 전체 중량에 대해서 0.01 내지 0.3중량%로 포함되어 조성되는 것이 바람직하다.Therefore, the vitamin B6 is preferably contained in an amount of 0.01 to 0.3% by weight based on the total weight of the composition for the treatment and prevention of periodontal disease using a natural extract.
따라서, 본 발명의 일 실시형태에 따른 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물은, 칼슘 35 내지 60중량%, 아보카도 추출물 0.5 내지 7중량%, 수용성 프로폴리스 추출물 5 내지 25중량%, 옥수수 추출물 2 내지 15중량%, 계피 추출물 0.5 내지 7중량%, 엉겅퀴 추출물 2 내지 15중량%, 비타민 C 1 내지 10중량%, 비타민 B1 0.01 내지 0.3중량%, 비타민 B2 0.01 내지 0.3중량% 및 비타민 B6 0.01 내지 0.3중량%를 포함하여 조성되는 것이 가장 바람직하다.Therefore, the composition for treating and preventing periodontal disease using a natural extract according to an embodiment of the present invention, calcium 35 to 60% by weight, avocado extract 0.5 to 7% by weight, water soluble propolis extract 5 to 25% by weight, corn extract 2 to 15% by weight, cinnamon extract 0.5 to 7% by weight, thistle extract 2 to 15% by weight, vitamin C 1 to 10% by weight, vitamin B1 0.01 to 0.3% by weight, vitamin B2 0.01 to 0.3% by weight and vitamin B6 0.01 to Most preferably, it comprises 0.3% by weight.
본 발명의 일 실시형태에 따르면, 상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물에, 이산화규소, 스테아린산마그네슘, 결정셀룰로스 및 색상코팅제로 이루어진 첨가제군에서 어느 하나 이상을 더 첨가하여 정제 형태의 제형으로 제조되는 것을 특징으로 할 수 있다.According to one embodiment of the present invention, to the composition for the treatment and prevention of periodontal disease using the natural extract, by adding any one or more from the additive group consisting of silicon dioxide, magnesium stearate, crystalline cellulose and a color coating agent in the form of a tablet It may be characterized in that it is manufactured as.
이는 상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 정제 형태의 제형으로 제조하여 섭취가 용이하도록 제조하기 위해 첨가제군의 성분을 첨가하는 것으로서, 첨가되는 이산화규소, 스테아린산마그네슘, 결정셀룰로스 및 색상코팅제로 이루어진 첨가제군의 성분은 상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 각각의 성분과 상호작용을 일으키지 않으며, 효과적인 측면에서도 영향을 끼치지 않는 성분으로 구성되는 것이 바람직하다.This is to add the components of the additive group to prepare the composition for the treatment and prevention of periodontal disease using the natural extract in the form of tablets for easy ingestion, added silicon dioxide, magnesium stearate, crystalline cellulose and color coating agent Components of the additive group consisting of does not cause interaction with each component of the composition for treating and preventing periodontal disease using the natural extract, it is preferable that the composition is composed of components that do not affect the effective aspect.
또한, 본 발명의 일 실시형태에 따르면, 상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 100중량부에 대해 첨가제군에 해당하는 이산화규소 0.1 내지 1중량부, 스테아린산마그네슘 0.1 내지 1.5중량부, 결정셀룰로스 12 내지 26중량부 및 색상코팅제 1 내지 5중량부의 비율로 더 첨가하여 정제 형태의 제형으로 제조되는 것을 특징으로 할 수 있다.In addition, according to an embodiment of the present invention, 0.1 to 1 parts by weight of silicon dioxide, 0.1 to 1.5 parts by weight of magnesium stearate, crystals, corresponding to an additive group based on 100 parts by weight of the composition for treating and preventing periodontal disease using the natural extract 12 to 26 parts by weight of cellulose and 1 to 5 parts by weight of the color coating agent may be added to form a tablet formulation.
이산화규소, 스테아린산마그네슘, 결정셀룰로스 및 색상코팅제로 이루어진 첨가제군의 성분의 함량은 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 정제 형태의 제형으로 제조하기에 적합하고, 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물의 효과에 영향을 끼치지 않을 정도로 첨가되도록 최적화된 함량으로 설정할 수 있다. 이로써, 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 100중량부에 대해 이산화규소 0.1 내지 1중량부, 스테아린산마그네슘 0.1 내지 1.5중량부, 결정셀룰로스 12 내지 26중량부 및 색상코팅제 1 내지 5중량부의 비율로 더 첨가하여 정제 형태의 제형으로 제조하는 것이 바람직하다.The content of the components of the additive group consisting of silicon dioxide, magnesium stearate, crystalline cellulose and a color coating agent is suitable for preparing a periodontal disease treatment and prevention composition using a natural extract in a tablet form, and treatment of periodontal disease using a natural extract. And it can be set to an optimized content so as not to affect the effect of the composition for prevention. Thus, the ratio of 0.1 to 1 parts by weight of silicon dioxide, 0.1 to 1.5 parts by weight of magnesium stearate, 12 to 26 parts by weight of crystalline cellulose and 1 to 5 parts by weight of the color coating agent based on 100 parts by weight of the composition for treating and preventing periodontal disease using a natural extract. It is preferred to prepare further in the form of tablet form by further addition.
[실시예]EXAMPLE
본 발명의 일 실시형태에 따른 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 제조한다.To prepare a composition for the treatment and prevention of periodontal disease using a natural extract according to an embodiment of the present invention.
칼슘 590㎎, 아보카도 추출물 35㎎, 수용성 프로폴리스 추출물 175㎎, 옥수수 추출물 100㎎, 계피 추출물 35㎎, 엉겅퀴 추출물 100㎎, 비타민 C 66㎎, 비타민 B1 1.2㎎, 비타민 B2 1.4㎎ 및 비타민 B6 1.5㎎의 천연 추출물을 혼합한 뒤, 첨가제인 이산화규소 5㎎, 스테아린산마그네슘 10㎎, 결정셀룰로스 280㎎ 및 색상코팅제 42㎎을 추가로 더 첨가하여 정제 형태의 제형으로 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 제조한다.590 mg of calcium, 35 mg of avocado extract, 175 mg of water-soluble propolis, 100 mg of corn extract, 35 mg of cinnamon extract, 100 mg of thistle extract, 66 mg of vitamin C, 1.2 mg of vitamin B1, 1.4 mg of vitamin B2 and 1.5 mg of vitamin B6 After mixing the natural extracts of the additives, silicon dioxide 2 mg, magnesium stearate 10 mg, crystalline cellulose 280 mg and 42 mg of color coating agent is further added to the tablet form to treat and prevent periodontal disease using natural extracts. Prepare the composition.
[설문조사][Poll]
본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 조성물의 적용범위와 구매환자들이 느끼는 효과와 사용현황을 파악하여 제시하고, 병원 내 치주질환 치료 및 예방용 조성물의 도입 근거를 마련하기 위해 설문조사를 실시하였다. 상기 실시예와 같이 제조된 천연 추출물을 이용한 치주질환 보조제 조성물을 정제 형태의 약물 레시피 더블유(Recipe W)로 제조하여 연구대상자들에게 복용하도록 하였으며, 설문지 및 설문지 결과에는 레시피 더블유(Recipe W)로 표현되어 있다.To investigate and present the application range of the composition for treating and preventing periodontal disease according to an embodiment of the present invention, the effects and usage of purchased patients, and to prepare a basis for introducing the composition for treating and preventing periodontal disease in a hospital. An investigation was conducted. The periodontal disease adjuvant composition using the natural extract prepared as in Example was prepared in a tablet form of the drug recipe W. (Recipe W) to be administered to the study subjects, and expressed in the recipe W. (Recipe W) in the questionnaire and the questionnaire results. It is.
1. 설문지 설계1. Questionnaire design
도 1은 본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 조성물에 대해서 구매환자들이 느끼는 효과와 사용현황을 파악하기 위해 실시한 설문조사의 설문지이다.1 is a questionnaire of a survey conducted to grasp the effects and use status of purchase patients with the composition for the treatment and prevention of periodontal disease according to an embodiment of the present invention.
이 연구의 설문 항목은 전체 환자 중 환자증상별 구분, 전화 응답 미 응답 여부, 레시피 더블유(Recipe W) 복용 한 달 후 효과 정도 여부, 타제품대비 효과 정도 여부, 복용기간별 구분, 치주 상태 개선 여부, 치주 증상별 개선 여부, 한 달간 재구매 현황, 지속적인 복용의사 여부 등의 총 9문항으로 구성되어 있다. 선정된 항목에 대해 서울대학교, 한림대학교, 부산대학교 치과의사 10여 명이 설문항목의 선정 및 표현의 적합성을 평가하도록 하여 타당성을 확보하였으며 통계학 전문가와 함께 수정 및 검토하였다.The questionnaire items in this study were classified by patient symptom, non-answered phone call, effectiveness of recipe W after 1 month of receiving dose, status of effect compared to other products, classification by period, periodontal condition improvement, periodontal The questionnaire consists of 9 questions such as improvement by symptom, repurchase status for one month, and intention of continuous taking. About 10 selected dentists at Seoul National University, Hallym University, and Pusan National University evaluated the selected items and evaluated the suitability of the selected items.
2. 연구대상선정 및 조사 실시2. Selection of research subjects and investigation
레시피 더블유(Recipe W)의 효과와 적용범위 파악을 위하여 본 연구의 취지를 설명하는 내용을 환자들에게 알렸으며, 해당 연구 및 통계 목적 이외에 사용하지 않는다는 전제하에서 환자들의 동의를 얻어 실시하였다.The purpose of this study was to inform patients of the purpose of this study to understand the effectiveness and scope of recipe W. It was conducted with the consent of patients under the premise that it was not used for the purpose of this study and statistical purposes.
연구대상자는 2014년 4월 9일부터 5월 8일까지 30일간 우치과의원에서 레시피 더블유(Recipe W)를 구매한 환자 356명 대상으로 전화 설문조사를 실시하였다. 레시피 더블유(Recipe W) 구매 환자의 남녀 인원수는 여성 251명, 남성 105명이고, 연령대는 20대 2명, 30대 4명, 40대 35명, 50대 127명, 60대 116명, 70대 65명, 80대 7명으로 분포되어있다.The subjects underwent a telephone survey of 356 patients who purchased Recipe W at the clinic from April 9 to May 8, 2014. The number of males and females of recipe W is 251 females and 105 males.The ages are 2 in 20s, 4 in 30s, 35 in 50s, 127 in 50s, 116 in 60s, and 70s. It is distributed in 65, 80 and 7 members.
증상별 인원은 임플란트 주위염 248명, 만성치주질환 80명, 일반치주질환 28명, 임플란트 계획 중 18명, 골다공증 약 복용환자 6명으로 총 356명이다.Symptoms included 248 patients with peri-implantitis, 80 chronic periodontal diseases, 28 general periodontal diseases, 18 in the implant plan, and 6 patients with osteoporosis medication.
본 연구에서는 기초적인 자료를 제공하여야 함으로 전수조사를 실시하였다. 전화 설문조사는 객관성을 갖기 위해 ㈜Cpm 창원점(서비스 대행업)을 이용하였으며, 전화설문을 실시하는 기간은 2014년 6월 9일부터 13일까지 5일간, 시간대는 오전 11시부터 오후 1시, 오후 2시부터 오후 5시까지로 정하여 최대한 연구인원들이 참가하도록 하였으며 시차를 두고 3회 이상 전화를 걸어도 받지 않는 경우 미 응답 처리하였다. 연구대상 356명 중 251명이 응답하여 총 251명을 대상으로 결과를 분석하였다.In this study, a complete survey was conducted to provide basic data. The telephone survey used Cpm Changwon Branch (service agency) for objectivity, and the telephone survey was conducted for five days from June 9 to 13, 2014, and from 11 am to 1 pm, From 2 pm to 5 pm, the maximum number of researchers was allowed to participate. If the user did not answer the phone more than 3 times with a time difference, it was not answered. Of the 356 subjects, 251 responded and analyzed the results on a total of 251 subjects.
3. 연구결과3. Research Results
3-1. 설문대상자의 일반적인 특성3-1. General Characteristics of Survey Subjects
응답자는 총 251명으로 우치과의원에서 레시피 더블유(Recipe W) 치주질환보조제를 구매한 환자이며, 증상별로는 임플란트 주위염이 182명(70%)으로 가장 많았고 만성치주질환 59명(23%), 치주질환 10명(4%), 임플란트 계획 중인 환자 7명(3%), 골다공증 약 대체 환자 1명(0%) 순이었다.A total of 251 respondents purchased the Recipe W periodontal disease adjuvant from a dental clinic. The most common symptom was peri-implantitis (182 patients, 70%), and chronic periodontal disease (59 patients, 23%). Ten patients (4%), seven patients planning implants (3%), and one patient replacing osteoporosis drugs (0%).
3-2. 3-2. 레시피recipe 더블유(Recipe W)의 복용기간 및 효과 Duration and Effect of W
한 달 이상 꾸준히 복용한 환자가 전체 응답자의 60.2%(151명)로 가장 많았고 2달 이상 22.7%(57명), 기타가 17.1%(43명)이었다.60.2% (151) of the total respondents were the most patients who took more than 1 month, 22.7% (57 people) and 17.1% (43) others.
설문에 참여한 251명 중 효과가 있다고 응답한 환자가 61%(153명)이고 효과가 없다고 응답한 환자가 39%(98명)이다. 효과 여부에서 세부항목으로 효과가 어느 정도 있다 35.1%(88명), 효과가 크다 25.9%(65명), 예방차원 14.3%(36명), 잘 복용하지 않음 12%(30명), 효과를 못 느낌 9.6%(24명), 효과가 없다 3.2%(8명)와 같은 순으로 나타났다.Of the 251 surveyed, 61% (153) said they worked, and 39% (98) said they didn't work. It has some effect in detail whether it is effective 35.1% (88 people), big effect 25.9% (65 people), preventive level 14.3% (36 people), not taking well 12% (30 people) 9.6% (24 people) with no feelings, no effect 3.2% (8 people).
치주질환 치료제로 타제품을 복용한 적이 있다고 응답한 환자가 총 43명이고 순위는 다음과 같다. 효과가 어느 정도 있다고 답변한 환자가 응답자의 49%(21명), 효과가 크다 44%(19명), 효과가 가없다 7%(3명)와 같은 순으로 나타났다.A total of 43 patients answered that they had taken other products as a treatment for periodontal disease. 49% (21 people) of respondents answered that there was some effect, 44% (19 people) were effective, and 7% (3 people) had no effect.
3-3. 치주상태 개선3-3. Periodontal condition improvement
치주상태가 개선되었다고 답변한 환자가 전체응답자의 86%(237건)이었고 개선되지 않았다고 응답한 환자가 14%(37건)이었다.86% (237) of the total respondents reported that their periodontal condition improved, and 14% (37) answered that they did not improve.
개선되었다고 응답한 86% 환자의 증상별로는 치아동요 및 잇몸 허약 개선 71건으로 가장 많았고, 통증 및 붓기 개선 61건, 양치할 때 피나는 것 개선 59건, 시린 이 개선 42건, 구취 개선 4건이었다.The most common symptom was improvement of tooth agitation and gum weakness (71 cases), improvement of pain and swelling of 61 cases, improvement of bleeding when brushing teeth, improvement of ache 42, and improvement of bad breath.
4. 재구매 의사4. Willingness to Repurchase
2014년 4월9일부터 5월8일까지 30일간 구매환자 356명의 한 달간 실제 재구매 현황은 22%(99명)이었다. 전화응답자 251명 중 재구매를 원하는 환자는 56.9%(143명)이었고, 재구매를 생각중이라고 응답한 환자는 36.3%(91명), 재구매를 원하지 않는 환자 6.7%(17명)이었다. 재구매를 원하지 않는 이유는 효과가 없다고 생각하는 7명과 프로폴리스 향이 강하다고 답변하는 환자가 7명, 완치 후 복용중단이 3명이었다.During the 30 days from April 9 to May 8, 2014, the actual repurchase rate of 356 patients was 22% (99 people). Of the 251 telephone respondents, 56.9% (143) wanted to repurchase, 36.3% (91) answered that they were considering repurchase, and 6.7% (17) did not want to repurchase. The reason for not wanting to repurchase was 7 people who thought it was ineffective, 7 patients who answered that the fragrance of propolis was strong, and 3 who stopped taking after cure.
따라서, 연구대상 356명 중 251명이 전화설문에 응답하였으며 표본조사가 아닌 전수조사임을 감안할 때 유의한 수치이다. 응답자 251명 중 레시피 더블유(Recipe W) 복용 증상별로 볼 때 임플란트 주위염 70%(182명), 만성치주질환 23%(59명), 치주질환 4%(10명), 임플란트 계획 중 3%(7명), 골다공증 약 대체 0%(1명)로 임플란트 주위염 환자에게 편중 적이지만 인원수로 생각할 때 치주질환 보조제 도입 근거로 적용할 수 있다고 판단된다. 또한, 연구대상 356명의 증상별 비중과 응답자 251명 증상별 비중이 거의 유사한 결과로 볼 때 설문조사 결과가 최종결과로 생각해도 무방할 것이다. 레시피 더블유(Recipe W)의 복용기간을 따른 결과를 보면 꾸준히 복용한 환자가 효과를 충분히 본다고 판단이 되며, 한 달 이상 복용환자 173명 중 실제 재구매환자는 22%(99명)이며 응답자 중 재구매를 희망하는 환자는 56.9%(143명)로 환자의 복용의 중요성을 나타낸다.Therefore, 251 of the 356 subjects responded to the telephone questionnaire. According to the symptom of receiving Recipe W, 251 respondents showed peri-implantitis 70% (182), chronic periodontal disease 23% (59), periodontal disease 4% (10), and 3% (7) of the implant plan. 0% (1 person) is a substitute for osteoporosis drugs, which is biased for patients with peri-implant peritonitis, but the number of patients is considered as a basis for introducing periodontal disease supplements. In addition, the results of the survey can be considered as the final result, considering that the proportion of symptom by 356 subjects and that of symptom by 251 respondents are almost similar. According to the results of Recipe W, the patients who took it continuously seemed to be effective enough. Among the 173 patients who took more than a month, 22% (99) of the actual repurchase patients were repurchased. 56.9% (143 patients) of the patients desired showed the importance of taking the patient.
레시피 더블유(Recipe W)의 효과 여부에 따른 결과를 보면 효과가 있다고 응답한 환자는 61%(153명)로 재구매를 희망하는 응답자 수 143명 유사성을 보인다. 이것은 꾸준한 복용이 효과를 판단할 수 있는 기초적인 부분이라 할 수 있다. 또한, 효과가 없다고 응답한 39%(98명) 중 복용을 제대로 하지 않는 환자 30명이 존재하며 예방차원에서 복용중인 환자가 36명, 잘 못 느끼는 환자 24명, 효과 없다고 응답한 환자가 8명임을 감안할 때 정확한 복용을 지도하는 것은 중요한 부분이라 할 수 있다. 타제품대비 효과 설문조사에 따르면 응답자의 43명(17%)이 다른 제품을 복용해 보았고 이 수치는 치과병원 및 의원에서 치주 관리를 받지 않고 약물에 의존하는 환자가 상당수 있을 수 있음을 시사한다. 타제품대비 효과 설문조사에 결과로 응답자의 93%(40명)가 효과가 어느 정도 있거나 효과가 크다고 응답하였다. 시중에 유통되는 다른 제품보다 유의하다고 판단된다. 환자가 판단할 때 치주상태 개선 여부의 설문조사에서 86%(237건)가 개선이 되었고 14%(37건)가 개선이 되지 않았다. 이 설문으로 내릴 수 있는 결론은 레시피 더블유(Recipe W) 복용 2달 정도에 86%의 개선이 있을 수 있고 더욱 장기간 복용할 경우 유의한 개선이 있을 수 있음을 시사한다. 증상별 개선 설문에 따르면 치아동요 및 잇몸 허약 개선 71건으로 가장 많았고, 통증 및 붓기 개선 61건, 양치할 때 피나는 것 개선 59건, 시린 이 개선 42건, 구취 개선 4건으로 대부분 다양하게 증상들을 나타내고, 구취에 관한 부분은 환자가 느끼지 못하는 것인지 응답하지 꺼리는 것인지 수치적으로 상당한 차이를 보여 의사의 상담이 필요하다고 생각된다.According to the results of Recipe W, 61% (153) of respondents said it was effective, showing similarity among 143 respondents who wanted to repurchase. This is the basic part of the constant dose to determine the effect. Of the 39% (98) who reported no effect, there were 30 patients who did not take it properly, including 36 patients taking prophylactic measures, 24 patients who felt poorly, and 8 patients who said they were ineffective. Given that, taking the correct dose is an important part. A survey of the effectiveness of other products shows that 43 (17%) of respondents have tried other products, which suggests that there may be a large number of patients who rely on drugs without periodontal care in dental hospitals and clinics. As a result of the survey compared to other products, 93% (40 people) of the respondents answered that the effect was large or large. We believe it is more significant than other products in the market. In the survey of patients with periodontal improvement, 86% (237 cases) improved and 14% (37 cases) did not. The conclusions that can be drawn from this survey suggest that there may be an improvement of 86% in about two months of Recipe W, and a significant improvement over longer periods. According to the symptom improvement questionnaire, there were 71 cases of improvement in tooth agitation and gum weakness, 61 cases of pain and swelling improvement, 59 cases of improvement in bleeding when brushing teeth, 42 cases of improvement in bad teeth, and 4 cases of bad breath improvement. However, there is a significant difference in terms of bad breath between the patient's feelings and the reluctance to respond.
전화 설문 환자의 재구매 의사는 56.9%(143명)가 원하고 있고 생각 중인 환자가 36.3%(91명)로 93.2%를 차지한다. 유의한 수치의 결과로 볼 때 치주질환 치료 보조제를 원내에 도입하였을 경우 환자가 지속적으로 치과를 방문하게 되는 연속성을 의미한다. 또한, 치료보조제의 판매가 하나의 진료가 될 것으로 판단되며 환자와 의사의 신뢰를 높일 수 있을 방안이 될 것으로 사료된다.56.9% (143 people) wanted repurchase doctors and 36.3% (91 people) were thinking about 93.2%. Significant numerical results indicate the continuity of the patient's visit to the dentist if the periodontal disease treatment adjuvant is introduced. In addition, the sale of treatment supplements is considered to be a single treatment, and it is expected to be a way to increase the trust of patients and doctors.
[치료 유효성 평가][Evaluation of Treatment Effectiveness]
본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 조성물의 치료 유효성을 평가하기 위해, 치주질환 치료 및 예방용 조성물을 섭취하기 전과 섭취한 후의 치주질환 유발 원인균의 정량수치(농도)를 분석하였다. 즉, 상기 실시예와 같이 제조된 천연 추출물을 이용한 치주질환 보조제 조성물을 정제 형태의 약물 레시피 더블유(Recipe W)로 제조하여 연구대상자들에게 복용하도록 하였다. 치료 유효성 평가는 한림대학교에 의뢰하였으며, “한림대학교 강동성심병원 임상연구심의위원회 IRB 승인번호 14-1-58”와 같이 임상승인 번호를 부여받았다.In order to evaluate the therapeutic efficacy of the composition for treating and preventing periodontal disease according to an embodiment of the present invention, the quantitative value (concentration) of the causative agent of periodontal disease-causing bacteria before and after ingestion of the composition for treating and preventing periodontal disease was analyzed. . That is, the periodontal disease adjuvant composition using the natural extract prepared as in Example was prepared as a drug recipe W. (Recipe W) in the tablet form to be taken by the subjects. The treatment efficacy evaluation was commissioned by Hallym University and was given a clinical approval number, such as “IRB Approval Number 14-1-58, Hallym University Institutional Review Board.”
1. 연구대상자선정 및 조사 실시1. Selection of research subjects and investigation
연구대상자는 총 30명으로 만 25세에서 75세 이하의 성인으로 구성되어 있으며, 연구대상자의 평균연령은 44.73세이다. 경도의 만성 단순 치주염으로 진단받은 환자를 대상으로 선정하였으며, 최근 6개월 이내에 치주질환에 대한 치료를 받지 않은 환자 중 임상시험에 대한 설명을 이해하여 자발적으로 동의하고 피험자 동의서에 자필 서명한 환자를 대상으로 하였다.A total of 30 subjects consisted of adults aged 25 to 75 years. The average age of the subjects was 44.73 years. Patients diagnosed with mild chronic simple periodontitis were selected. Patients who had not received treatment for periodontal disease within the last 6 months and who voluntarily agreed and signed the subject's consent It was made.
또한, 기존에 시판되어 있는 잇몸 보조 약물을 복용하고 있는 자, 임산부 또는 모유수유 중인 자, 조절되지 않는 내과적 질환 보유자, 치과 치료가 곤란한 전신적 질환자, 만성 동통을 호소하며 만성 소모성 또는 염증성 질환자, 최근 3개월 이내에 다른 임상시험에 참여한 자, 기타 윤리적으로 또는 임상시험 결과에 영향을 줄 수 있어 임상시험의 참여가 부적절하다고 시험자가 판단한 경우에는 제외되었다.In addition, those who are taking commercially available gum supplements, pregnant or breastfeeding patients, uncontrolled medical disorders, systemic diseases that are difficult to treat, chronic painful or chronic consuming or inflammatory diseases, Those who participated in other clinical trials within three months, or other ethical or clinical trial results, were excluded if the investigator determined that participation in the trial was inappropriate.
2. 치료 유효성 평가 방법2. Evaluation of Treatment Effectiveness
연구대상자의 약물 복용 전과 복용 2주 이후 및 복용 3주 이후의 가글 채취액을 cytoperio analysis system(cytogen co. Ltd, 싸이토젠 유전자 검사기관)의 보존용액과 용기에 넣고 밀봉한 다음 cytoperio analysis system(cytogen co. Ltd,) 유전자 검사기관 연구실로 보내, 검체에서 DNA를 추출하고 DNA probe(형광표지자)를 부착한 뒤 real-time PCR을 통해 치주질환 유발 원인균의 종류와 정량수치(농도)를 분석하였다. 조사 원인균은 aggregatibacter actinomycetemcomitans(Aa) , porphyromonas gingivalis(Pg), tannerella forsythia(Tf) , treponema denticola(Td), prevotella intermedia(Pi), fusobacterrium nucleatum(Fn), parvimonas micra(Pm), campylobacter rectus(Cr), eikenella corrodens(Ec), streptococcus mutans(Sm) 및 streptococcus sorbinus(Ss)와 같이 치주질환 유발 원인균인 총 11종의 세균이며, 총 11종의 세균을 검출하였다.Before and after 2 weeks and 3 weeks after the drug was taken, the sample was collected and sealed in a preservative solution and container of the cytoperio analysis system (cytogen co. Ltd). Co. Ltd,) was sent to a laboratory for genetic testing, extracted DNA from the sample and attached a DNA probe (fluorescent marker) and analyzed the type and quantitative value (concentration) of the causative agent causing periodontal disease by real-time PCR. The causative agents of investigation were aggregatibacter actinomycetemcomitans (Aa), porphyromonas gingivalis (Pg), tannerella forsythia (Tf), treponema denticola (Td), prevotella intermedia (Pi), fusobacterrium nucleatum (Fn), parvimonas micra (Pm), campylob camp A total of 11 bacteria were identified, including eikenella corrodens (Ec), streptococcus mutans (Sm), and streptococcus sorbinus (Ss).
즉, 약물 복용 전과 복용 2주 이후 및 복용 3주 이후의 각각의 세균을 정량 분석하여 세균의 감소를 확인하였다. 연구대상자는 총 30명으로 단일군으로, 복용 2주 후 치주질환 유발 원인균의 감소량을 측정한 연구대상자는 30명이며, 복용 3주 후 치주질환 유발 원인균의 감소량을 측정한 연구대상자는 13명이다. 시험 결과는 치료 전후를 객관적으로 평가하는 방법으로 모든 균주에서 정규성 분포를 따르지 않았기에, 비모수 크기 비교 방법인 Wilcoxon signed rank test로 통계학적 유의성을 평가하였으며 하기 표 1의 조건으로 평가하였으며, 통계학적 유의성은 P <0.05에서 결정되었다.That is, the reduction of bacteria was confirmed by quantitative analysis of each bacterium before and after taking the drug and after 3 weeks of taking the drug. A total of 30 subjects were included in a single group. Thirty subjects measured the reduction of periodontal disease-causing bacteria after two weeks of administration, and thirteen subjects measured the reduction of periodontal disease-causing bacteria after three weeks of administration. . Since the test results did not follow the normal distribution in all strains as an objective evaluation method before and after treatment, the statistical significance was evaluated by the Wilcoxon signed rank test, a nonparametric size comparison method, and evaluated under the conditions shown in Table 1 below. Was determined at P <0.05.
Case Processing SummaryCase Processing Summary
casescases
ValidValid MissingMissing TotalTotal
NN PercentPercent NN PercentPercent NN PercentPercent
Diff.TfDiff.Tf 3030 100.0 % 100.0% 00 0.0 % 0.0% 3030 100.0 % 100.0%
3. 치료 유효성 평가 결과3. Evaluation of Treatment Effectiveness
상기의 방법 및 조건으로 실시한 치료 유효성 평가는 약물 복용 전과 복용 2주 이후 및 복용 3주 이후의 치주질환 유발 원인균의 정량수치(농도)를 분석하였으며, 그 결과는 하기 표 2에 나타내었다.The treatment efficacy evaluation conducted by the above methods and conditions analyzed the quantitative value (concentration) of the causative agent of periodontal disease-causing bacteria before, after 2 weeks and after 3 weeks of taking the drug, and the results are shown in Table 2 below.
  AaAa PgPg TfTf TdTd
2주 이상More than 2 weeks 복용 전Before taking 00 2138233221382332 1029843010298430 4704116347041163
복용 후After taking 00 1650455316504553 54805905480590 58178565817856
3주 이상More than 3 weeks 복용 전Before taking 00 2038327320383273 81298788129878 4203089542030895
복용 후After taking 00 1533708115337081 47310044731004 52022825202282
  PiPi FnFn PmPm CrCr
2주 이상More than 2 weeks 복용 전Before taking 6481525464815254 160339949160339949 283459510283459510 43360814336081
복용 후After taking 3714635137146351 145480408145480408 164115238164115238 34811783481178
3주 이상More than 3 weeks 복용 전Before taking 5872053258720532 9408309994083099 230300803230300803 39613753961375
복용 후After taking 2987029129870291 9870468698704686 154636079154636079 34111093411109
  EcEc SmSm SsSs 총 균수Total bacteria
2주 이상More than 2 weeks 복용 전Before taking 282089497282089497 1742808817428088 88878728887872 1605710572616057105726
복용 후After taking 261607670261607670 1054271610542716 37687293768729 1324783850013247838500
3주 이상More than 3 weeks 복용 전Before taking 247341264247341264 97481039748103 29496692949669 77641968127764196812
복용 후After taking 228009316228009316 51921115192111 14798411479841 50055805205005580520
상기 표 2는 치주질환 유발 원인균인 11종의 세균 수치에 대해 나타낸 것이며, 모든 연구대상자에서 aggregatibacter actinomycetemcomitans(Aa)는 검출되지 않았다. 또한, Aa 이외의 나머지 10종의 세균의 수치는 모두 감소하는 것으로 나타났으며, 2주 이상 약물을 복용하였을 때보다, 3주 이상 약물을 복용하였을 때 치주질환 유발 원인균인 11종의 세균 수치의 감소율이 더 크게 나타나는 것으로 확인되었다. 2주 이상 약물을 복용하였을 때 발생하는 치주질환 유발 원인균인 11종의 세균 수치의 감소율은 도 2 및 도 3의 그래프로 나타내었으며, 3주 이상 약물을 복용하였을 때 발생하는 치주질환 유발 원인균인 11종의 세균 수치의 감소율은 도 4 및 도 5의 그래프로 나타내었다.Table 2 shows the 11 bacterial levels causing periodontal disease, aggregatibacter actinomycetemcomitans (Aa) was not detected in all subjects. In addition, the levels of the remaining 10 bacteria except for Aa were all decreased, and the levels of 11 bacteria, which cause periodontal disease, were higher when taking drugs for 3 weeks or more than when taking drugs for 2 weeks or more. The decrease was found to be greater. The decrease rate of the 11 bacterial bacteria causing the periodontal disease caused by taking the drug for two weeks or more is shown in the graphs of FIGS. 2 and 3, and the cause of the periodontal disease caused by taking the drug for three weeks or more 11 The rate of reduction of bacterial levels of the species is shown in the graphs of FIGS. 4 and 5.
또한, 치주질환 유발 원인균인 11종 중에서도 특히 treponema denticola(Td) 및 parvimonas micra(Pm)와 같은 균의 감소율이 더 크게 나타나는 것으로 확인되었으며, Td와 Pm 균의 감소율은 도 6 및 도 7의 그래프로 나타내었다.In addition, among 11 species causing the periodontal disease, it was confirmed that the reduction rate of the bacteria such as treponema denticola (Td) and parvimonas micra (Pm) was greater, and the reduction rate of the Td and Pm bacteria was shown in the graphs of FIGS. Indicated.
상기 표 2에 나타난 치주질환 유발 원인균의 정량수치(농도) 결과를 균의 수가 증가 및 감소하거나 균의 수가 변화가 없는 상태를 고려하여 치료 유효성 평가 시험의 정규성 및 P 값에 의한 통계학적 유의성에 대해 정리한 결과를 하기 표 3 및 표 4에 나타내었다. 하기 표 3은 약물 복용 전과 복용 2주 이후에 해당하는 치료 유효성 평가 시험의 정규성 및 P 값에 의한 통계학적 유의성에 대해 정리한 결과이며, 하기 표 4는 약물 복용 전과 복용 3주 이후에 해당하는 치료 유효성 평가 시험의 정규성 및 P값에 의한 통계학적 유의성에 대해 정리한 결과이다.Considering the results of quantitative value (concentration) of periodontal disease-causing bacteria shown in Table 2 above, the number of bacteria was increased and decreased or the number of bacteria was not changed, and the statistical significance of the normality and P value of the treatment efficacy evaluation test. The summarized results are shown in Tables 3 and 4 below. Table 3 below summarizes the statistical significance according to the normality and P value of the treatment efficacy evaluation test before and after 2 weeks of taking the drug, and Table 4 below shows the treatment corresponding to before and after 3 weeks of taking the drug. It is the result that summarized the statistical significance by the normality and P-value of the efficacy evaluation test.
하기의 표 3 및 표 4를 살펴보면, 본 발명의 일 실시형태에 따라 제조된 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물을 2주 이상 섭취한 연구대상자보다 3주 이상 섭취한 연구대상자들에서 치주질환 유발 원인균의 정량수치(농도) 감소율이 더 크게 나타나는 것으로 확인되었다.Referring to Tables 3 and 4 below, periodontal subjects ingested for 3 weeks or more than those subjects ingested for 2 weeks or more of the composition for treating and preventing periodontal disease using a natural extract prepared according to an embodiment of the present invention It was confirmed that the reduction rate of quantitative value (concentration) of disease-causing bacteria appeared more.
단위(연구대상자 수)Unit (Number of Research Subjects) AaAa PgPg TfTf TdTd PiPi FnFn
2주 이상More than 2 weeks 균 증가Fungus increase -- 55 1515 1One 77 1414
균 감소Bacteria reduction -- 66 1212 99 1212 1616
균 동일Fungus equal 3030 1919 33 2020 1111 --
정규성Normality XX OO OO OO OO OO
p값p value -- 0.6570.657 0.6650.665 0.0090.009 0.2950.295 0.7340.734
유의성valence -- XX XX OO XX XX
단위(연구대상자 수)Unit (Number of Research Subjects) PmPm CrCr EcEc SmSm SsSs 총 균수Total bacteria
2주 이상More than 2 weeks 균 증가Fungus increase 99 44 99 99 1616 1313
균 감소Bacteria reduction 1919 88 77 99 1212 1717
균 동일Fungus equal 22 1818 1414 1212 22 --
정규성Normality OO OO OO OO OO OO
p값p value 0.040.04 0.3880.388 0.7960.796 0.9480.948 0.6330.633 0.2990.299
유의성valence OO XX XX XX XX XX
단위(연구대상자 수)Unit (Number of Research Subjects) AaAa PgPg TfTf TdTd PiPi FnFn
3주 이상More than 3 weeks 균 증가Fungus increase -- 33 66 1One 22 77
균 감소Bacteria reduction -- 33 55 33 66 66
균 동일Fungus equal 1313 77 22 99 55 00
정규성Normality XX OO OO OO OO OO
p값p value -- 0.4630.463 0.8140.814 01440144 0.1230.123 0.3820.382
유의성valence -- XX XX XX XX XX
단위(연구대상자 수)Unit (Number of Research Subjects) PmPm CrCr EcEc SmSm SsSs 총 균수Total bacteria
3주 이상More than 3 weeks 균 증가Fungus increase 44 22 33 55 55 44
균 감소Bacteria reduction 99 44 55 22 66 99
균 동일Fungus equal 00 77 55 66 22 --
정규성Normality OO OO OO OO OO OO
p값p value 0.1730.173 0.6000.600 0.4010.401 0.3100.310 0.9290.929 0.0330.033
유의성valence XX XX XX XX XX OO
따라서, 본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 조성물의 치료 유효성을 평가하기 위해, 치주질환 치료 및 예방용 조성물을 섭취하기 전과 섭취한 후의 치주질환 유발 원인균의 정량수치(농도)를 분석한 결과를 종합해보면, 모든 연구대상자에서 aggregatibacter actinomycetemcomitans(Aa)는 검출되지 않았으며, 총 10개의 치주질환 유발 원인균 중에서 과반수 이상의 환자가 균 수의 감소를 보였던 것은 porphyromonas gingivalis(Pg), treponema denticola(Td), prevotella intermedia(Pi), fusobacterrium nucleatum(Fn), parvimonas micra(Pm), campylobacter rectus(Cr) 총 6개의 원인균이었다. 총 10개의 치주질환 유발 원인균 중에서 과반수 이상의 환자가 균 수의 감소를 보였던 6개의 원인균 중 Pg는 혐기성 간균이며, 급성 또는 만성 치주염과 밀접한 관계가 있으며, 성인성 치주염 환자의 치주낭에 높은 빈도로 존재하는 것으로 조사되었다. Td 는 나선균이고 치주낭의 대부분의 부위에서 검출되며 급성 진행성 치주염과 괴사 또는 궤양성 치주염과 관계가 있다고 알려져 있다. Pi 는 흑색 색소생산균이며 호르몬 관련성 치주염을 유발하며 복합 감염을 촉진한다고 알려져 있다. Fn 은 혐기성 그람 음성 세균이며 급성 괴사성 궤양성 치은염이 일어나는 부위의 거의 모든 곳에서 나선균과 함께 높은 빈도로 검출되는 것으로 알려져 있다. Pm 은 혐기성 그람 양성 구균이며 재발성 또는 난치성 치주질환과 임플란트 실패에 연관이 있다는 보고가 있다. Cr 은 혐기성 그람 음성 간균이며 치주낭 형성 및 2차 세균 감염을 유발하는 것으로 알려져 있다. 또한, 이중 Td와 Pm은 복용 후의 미생물 감소량이 통계학적 유의성도 나타내는 것으로 확인되었다.Therefore, in order to evaluate the therapeutic efficacy of the composition for treating and preventing periodontal disease according to one embodiment of the present invention, the quantitative value (concentration) of the causative agent of periodontal disease-causing bacteria before and after ingestion of the composition for treating and preventing periodontal disease According to the analysis results, no aggregatibacter actinomycetemcomitans (Aa) was detected in all the subjects, and among the 10 causes of periodontal disease, more than half of the patients showed a decrease in the number of bacteria. Td), prevotella intermedia (Pi), fusobacterrium nucleatum (Fn), parvimonas micra (Pm), and campylobacter rectus (Cr). Pg is anaerobic bacilli, closely related to acute or chronic periodontitis, and high frequency in periodontal sac of adult periodontitis patients. It was investigated. Td is a helix bacteria and is detected in most parts of periodontal pockets and is known to be associated with acute progressive periodontitis and necrosis or ulcerative periodontitis. Pi is a black pigment producing bacterium that causes hormone-related periodontitis and promotes complex infections. Fn is an anaerobic Gram-negative bacterium and is known to be detected with high frequency with helix bacteria in almost all areas where acute necrotic ulcerative gingivitis occurs. Pm is an anaerobic Gram-positive cocci and has been reported to be associated with recurrent or refractory periodontal disease and implant failure. Cr is an anaerobic Gram-negative bacillus and is known to cause periodontal pocket formation and secondary bacterial infections. In addition, it was confirmed that the amount of microbial reduction after taking Td and Pm also showed statistical significance.
결론적으로, 본 치료 유효성 평가 시험 방법에서는 PCR 방법에 의해 치주질환 원인균으로 알려진 11종류의 치주질환 유발 원인균을 분석함으로써, 기존에 배양법에서 존재했던 여러 가지 한계점을 극복할 수 있었으며, 이를 통해 더욱 객관적인 결과가 얻어질 수 있었다. 각군의 초진과 식품 복용 2주 후에 가글액을 채취해 미생물 정량 분석을 비교한 결과, 레시피 더블유(Recipe W)는 만성 치주염 환자에서 기계적인 술식에 보조적인 치료로 효과가 있는 것으로 사료된다. 따라서, 본 발명의 일 실시형태에 따른 치주질환 치료 및 예방용 조성물로 제조한 레시피 더블유(Recipe W)의 복용 후의 치은 열구액에 함유된 병원성 미생물의 균 정량 수치 감소의 의미는 치주염의 원인균의 감소로 인해 진행성 치주염의 치유에 긍정적 효과를 줄 것으로 예상된다.In conclusion, in this study, we could overcome 11 limitations of existing periodontal disease-causing bacteria known as periodontal disease-causing bacteria by PCR method, and overcome several limitations that existed in culture methods. Could be obtained. As a result of comparing the microbial quantitative analysis by collecting gargle solution two weeks after the first visit of each group and taking food, Recipe W. is considered to be effective as a mechanical treatment in chronic periodontitis patients. Therefore, the meaning of reducing the bacterial quantitative value of the pathogenic microorganisms contained in the gingival fissure after taking the recipe W prepared with the composition for treating and preventing periodontal disease according to one embodiment of the present invention is to reduce the causative agent of periodontitis. This is expected to have a positive effect on the healing of advanced periodontitis.
이상, 구현예 및 실시예를 들어 본 발명을 상세하게 설명하였으나, 본 발명은 상기 구현예들에 한정되지 않으며, 여러 가지 다양한 형태로 변형될 수 있으며, 본 발명의 기술적 사상 내에서 당 분야에서 통상의 지식을 가진 자에 의하여 여러 가지 많은 변형이 가능함이 명백하다. 또한, 청구범위에 기재된 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 당 기술분야의 통상의 지식을 가진 자에 의해 다양한 형태의 치환, 변형 및 변경이 가능할 것이며, 이 또한 본 발명의 범위에 속한다고 할 것이다.Although the present invention has been described in detail with reference to the embodiments and examples, the present invention is not limited to the above embodiments, and may be modified in various forms, and is commonly used in the art within the technical spirit of the present invention. It is evident that many variations are possible by those of skill in the art. In addition, various forms of substitution, modification, and alteration may be made by those skilled in the art without departing from the technical spirit of the present invention described in the claims, which are also within the scope of the present invention. something to do.
본 발명은 천연 추출물을 이용하여 치주질환 치료 및 예방용 조성물을 제조하였기 때문에 치과 치료와 병행하여 사용할 수 있으므로 치주질환 치료에 도움이 될 수 있고, 항생제에 의존하지 않고 장기적으로 복용할 수 있는 장점이 있는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물이므로, 장기적인 치주질환 치료 및 예방 치료에 유용하게 이용될 수 있다.The present invention can be used in combination with dental treatment because it was prepared using a natural extract for the treatment and prevention of periodontal disease can be useful in the treatment of periodontal disease, and can be taken in the long term without depending on antibiotics Since it is a composition for treating and preventing periodontal disease using a natural extract, it can be usefully used for long-term periodontal disease treatment and prophylaxis.

Claims (4)

  1. 칼슘, 아보카도 추출물, 수용성 프로폴리스 추출물, 옥수수 추출물, 계피 추출물, 엉겅퀴 추출물, 비타민 C, 비타민 B1, 비타민 B2 및 비타민 B6를 포함하여 조성되는 것을 특징으로 하는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물.Calcium, Avocado Extract, Water Soluble Propolis Extract, Corn Extract, Cinnamon Extract, Thistle Extract, Vitamin C, Vitamin B1, Vitamin B2 and Vitamin B6 Compositions for the treatment and prevention of periodontal disease using natural extracts .
  2. 청구항 1에 있어서,The method according to claim 1,
    상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물은,Composition for treating and preventing periodontal disease using the natural extract,
    칼슘 35 내지 60중량%, 아보카도 추출물 0.5 내지 7중량%, 수용성 프로폴리스 추출물 5 내지 25중량%, 옥수수 추출물 2 내지 15중량%, 계피 추출물 0.5 내지 7중량%, 엉겅퀴 추출물 2 내지 15중량%, 비타민 C 1 내지 10중량%, 비타민 B1 0.01 내지 0.3중량%, 비타민 B2 0.01 내지 0.3중량% 및 비타민 B6 0.01 내지 0.3중량%를 포함하여 조성되는 것을 특징으로 하는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물.Calcium 35-60%, Avocado Extract 0.5-7%, Water Soluble Propolis Extract 5-25%, Corn Extract 2-15%, Cinnamon Extract 0.5-7%, Thistle Extract 2-15%, Vitamin C 1 to 10% by weight, vitamin B1 0.01 to 0.3% by weight, vitamin B2 0.01 to 0.3% by weight and vitamin B6 0.01 to 0.3% by weight composition for treating and preventing periodontal disease using a natural extract, characterized in that .
  3. 청구항 1 또는 2에 있어서,The method according to claim 1 or 2,
    상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물에,In the composition for the treatment and prevention of periodontal disease using the natural extract,
    이산화규소, 스테아린산마그네슘, 결정셀룰로스 및 색상코팅제로 이루어진 첨가제군에서 어느 하나 이상을 더 첨가하여 정제 형태의 제형으로 제조되는 것을 특징으로 하는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물.Composition for the treatment and prevention of periodontal disease using natural extracts, characterized in that the addition of any one or more from the additive group consisting of silicon dioxide, magnesium stearate, crystalline cellulose and a color coating agent to form a tablet form.
  4. 청구항 3에 있어서,The method according to claim 3,
    상기 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 100중량부에 대해 첨가제군에 해당하는 이산화규소 0.1 내지 1중량부, 스테아린산마그네슘 0.1 내지 1.5중량부, 결정셀룰로스 12 내지 26중량부 및 색상코팅제 1 내지 5중량부의 비율로 더 첨가하여 정제 형태의 제형으로 제조되는 것을 특징으로 하는 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물.0.1 to 1 parts by weight of silicon dioxide, 0.1 to 1.5 parts by weight of magnesium stearate, 12 to 26 parts by weight of crystalline cellulose, and 1 to 2 parts by weight of colorant, based on 100 parts by weight of the composition for treating and preventing periodontal disease using the natural extract. Composition for the treatment and prevention of periodontal disease using natural extracts, characterized in that the addition of 5 parts by weight to prepare a dosage form.
PCT/KR2015/010428 2014-12-03 2015-10-02 Composition, using natural extracts, for treating and preventing periodontal diseases WO2016088996A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140171932A KR101517095B1 (en) 2014-12-03 2014-12-03 Periodontal diseases treatment and prevention composition using the natural extracts
KR10-2014-0171932 2014-12-03

Publications (1)

Publication Number Publication Date
WO2016088996A1 true WO2016088996A1 (en) 2016-06-09

Family

ID=53393708

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/010428 WO2016088996A1 (en) 2014-12-03 2015-10-02 Composition, using natural extracts, for treating and preventing periodontal diseases

Country Status (2)

Country Link
KR (1) KR101517095B1 (en)
WO (1) WO2016088996A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101517095B1 (en) * 2014-12-03 2015-05-04 주식회사 제이앤케이 글로벌리소스 Periodontal diseases treatment and prevention composition using the natural extracts
KR101665093B1 (en) * 2015-06-15 2016-10-12 서재원 Composition for teeth-alveolar bone and functional food containing the same
KR102141623B1 (en) * 2018-12-20 2020-08-05 동의대학교 산학협력단 Composition for prevention or treatment of dental disease comprising an extract of cinnamon
KR102441460B1 (en) * 2020-04-01 2022-09-06 김종길 Nutritional composition for pets for prevention and improvement of periodontal disease and nutritional agent manufactured thereby
KR20230052731A (en) 2021-10-13 2023-04-20 서울프로폴리스 주식회사 Wrinkle improvement functional cosmetic composition using propolis supercritical extract mixed with propolis of different origins and supercritical extract residues and manufacturing method thereof
KR20230159770A (en) 2022-05-13 2023-11-22 서울프로폴리스 주식회사 Dual functional water soluble propolis extract that strengthens immune function and blends several raw materials with different origins, and method for manufacturing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060108917A (en) * 2005-04-13 2006-10-18 최인오 Inmonsarang tooth-paste
KR101078765B1 (en) * 2009-06-26 2011-11-01 한국생명공학연구원 Edible composition for prevention of periodontal disease by growth of bacteria in the mouth
KR20140122235A (en) * 2011-12-26 2014-10-17 라보라토이레즈 익스펜사이언스 Use of whole soft avocados for preparing avocado oil rich in unsaponifiables
KR101517095B1 (en) * 2014-12-03 2015-05-04 주식회사 제이앤케이 글로벌리소스 Periodontal diseases treatment and prevention composition using the natural extracts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920011469A (en) * 1990-12-20 1992-07-24 하기주 Oral composition
AU2003252683A1 (en) * 2002-08-02 2004-04-08 Kanebo Chemical Industries, Ltd. Composition for oral use
KR101391545B1 (en) * 2013-09-09 2014-05-02 주식회사 경방 Toothpaste containing medicinal herbs and propolis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060108917A (en) * 2005-04-13 2006-10-18 최인오 Inmonsarang tooth-paste
KR101078765B1 (en) * 2009-06-26 2011-11-01 한국생명공학연구원 Edible composition for prevention of periodontal disease by growth of bacteria in the mouth
KR20140122235A (en) * 2011-12-26 2014-10-17 라보라토이레즈 익스펜사이언스 Use of whole soft avocados for preparing avocado oil rich in unsaponifiables
KR101517095B1 (en) * 2014-12-03 2015-05-04 주식회사 제이앤케이 글로벌리소스 Periodontal diseases treatment and prevention composition using the natural extracts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WOO, JIN O ET AL.: "Recipe W- Effect of Adjuvant to Periodontal disease", GYEONGSANGNAM-DO DENTAL ASSOCIATION 2014 CONFERENCE, 22 June 2014 (2014-06-22) *

Also Published As

Publication number Publication date
KR101517095B1 (en) 2015-05-04

Similar Documents

Publication Publication Date Title
WO2016088996A1 (en) Composition, using natural extracts, for treating and preventing periodontal diseases
KR900006885B1 (en) Active oxygen suppressive compound
Forouzanfar Review of the therapeutic effects of Camellia sinensis (green tea) on oral and periodontal health
US6814958B1 (en) Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis
US20090110674A1 (en) Health supplement
US5925335A (en) Dental formulation
US6207137B1 (en) Dental formulation
KR20090129490A (en) Extract of trigonella foenum-graecum
KR101704589B1 (en) Composition comprising extracts of Magnolia flower and Magnolia officinlis for preventing or treating periodentitis as an active ingredient
KR102441460B1 (en) Nutritional composition for pets for prevention and improvement of periodontal disease and nutritional agent manufactured thereby
CN102858308A (en) Toothpaste composition for tooth health
Kaur et al. Micronutrients and bioactive compounds in oral inflammatory diseases
DE10321725A1 (en) Enzyme-containing compositions, dietetic foods and pharmaceuticals made therefrom and their use for medical purposes
US20040214750A1 (en) Medicaments for healing skin conditions in humans
US20080085330A1 (en) Compounds for stimulating stem cell proliferation including spirulina
CN110384725B (en) A Chinese medicinal composition for regulating oral flora and preparation method of active extract thereof
CA2441940A1 (en) Dental formulation
CN105920202A (en) Coenzyme Q10 gum for protecting teeth, strengthening brain and removing odor
KR102207872B1 (en) Oral composition for preventation or treatment of oral disease
KR100431170B1 (en) Compositions for Dental Clinic Comprising Extracts of Plant
JP2009263332A (en) Medicine containing olive leaf extract for maintaining health of periodontium
KR102572961B1 (en) Compositions for preventing, improving or treating periodontal disease containing dendropanax morbifera lev. extracts
JP2003024010A (en) Function-enhancing supplementary food comprising as main ingredient green tea catechin
Nair et al. Green tea: a friendly oral beverage
US20080089905A1 (en) COMPOUNDS FOR STIMULATING STEM CELL PROLIFERATION INCLUDING AFA-OMEGA (EtOH)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15865738

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15865738

Country of ref document: EP

Kind code of ref document: A1